JP2001149087A - HETEROTROPHIC PRODUCTION OF MICROBIAL PRODUCT CONTAINING ω-3 HIGHLY UNSATURATED FATTY ACID AT HIGH CONCENTRATION - Google Patents

HETEROTROPHIC PRODUCTION OF MICROBIAL PRODUCT CONTAINING ω-3 HIGHLY UNSATURATED FATTY ACID AT HIGH CONCENTRATION

Info

Publication number
JP2001149087A
JP2001149087A JP2000297654A JP2000297654A JP2001149087A JP 2001149087 A JP2001149087 A JP 2001149087A JP 2000297654 A JP2000297654 A JP 2000297654A JP 2000297654 A JP2000297654 A JP 2000297654A JP 2001149087 A JP2001149087 A JP 2001149087A
Authority
JP
Japan
Prior art keywords
fatty acids
schizochytrium
atcc
microorganisms
thraustochytrium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000297654A
Other languages
Japanese (ja)
Other versions
JP4187133B2 (en
Inventor
William R Barclay
アール ハークレイ、ウィリアム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Martek Biosciences Boulder Corp
Original Assignee
OmegaTech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27031913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2001149087(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by OmegaTech Inc filed Critical OmegaTech Inc
Publication of JP2001149087A publication Critical patent/JP2001149087A/en
Application granted granted Critical
Publication of JP4187133B2 publication Critical patent/JP4187133B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6432Eicosapentaenoic acids [EPA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07Soya beans, e.g. oil-extracted soya bean flakes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/40Meat products; Meat meal; Preparation or treatment thereof containing additives
    • A23L13/42Additives other than enzymes or microorganisms in meat products or meat meals
    • A23L13/43Addition of vegetable fats or oils; Addition of non-meat animal fats or oils; Addition of fatty acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/50Poultry products, e.g. poultry sausages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00Egg products; Preparation or treatment thereof
    • A23L15/20Addition of proteins, e.g. hydrolysates, fats, carbohydrates, natural plant hydrocolloids; Addition of animal or vegetable substances containing proteins, fats, or carbohydrates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/40Shell-fish
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/09Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L25/00Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
    • A23L25/30Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/10Production of fats or fatty oils from raw materials by extracting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6434Docosahexenoic acids [DHA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6472Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish
    • Y02A40/818Alternative feeds for fish, e.g. in aquacultures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/946Microorganisms using algae

Abstract

PROBLEM TO BE SOLVED: To provide a method of preparing an edible product for animal or the like by formulating a microorganism or the like selected from the group consisting of microorganisms belonging to the order Thraustochytriale, a ω-3 highly unsaturated fatty acid (ω-3 HUFA) extracted from the microorganism and these mixtures to a food. SOLUTION: This edible product is prepared by formulating the microorganism or the extracted ω-3 HUFA selected from the group consisting of microorganisms belonging to the order Thraustochytriale, the ω-3 HUFA extracted from the microorganism and these mixtures to an edible substance. As an actual example of the edible substance, a food for animal or a food for human being is illustrated and it is suitable to formulate an antioxidant to this edible product. Further, as an actual example of the above group, Thraustochytrium, Schizochytrium or the ω-3 HUFA extracted from Thraustochytrium is illustrated.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】関連出願との相互関係 この出願は、1989年11月17日に出願され、「ω
-3高度不飽和脂肪酸を高濃度で含む微生物産物のヘテ
ロトロピックな製造方法」との名称の、共に係属中のか
つ共通の譲渡人の米国特許出願第07/439,093号
の一部継続出願である。原出願は、その全体を本明細書
中に参照として組み入れるものであり、また、先に明示
的に放棄された1988年9月7日に出願され、「ω-
3高度不飽和脂肪酸を高濃度で含む微生物産物のヘテロ
トロピックな製造方法」との名称の、米国特許出願第0
7/241,410号の一部継続出願である。
[0001]Interaction with related applications  This application was filed on November 17, 1989,
-3 Microbial products containing high levels of polyunsaturated fatty acids
Are pendant together under the name "Rotropic manufacturing method"
Common Assignee U.S. Patent Application Serial No. 07 / 439,093
Is a continuation-in-part application. The original application is incorporated herein in its entirety.
Incorporated by reference in
Was filed on September 7, 1988, which was abandoned, and "ω-
3 Heterologous products of microbial products containing high levels of polyunsaturated fatty acids
US Patent Application No. 0, entitled "Tropic Manufacturing Method"
It is a continuation-in-part application of 7 / 241,410.

【0002】[0002]

【発明の属する技術分野】本発明の分野は、ヘテロトロ
ピック(従属栄養的)生物及び、食品添加物として人間
や動物が消費するのに好適な、あるいは薬学的、工業的
製品中で使用するのに好適なω-3高度不飽和脂肪酸
(HUFA)を高濃度で含む脂質を製造するために該生
物を培養する方法に関する。
The field of the invention is that of heterotrophic (heterotrophic) organisms and that they are suitable for human or animal consumption as food additives or for use in pharmaceutical and industrial products. The present invention relates to a method for culturing an organism for producing a lipid containing a high concentration of ω-3 polyunsaturated fatty acid (HUFA), which is suitable for the present invention.

【0003】本発明の説明において、「ATCC番号」
とは、アメリカ合衆国メリーランド州ロックビルの the
American Type Culture Collection(ATCC)
に寄託された株の受託番号を意味しており、文中、「A
TCC番号XXXXX」は、特に説明されていない限
り、ATCCに寄託された株のうちの受託番号XXXX
Xの株を指す。
In the description of the present invention, "ATCC number"
The Rockville, Maryland, United States
American Type Culture Collection (ATCC)
Means the accession number of the strain deposited at
TCC No. XXXXXX ”is the accession number XXXX of the strains deposited with the ATCC unless otherwise indicated.
X refers to the strain.

【0004】[0004]

【従来の技術】ω-3高度不飽和脂肪酸は、動脈硬化症
及び冠状動脈心疾患の予防、炎症状態の軽減、並びに腫
瘍細胞の増殖抑制のための重要な食餌療法用化合物とし
て近年認識されてきており、工業的に多大な興味をもた
れている。これらの有益な効果は、ω-3高度不飽和脂
肪酸がω-6脂肪酸から合成される化合物の競争的阻害
を引きおこすこと及び、ω-3高度不飽和脂肪酸それ自
体から直接合成される有益化合物の両者によりもたらさ
れる(Simopoulos 他, 1986)。ω-6脂肪酸は植物及び
動物中で見出される主な高度不飽和脂肪酸である。近
年、ω-3高度不飽和脂肪酸の商業的な食用物として入
手源は唯一ある種の魚油からであり、この魚油はこれら
の脂肪酸を20〜30%まで含み得る。これらの脂肪酸
の有益な効果は、週に数回魚を食べるか、あるいは濃縮
魚油を毎日摂取することによって得ることができる。こ
のため多量の魚油が毎年、食用補助剤として販売するた
めに加工され、カプセル化されている。
BACKGROUND OF THE INVENTION Omega-3 polyunsaturated fatty acids have recently been recognized as important dietary compounds for preventing arteriosclerosis and coronary heart disease, reducing inflammatory conditions, and inhibiting tumor cell proliferation. And is of great industrial interest. These beneficial effects are that ω-3 polyunsaturated fatty acids cause competitive inhibition of compounds synthesized from ω-6 fatty acids and that beneficial compounds synthesized directly from ω-3 polyunsaturated fatty acids themselves. Produced by both (Simopoulos et al., 1986). ω-6 fatty acids are the main highly unsaturated fatty acids found in plants and animals. In recent years, the only commercially available source of omega-3 polyunsaturated fatty acids as commercial food is from certain fish oils, which can contain up to 20-30% of these fatty acids. The beneficial effects of these fatty acids can be obtained by eating fish several times a week or by taking concentrated fish oil daily. For this reason, large quantities of fish oil are processed and encapsulated each year for sale as edible supplements.

【0005】しかしながら、これらの魚油補助剤にはい
くつかの重大な問題がある。第一に、これらには天然に
魚油中に見いだされる脂溶性ビタミンが高濃度に含まれ
ている。摂取すると、これらのビタミンは、尿中に排泄
されるよりもむしろ、人間の脂肪中に蓄積され、代謝さ
れる。これらのビタミンを大量に与えると、腎臓障害や
失明もたらす点で、安全性に問題があり、いくつかのア
メリカの医学会が実際の魚よりもむしろカプセル補助剤
を用いることに対して警告を発している。第二に、魚油
は飽和脂肪酸及びω-6脂肪酸を80%まで含有してお
り、これら両方の脂肪酸は健康上、悪い影響をもたらし
得る。そのうえ、魚油は強烈な魚の味と臭いを持ってお
り、そのままでは食用製品の味に悪い影響を与えること
なく、食品添加物として加工食品に添加することはでき
ない。さらに、この混合物から純粋なω-3高度不飽和
脂肪酸の単離は、高価なプロセスを含んでいるため、こ
れらの脂肪酸の純品は高価格(200〜1000ドル/
g)となっている(Sigma Chemical Co., 1988; CalBio
chem Co., 1987)。
[0005] However, these fish oil supplements have several significant problems. First, they contain high levels of fat-soluble vitamins found naturally in fish oil. Upon ingestion, these vitamins accumulate and metabolize in human fat, rather than being excreted in urine. Large doses of these vitamins have safety implications in causing kidney damage and blindness, and some American medical communities have warned against using capsule supplements rather than real fish. ing. Second, fish oil contains up to 80% saturated and ω-6 fatty acids, both of which can have adverse health effects. In addition, fish oil has an intense fish taste and smell and cannot be added to processed foods as a food additive as it is without adversely affecting the taste of edible products. Furthermore, the isolation of pure ω-3 polyunsaturated fatty acids from this mixture involves an expensive process, so that pure products of these fatty acids are expensive ($ 200-1000 /
g) (Sigma Chemical Co., 1988; CalBio
chem Co., 1987).

【0006】魚油中のω-3高度不飽和脂肪酸の天然源
は藻類である。これらの高度不飽和脂肪酸は光合成膜の
重要な成分である。ω-3高度不飽和脂肪酸は食物連鎖
中に蓄積され、最終的に魚油中に取り込まれる。バクテ
リヤや酵母はω-3高度不飽和脂肪酸を合成することは
できず、二、三のカビが微量のω-3高度不飽和脂肪酸
を産生し得ることが知られているのみである(Weete, 1
980; Wassef, 1977;Erwin, 1973)。
[0006] The natural source of ω-3 polyunsaturated fatty acids in fish oil is algae. These polyunsaturated fatty acids are important components of the photosynthetic membrane. ω-3 polyunsaturated fatty acids accumulate in the food chain and are eventually incorporated into fish oil. Bacteria and yeasts cannot synthesize ω-3 polyunsaturated fatty acids, only a few molds are known to be able to produce trace amounts of ω-3 polyunsaturated fatty acids (Weete, 1
980; Wassef, 1977; Erwin, 1973).

【0007】藻類は、バイオマスを含むω-3高度不飽
和脂肪酸を含有する多種の産物を光合成栄養的に生産す
るため戸外培養池で生育されている。例えば、米国特許
第4,341,038号には藻類から油の光合成的な製造
方法が記載されており、また米国特許第4,615,83
9号には緑藻類クロレラの数種によって光合成的に製造
されるエイコサペンタエン酸(ω-3高度不飽和脂肪酸
の一種)の濃縮方法が記載されている。光合成栄養法
は、光をエネルギー源として使用して、細胞が光合成プ
ロセスにより二酸化炭素と水から有機化合物を構築する
プロセスのことである。太陽光がこのタイプの産生系の
ドライビングホース(駆動力)であるので、藻類培養池
が、経済的に成り立つためには、大表面積(広い土地)
を必要とする。規模が大きいため、コストが高くつきま
た技術的に問題があるので、これらの系を経済的にカバ
ーすることは不可能である。さらに、たとえ透明なカバ
ーであっても、太陽光のかなりの部分をブロックしやす
いという問題もある。したがって、このような生産シス
テムは無菌的ではなく、単一培養として維持するのは難
しい。このことは、培養において所望の産物を生産する
のに操作したり、ストレスをかけたり(例えば窒素量を
制限する)することが必要な場合には、特に重大な問題
となる。典型的には、不純物が培養系に容易に侵入する
のは、細胞が産物のみを生産し、増殖しない、ストレス
下にあるこのこの期間である。そこで、多くの場合、産
生されたバイオマスは、脂質を回収するためにコストの
かかる抽出プロセスを経ずには、人間が消費するための
食品添加物としては望ましいものとはならない。そのう
え、戸外系での藻類の光合成的生産は非常にコストがか
かる。これは、栽培系への入力光の減少を避けるため
に、低密度(1〜2g/l)に培養系を維持しなくてはな
らないからである。この結果、少量の藻類を回収するの
に大量の水を処理する必要があり、また、藻類細胞は大
変小さいので、コストのかかる採集プロセスを使用しな
くてはならない。
[0007] Algae are grown in outdoor culture ponds to produce a variety of products containing ω-3 polyunsaturated fatty acids, including biomass, phototrophically. For example, U.S. Pat. No. 4,341,038 describes a photosynthetic process for producing oil from algae, and U.S. Pat. No. 4,615,83.
No. 9 describes a method for concentrating eicosapentaenoic acid (a type of ω-3 highly unsaturated fatty acid) photosynthetically produced by several types of green alga Chlorella. Phototrophic is the process by which cells use light as an energy source to build organic compounds from carbon dioxide and water through a photosynthetic process. Since sunlight is the driving hose (driving force) for this type of production system, a large surface area (large land) is required for the algae culture pond to be economically viable.
Need. The large scale, high cost and technical problems make it impossible to cover these systems economically. Another problem is that even a transparent cover can easily block a significant portion of sunlight. Therefore, such production systems are not aseptic and are difficult to maintain as a single culture. This is a particularly serious problem when it is necessary to manipulate or stress (eg, limit the amount of nitrogen) to produce the desired product in culture. Typically, it is during this period of stress that the cells readily produce products and do not proliferate, and the impurities readily enter the culture system. Thus, in many cases, the biomass produced is not desirable as a food additive for human consumption without a costly extraction process to recover the lipids. Moreover, the photosynthetic production of algae in open-air systems is very costly. This is because the culture system must be maintained at a low density (1-2 g / l) in order to avoid a decrease in the input light to the culture system. As a result, large volumes of water must be treated to recover small algae, and the algal cells are so small that costly harvesting processes must be used.

【0008】混合栄養法は生産の別法であり、この方法
では藻類のある種の株が必要なエネルギー源として光を
用いて光合成を行うが、付加的に系中に有機化合物を供
給する。混合栄養法によってより高密度化を達成するこ
とができ、培養を無菌生産用の密閉反応器中で維持する
ことができる。米国特許第3,444,647号及び第
3,316,674号に、藻類の混合栄養的生産方法が記
載されている。しかしながら、培養基に光を供給する必
要があるため、このタイプの生産反応器は建造及び操作
が極めて高価であり、しかも培養密度は依然として非常
に制限されている。
Mixed nutrition is an alternative method of production in which certain strains of algae perform photosynthesis using light as the required energy source, but additionally supply organic compounds into the system. Densification can be achieved by mixed nutrients and the culture can be maintained in a closed reactor for aseptic production. U.S. Pat. Nos. 3,444,647 and 3,316,674 describe mixed nutritional production of algae. However, due to the need to supply light to the culture medium, this type of production reactor is very expensive to build and operate, and the culture density is still very limited.

【0009】ω-3高度不飽和脂肪酸生産のための藻類
の培養におけるもう一つの問題は、ω-3高度不飽和脂
肪酸がある株の全脂肪酸の20〜40%を構成するとし
ても、これらの藻類の全脂肪酸含量は一般に極めて低
く、灰分を除いた乾燥重量の5〜10%程度であること
である。細胞の脂肪酸含量を増大させるために、脂質の
産生を刺激する窒素量制限期間を設けなくてはならな
い。しかしながら、これまでに文献に記載されたすべて
の株のうち、本発明者が評価した60以上の株におい
て、すべての株が窒素制限下において全脂肪酸中のパー
セントとしてω-3高度不飽和脂肪酸の顕著な減少をも
たらした(Erwin, 1973; Pohl & Zurheide, 1979)。
Another problem in algae culture for the production of ω-3 polyunsaturated fatty acids is that even though ω-3 polyunsaturated fatty acids constitute 20-40% of the total fatty acids of a strain, these The total fatty acid content of algae is generally very low, about 5 to 10% of the dry weight excluding ash. In order to increase the fatty acid content of the cells, there must be a nitrogen limitation period that stimulates lipid production. However, of all the strains described so far in the literature, of the 60 or more strains evaluated by the present inventors, all strains showed the percentage of ω-3 highly unsaturated fatty acids as a percentage of total fatty acids under nitrogen limitation. Resulted in a significant decrease (Erwin, 1973; Pohl & Zurheide, 1979).

【0010】経済性及びω-3高度不飽和脂肪酸の食品
添加物としての使用の観点からは、これらの脂肪酸をヘ
トロトロピック培地中で生産することが望ましいであろ
う。ヘテロトロピー(従属栄養)とは、暗所での持続的
かつ連続的な生育及び細胞分裂のための能力のことであ
り、細胞炭素は唯一有機化合物の代謝で得られる。光を
ヘテロトロピック培地に供給する必要はないので、密閉
反応器中極めて高密度で培養物を生育することができ
る。ヘテロトロピック生物とは、エネルギー及び細胞炭
素を有機基質から得る生物のことであり、暗所で増殖で
きる。ヘテロトロピック条件とは、光が存在するしない
にかかわらず、ヘテロトロピック生物が生長できる条件
のことである。しかしながら、藻類のほぼ大部分は、主
として光合成栄養的であり、ほんの二、三のヘテロトロ
ピック藻類が知られているにすぎない。米国特許第3,
142,135号及び第3,882,635号に、クロレ
ラ(Chlorella)、スポンジオコクム(Spongiococcum)、
及びプロトセカ(Prototheca)のような藻類からのタン
パク質及び色素のヘテロトロピックな生産方法が記載さ
れている。しかしながら、従属栄養的に非常に良好に生
長すると記されているこれらの属及び他のもの(例え
ば、セネデスムス(Scenedosmus))は、ω-3高度不飽
和脂肪酸を産生しない(Erwin, 1973)。多少なりともω
-3高度不飽和脂肪酸を産生することが知られている極
めて少数のヘテロトロピック藻類(例えば、アポクロロ
ティック珪藻又はアポクロロティック双鞭毛藻類)は、
一般に生長が遅く、灰分を除いた乾燥重量の数%という
少ない量のω-3高度不飽和脂肪酸を産生する(Harring
ton と Holfz, 1968; Tornabene 他、1974)。
From the viewpoint of economy and the use of ω-3 polyunsaturated fatty acids as food additives, it would be desirable to produce these fatty acids in a heotropic medium. Heterotropic (heterotrophic) refers to the capacity for sustained and continuous growth and cell division in the dark, with cellular carbon being obtained solely through the metabolism of organic compounds. Because light need not be supplied to the heterotrophic medium, cultures can be grown at very high density in a closed reactor. Heterotropic organisms are organisms that obtain energy and cellular carbon from organic substrates and can grow in the dark. Heterotropic conditions are those conditions under which heterotrophic organisms can grow regardless of the presence or absence of light. However, almost all algae are mainly phototrophic, and only a few heterotrophic algae are known. U.S. Patent No. 3,
Nos. 142,135 and 3,882,635 describe Chlorella, Spongiococcum,
And methods for heterotrophic production of proteins and pigments from algae such as Prototheca. However, these genera and others (for example, Scenedosmus), which are described as heterotrophically growing very well, do not produce ω-3 polyunsaturated fatty acids (Erwin, 1973). More or less ω
Very few heterotrophic algae known to produce -3 highly unsaturated fatty acids (eg, apochlorotic diatoms or apochlorotic diflagellates)
It is generally slow growing and produces small amounts of ω-3 polyunsaturated fatty acids, only a few percent of its dry weight excluding ash (Harring
ton and Holfz, 1968; Tornabene et al., 1974).

【0011】二、三の高級菌類がω-3高度不飽和脂肪
酸を産生することが知られているが、これらは細胞中で
全脂肪酸のほんの少ない部分を構成するにすぎない(Er
win,1973; Wassef, 1977; Weete, 1980)。このよう
に、それらはω-3高度不飽和脂肪酸の工業的生産の良
い候補とは考えられない。例えば、ヤマダら(1987)は
最近、ω-6脂肪酸、アラキドン酸の生産のために、い
くつかの種の細菌、クサレケカビ(Morfierella)(土壌
より単離)の培養について報告している。これらの細菌
は、低温(5〜24℃)で生育すると、アラキドン酸と
共に、ω-3エイコサペンタエン酸をも少量産生する。
しかしながら、得られるエイコサペンタエン酸の含量
は、細胞の乾燥重量のわずか2.6%にすぎず、これら
の種の中でこの脂肪酸の産生を促進するのに必要な低い
温度は、培養系の産生能(及び経済性)の大巾な減少を
もたらす。
A few higher fungi are known to produce ω-3 highly unsaturated fatty acids, which make up only a small fraction of total fatty acids in cells (Er
win, 1973; Wassef, 1977; Weete, 1980). Thus, they are not considered good candidates for industrial production of ω-3 polyunsaturated fatty acids. For example, Yamada et al. (1987) recently reported the culture of several bacteria, Morfierella (isolated from soil), for the production of ω-6 fatty acids, arachidonic acid. When grown at low temperatures (5-24 ° C.), these bacteria produce small amounts of ω-3 eicosapentaenoic acid along with arachidonic acid.
However, the resulting eicosapentaenoic acid content is only 2.6% of the dry weight of the cells, and the low temperature required to promote the production of this fatty acid in these species depends on the production of the culture system. Resulting in a significant reduction in performance (and economy).

【0012】トロウストチトリアレ目の単細胞類のいく
つかも、ω-3高度不飽和脂肪酸を産生することが知ら
れている(Ellenbogen, 1969; Wassef, 1977; Weete,
1980; Findlay 他、1986)が、これらは培養するのが
難しいとされている。Sparrow (1960) はトロウストチ
トリアセ族(トロウストチトリアレ目)の葉状体 (thal
li) の微小さと単純な性質が、増殖を極めて困難なもの
にしていると述べている。この困難さの他の理由が Eme
rson (1950) によって大まかに挙げられ、Schneider (1
976) によってまとめられている: 「 1) これらの菌類
はただ1個か数個の細胞の非常に小さな葉状体から成っ
ており、一般に極めて生長が遅く、環境の変化に極めて
敏感である; 2) それらは一般に極めて特殊な栄養上及
び環境上の必要を有する腐生植物か寄生植物である;
3) 純粋な培地中で、それらは一般に、二、三世代で終
わってしまう栄養増殖という、限られた増殖を示す。」
(いくつかの先行文献はトロウストチトリドを菌類とし
て分類しているが、最新の共通認識においては、藻類と
して分類すべきだとされている。以下の記載を参照のこ
と)。その結果、これらの微生物の数多くの目に対して
ほとんど注意が向けられていない。これまでになされた
研究は、主として分類学的及び生態学的な観点からなさ
れている。例えばトロウストチトリアレのいくつかの構
成菌が単純な脂肪酸分布をもっていることが混合栄養的
見地から報告されているけれども(Ellenbogen, 1969;
Findlay 他、1986)、その全脂肪酸含量あるいは脂質含
量の乾燥重量パーセントとしての報告はまったくない。
全脂質含量についてのデータが手に入らない限り、任意
のタイプの脂肪酸の生産への使用について、ある生物の
能力を評価することはできない。例えば、いくつかの海
洋性大藻類(海藻類)の脂質中のω-3高度不飽和脂肪
酸含量は全脂肪酸の51%にも達して非常に高いと報告
されている(Pohl とZurheide, 1979)。しかしながら、
大藻類の脂質含量は一般に少なく、細胞の乾燥重量の1
〜2%にすぎない(Ryther, 1983)。したがって、大藻
類の脂肪酸中でのω-3高度不飽和脂肪酸の含量は高い
と報告されているにもかかわらず、ω-3高度不飽和脂
肪酸の生産のための候補となる生物としては、不適格と
考えられる。本発明者による熱心な探索にもかかわら
ず、トロウストチトリアレの簡単なおよその分析(タン
パク質、炭水化物、及び脂質の%)報告は見い出され
ず、その分類学、生理活性あるいは生態学についての実
験室的な研究以外の目的でこれらの種を培養する試みは
全く報告されていない。さらに、これらの微生物の多く
の種は、簡単なポーレンバイティング(pollen baitin
g)法によって単離されている(例えば、Gaertner, 196
8)。ポーレンバイティング法はトロウストチトリアレの
構成員に極めて特異的ではあるが、微生物の大規模培養
に望ましい任意の特徴について選択するものではない。
Some single cells of the order Thraustochytriales are also known to produce ω-3 highly unsaturated fatty acids (Ellenbogen, 1969; Wassef, 1977; Weete,
1980; Findlay et al., 1986), which make these difficult to culture. Sparrow (1960) is a frond of the Thraustochytriaceae
li) 's small size and simple nature make proliferation extremely difficult. Another reason for this difficulty is Eme
rson (1950)
976): "1) These fungi consist of very small fronds of only one or a few cells and are generally very slow growing and very sensitive to environmental changes; 2 ) They are generally saprophytic or parasitic plants with very specific nutritional and environmental needs;
3) In pure media, they generally show limited growth, vegetative growth that ends in a few generations. "
(Some prior references classify troost titride as a fungus, but the latest consensus states that it should be classified as an algae; see below). As a result, little attention has been paid to the numerous eyes of these microorganisms. The work done so far has been mainly based on taxonomic and ecological aspects. For example, it has been reported from a mixed nutritional point of view that some constituents of troost chitriale have a simple fatty acid distribution (Ellenbogen, 1969;
Findlay et al., 1986), there is no report of its total fatty acid or lipid content as a dry weight percent.
Unless data on total lipid content is available, the ability of an organism to be used for the production of any type of fatty acid cannot be assessed. For example, the ω-3 polyunsaturated fatty acid content in lipids of some marine macroalgae (sea algae) has been reported to be very high, up to 51% of total fatty acids (Pohl and Zurheide, 1979). . However,
The algae generally have a low lipid content and are 1% of the dry weight of the cells.
Only ~ 2% (Ryther, 1983). Thus, despite the reported high content of ω-3 polyunsaturated fatty acids in the fatty acids of macroalgae, the candidate organisms for the production of ω-3 polyunsaturated fatty acids are not Deemed eligible. Despite the intense search by the inventor, no simple approximate analysis (% protein, carbohydrates and lipids) of troost chitriale was found and a laboratory for its taxonomy, bioactivity or ecology. No attempt has been made to culture these species for purposes other than classical research. In addition, many species of these microorganisms have a simple pollen bait (pollen baitin).
g) method (eg, Gaertner, 196
8). The pollen biting method is very specific to members of the Troost chitriale, but does not select for any characteristics desired for large-scale culture of microorganisms.

【0013】このように、本発明に至まで、ω-3高度
不飽和脂肪酸を実用的なレベルで産生する培養に適した
ヘテロトロピックな生物は知られておらず、このような
生物は自然環境中には極めて希であると考えられてい
た。
As described above, up to the present invention, no heterotrophic organism suitable for cultivation that produces ω-3 highly unsaturated fatty acids at a practical level has been known, and such an organism is known as a natural environment. Some were considered extremely rare.

【0014】[0014]

【発明が解決しようとする課題】本発明は、ヘテロトロ
ピック(従属栄養的)生物及び、食品添加物として人間
や動物が消費するのに好適な、あるいは薬学的、工業的
製品中で使用するのに好適なω-3高度不飽和脂肪酸
(HUFA)を高濃度で含む脂質を効果的に製造するた
めの該生物並びにそれを培養する方法およびそれを用い
た食用製品を提供しようとするものである。
The present invention relates to heterotrophic (heterotrophic) organisms and to their use in humans and animals as food additives or for use in pharmaceutical and industrial products. The object of the present invention is to provide an organism for effectively producing a lipid containing a high concentration of ω-3 polyunsaturated fatty acids (HUFA), which is suitable for the organism, a method for culturing the organism, and an edible product using the same. .

【0015】[0015]

【課題を解決するための手段】本発明は、その大部分が
ω-3高度不飽和脂肪酸である脂肪酸を高濃度で有する
微生物を含むω-3高度不飽和脂肪酸(HUFA)を高
濃度で含有する食用製品に関する。さらに、あるいは、
別に、この食用製品は微生物から抽出したω-3HUF
Aを含み得る。特に、その微生物はトロウストチトリア
レつまりトロウストチトリウム又はシゾチトリウムであ
る。微生物又は抽出したω-3HUFAは添加用の食品
材料(食用物質)に加えられる。この食品材料は動物用
食品や人間用食品のどちらでもよい。本発明の食用製品
は微生物の細胞を破壊することにより、その中に含まれ
るω-3HUFAの生物学的利用性を増大させてもよ
い。食用製品はまた、押出し加工してもよい。ω-3H
UFAの劣化を防止するために、食用製品は非酸化性条
件下に包装してもよく、あるいはさらに抗酸化剤をふく
んでいてもよい。
SUMMARY OF THE INVENTION The present invention comprises high concentrations of ω-3 polyunsaturated fatty acids (HUFA), including microorganisms having a high concentration of fatty acids, most of which are ω-3 polyunsaturated fatty acids. Edible products. In addition, or
Separately, this edible product is ω-3HUF extracted from microorganisms
A. In particular, the microorganism is Thraustochytriale or Thraustochytrium or Schizochytrium. The microorganism or the extracted ω-3HUFA is added to the food material (edible substance) for addition. This food material may be either animal food or human food. The edible product of the present invention may increase the bioavailability of ω-3 HUFA contained therein by destroying microbial cells. The edible product may also be extruded. ω-3H
To prevent UFA degradation, the edible product may be packaged under non-oxidizing conditions or may further contain an antioxidant.

【0016】本発明の他の態様は、動物にトロウストチ
トリウム又はそれから抽出したω-3HUFAを食べさ
せることを含む動物の飼育方法に関する。本発明の方法
で飼育する動物としては、家禽類、牛、豚及び魚、エ
ビ、貝などの海洋生物が挙げられる。ω-3HUFA
は、これらの動物の肉、卵及び他の製造中に取り込まれ
る。ω-3HUFAは、全細胞微生物製品、抽出ω-3H
UFA製品、又はω-3HUFAを取り込んだ動物もし
くは動物製品の形で消費される。本発明に従って生産さ
れるω-3HUFAを人間がより多く摂取すると、心血
管疾患、炎症、及び/又は免疫学的疾患、並びに癌の予
防もしくは治療に効果的である。
[0016] Another aspect of the present invention relates to a method of breeding an animal, comprising feeding the animal with Troost thytrium or ω-3HUFA extracted therefrom. Animals bred by the method of the present invention include marine organisms such as poultry, cattle, pigs and fish, shrimp and shellfish. ω-3HUFA
Is incorporated during the production of meat, eggs and other of these animals. ω-3HUFA is a whole cell microbial product, extracted ω-3H
Consumed in the form of a UFA product, or an animal or animal product incorporating ω-3HUFA. The higher the human consumption of ω-3HUFA produced according to the present invention, the more effective it is at preventing or treating cardiovascular diseases, inflammation and / or immunological diseases, and cancer.

【0017】本発明のさらに他の態様は、培養基中で、
有機性炭素源と同化しうる窒素源と共にトロウストチト
リアレを培養することを含む、ω-3HUFAの生産方
法である。好ましくは、有機性炭素源と同化しうる窒素
源は粉砕穀物からなる。この方法はさらに、トロウスト
チトリウム、シゾチトリウム又はこれらの混合物からな
るトロウストチトリアレを、栄養制限条件下もしくは窒
素制限条件下に、効果的な時間のあいだ、好ましくは約
6〜24時間培養し、ついでトロウストチトリアレを微
生物中のω-3HUFAの濃度を高めるために窒素制限
期間のあいだに、収穫することを含む。この方法はさら
に、ω-3HUFAの劣化を防止するために、収穫後の
加工中に、BHT,BHA,TBHQ、エトキシキュイ
ン、β-カロチン、ビタミンE、及びビタミンCからな
る群から選択される抗酸化剤を添加することを含む。こ
の方法はさらに、培養中に低温として微生物にストレス
をかけること、培養中に培地を高溶存酵素濃度に維持す
ること、並びに微生物の持続的な生長をもたらすために
有効量のリン及び微生物生長因子(酵母エキスあるいは
コーン浸漬液)を培地に加えることを含む。本方法はさ
らに、ATCC番号20888,20889,2089
0,20891,20892及びこれら由来の変異株と
同様な特性を有する単細胞微生物を培養することを含
む。これらの方法で生産されたω-3HUFAは次いで
微生物から抽出された脂質から分別結晶法により単離し
得る。この方法は、微生物細胞を破砕し、破砕細胞から
脂質混合物を溶媒で抽出し、脂質混合物を加水分解し、
不ケン化化合物を除去し、さらに脂質混合物中の非HU
FAを冷時結晶化することを含む。
[0017] Still another embodiment of the present invention provides a method comprising:
A method for producing ω-3 HUFA, comprising culturing Troost titriale with a nitrogen source that can be assimilated with an organic carbon source. Preferably, the nitrogen source that can be assimilated with the organic carbon source consists of ground grains. The method further comprises culturing Troost titriale consisting of Troost titorium, Schizochytrium or a mixture thereof under nutrient-restricted or nitrogen-restricted conditions for an effective time, preferably for about 6 to 24 hours, This involves then harvesting the Troost titriale during a nitrogen limitation period to increase the concentration of omega-3 HUFA in the microorganism. The method further comprises, during post-harvest processing, an antioxidant selected from the group consisting of BHT, BHA, TBHQ, ethoxycuin, β-carotene, vitamin E, and vitamin C to prevent degradation of ω-3HUFA. Including adding an oxidizing agent. The method further comprises stressing the microorganism at a low temperature during the culture, maintaining the medium at a high dissolved enzyme concentration during the culture, and an effective amount of phosphorus and a microbial growth factor to provide sustained growth of the microorganism. (Yeast extract or corn immersion liquid) to the culture medium. The method further comprises ATCC numbers 20888, 20889, 2089.
0, 20891, 20892 and mutants derived therefrom, including culturing unicellular microorganisms having similar properties. Ω-3 HUFA produced by these methods can then be isolated by fractional crystallization from lipids extracted from microorganisms. This method disrupts microbial cells, extracts the lipid mixture from the disrupted cells with a solvent, hydrolyzes the lipid mixture,
Remove unsaponifiable compounds and remove non-HU in the lipid mixture
Including cold crystallization of the FA.

【0018】本発明の別の態様は、ヘテロトロピックな
増殖が可能であり、またω-3HUFAを産生し得る水
中で生息する単細胞微生物を選択する方法である。この
方法は、天然由来の浅い海水の生息地から収集した微生
物の小集団から約1μm〜25μmの間のサイズの微生物
を選択し、有機性炭素、同化しうる窒素、同化しうるリ
ン、及び微生物生長因子を含む培養基中、ヘテロトロピ
ック条件下で微生物を培養し、ついで、粗いあるいは織
り目様の表面を有する、透明な、白色、オレンジ色もし
くは赤色のフィラメント状ではないコロニーを選択する
ことを包含する。
Another embodiment of the present invention is a method for selecting a unicellular microorganism capable of heterotrophic growth and capable of producing ω-3HUFA and living in water. The method comprises selecting microorganisms of a size between about 1 μm and 25 μm from a small population of microorganisms collected from naturally occurring shallow seawater habitats, and comprising organic carbon, assimilable nitrogen, assimilable phosphorus, and microorganisms. Culturing the microorganism under heterotrophic conditions in a culture medium containing growth factors, and then selecting non-filamentous, transparent, white, orange or red filamentous colonies having a rough or textured surface. .

【0019】[0019]

【発明の実施の形態】この出願全体を通しての定義とし
て、本明細書中、脂肪酸とは脂肪族モノカルボン酸のこ
とであると理解されたい。脂質とは、ホスファチド類、
ステロイド類、アルコール類、炭化水素類、ケトン類、
及び関連化合物を伴った脂肪酸のグリセリドエステルを
包含する油脂類のことであると理解されたい。
DETAILED DESCRIPTION OF THE INVENTION As defined throughout this application, fatty acids are understood herein to mean aliphatic monocarboxylic acids. Lipids are phosphatides,
Steroids, alcohols, hydrocarbons, ketones,
And fats and oils, including glyceride esters of fatty acids with associated compounds.

【0020】一般に使用されている略記システムを本明
細書中でも脂肪酸の構造を表現するのに使用している
(例えば、Weete, 1980)。このシステムでは、炭化水素
鎖中の炭素数を示す数字を伴った文字「C」を用い、こ
れにコロンと二重結合の数を示す数字が続く。つまり、
C20:5はエイコサペンタエン酸を表す。脂肪酸はカ
ルボニル炭素から番号づけを始める。二重結合の位置は
ギリシヤ文字デルタ(Δ)に二重結合の炭素数を付けて
表す。すなわち、C20:5ω-3Δ5,8,11,14,17という
ふうに。「ω」表示は不飽和脂肪酸についての略記シス
テムであり、カルボキシ末端炭素から番号づけが使用さ
れる。便宜上、特に本明細書中で数字略記命名法を用い
る場合に、w3が「オメガ-3」を記号化するために使
用される。ω-3高度不飽和脂肪酸は、最後のエチレン
性結合が脂肪酸の末端メチル基を含んでそれから三炭素
であるポリエチレン性脂肪酸であると理解される。従っ
て、一つのω-3高度不飽和脂肪酸であるエイコサペン
タエン酸の完全な命名は、C20:5w3Δ
5,8,11,14,17 となる。簡単化のために、二重結合位置
(Δ5,8,1 1,14,17)は省略されうる。そこでエイコサペ
ンタエン酸はC20:5w3と表示され、ドコサペンタ
エン酸(C22:5w3Δ7,10,13,16,19)はC22:5
w3であり、ドコサペンタエン酸(C22:6w3Δ
4,7,10,13,16,19)はC22:6w3である。「高度不飽
和脂肪酸」なる命名は、4個あるいはそれ以上の二重結
合をもつ脂肪酸を意味する。「飽和脂肪酸」は1〜3個
の二重結合をもつ脂肪酸を意味する。
A commonly used abbreviation system is used herein to describe the structure of fatty acids (eg, Weete, 1980). This system uses the letter "C" with a number indicating the number of carbons in the hydrocarbon chain, followed by a colon and a number indicating the number of double bonds. That is,
C20: 5 represents eicosapentaenoic acid. Fatty acids start numbering from the carbonyl carbon. The position of the double bond is represented by the Greek letter delta (Δ) with the number of carbon atoms of the double bond. In other words, C20: to Fu that 5ω-3Δ 5,8,11,14,17. The “ω” designation is an abbreviated system for unsaturated fatty acids, where numbering is used from the carboxy terminal carbon. For convenience, w3 is used to symbolize "omega-3", especially when using numeric abbreviation nomenclature herein. ω-3 polyunsaturated fatty acids are understood to be polyethyleneic fatty acids in which the last ethylenic bond contains the terminal methyl group of the fatty acid and is then three carbons. Thus, the complete nomenclature of one ω-3 highly unsaturated fatty acid, eicosapentaenoic acid, is C20: 5w3Δ
5,8,11,14,17 . For simplicity, the double bond position (Δ 5,8,1 1,14,17 ) may be omitted. Thus, eicosapentaenoic acid is indicated as C20: 5w3, and docosapentaenoic acid (C22: 5w3Δ 7,10,13,16,19 ) is C22: 5w3.
w3 and docosapentaenoic acid (C22: 6w3Δ
4,7,10,13,16,19 ) is C22: 6w3. The designation “highly unsaturated fatty acids” refers to fatty acids having four or more double bonds. "Saturated fatty acid" means a fatty acid having 1 to 3 double bonds.

【0021】ω-3高度不飽和脂肪酸生産のために、経
済的に望ましい以下の特性の組合せを有する多くの微生
物株を容易に単離するために、本発明者は収集及びスク
リーニング法を開発した: 1)ヘテロトロピックな生長
(増殖)が可能; 2)ω-3高度不飽和脂肪酸が高含
量; 3)単細胞; 3)好ましくは、飽和及びω-6高度
不飽和脂肪酸が低含量; 5)好ましくは、色素をもた
ず、白色もしくは実質的に無色の細胞; 6)好ましく
は、耐熱性であること(30℃以上の温度で生育できる
こと);並びに 7)好ましくは、広塩性(広範囲の塩分
濃度にわたって、特に低塩分濃度で生育できること)。
To facilitate the isolation of many microbial strains having the following combination of properties that are economically desirable for production of ω-3 polyunsaturated fatty acids, the inventors have developed collection and screening methods. : 1) capable of heterotrophic growth (proliferation); 2) high content of ω-3 highly unsaturated fatty acids; 3) single cells; 3) preferably low content of saturated and ω-6 highly unsaturated fatty acids; 5) Preferably, they are pigment-free, white or substantially colorless cells; 6) are preferably heat-resistant (can grow at a temperature of 30 ° C. or higher); and 7) are preferably broad-salt (broad-ranged) Can grow over low salinity, especially at low salinity).

【0022】多数の適したヘテロトロピック株の収集、
単離及び選択には、以下の方法が伴い得る。適切な水試
料と生物は、一般に、好ましくは、広範囲の温度及び塩
分変動をうける浅い塩水生息地から収集できる。これら
の生息地としては、海の潮だまり、河口(河潟)及び内
陸部の塩水池、泉、プラヤ及び湖が挙げられる。これら
の収集地の特定の例として、 1)コロラド州のグレンウ
ッドスプリングスにあるコロラド川に沿った所、あるい
はユタ州のスタンズバリイ山脈の西側の端に沿った所の
ような暖かい塩水泉; 2)ユタ州のゴシェンの近くにあ
るゴシェンプラヤのようなプラヤ; 3)カリフォルニア
州のラ・ジョラのバードロックス地域にあるような海の
潮だまり; 4)カリフォルニア州のサンジエゴ郡のチア
ジュアナ河口のような河口がある。水試料と共に、いく
らかの生きた植物分と天然由来の岩屑(分解しつつある
植物及び動物分)を含むようにとくに努力する。その
後、試料は実験室に戻るまで冷蔵する。水試料を15〜
30秒間振とうしたのち、フィルターユニットへ、例え
ば1〜10mlをピペットで取るか、一部を注ぐかすれ
ばサンプリング時の誤差が最小となる。フィルターユニ
ットは2つのタイプのフィルターを含んでいる。すなわ
ち 1)上部に、減菌したワットマン#4フィルター(商
標、ワットマン社、クリフトン、N.J.);及び 2)ワ
ットマンフィルターの下に、1.0μm孔径のポリカーボ
ネートフィルターである。第一の(上部の)フィルター
の目的は、約25μm以上の大きさのすべての粒子分を
除去することであり、一般的には単細胞タイプの物質の
みが1.0μmのポリカーボートフィルター上へ透過しう
る。第一のフィルターは、他のコロニーの増殖する機会
を増大させるより高い温度でのポリカーボネートフィル
ターの培養において引き続いて増殖するカビのコロニー
の数を著しく減少させる。カビの胞子は海辺の塩水及び
内陸の塩水中に非常に多数であり、カビのコロニーはス
クリーニングで除かないと、寒天プレート上を急速に覆
いつくしてしまう。1.0μmサイズのポリカーボネート
フィルターは、バクテリヤの多くが通り抜けてろ液に行
くようにと選択された。サンドイッチ型のフィルターデ
ザインを使用した目的は、単細胞生物のうち大きさが直
径で約1μmから約25μmの範囲の細胞の少なくとも一
部を選択することである(大規模の生産用の発酵システ
ムにおいて、潜在的に容易に増殖しうる生物)。これら
の単細胞生物のさらなる増殖は、寒天プレート上でポリ
カーボネートフィルターを培養することによって促進す
ることができる。フィルター上で増殖する生物間の競争
は、単細胞微生物の競争的な強健な株を単離しやすくす
る。上述の方法によって選択される単細胞の水生微生物
は、生育条件及び増殖サイクルの段階に応じてある範囲
の細胞の大きさを示す。培養物中の大部分の細胞は、約
1μm〜約25μmの範囲の直径を有している。ただし、
培養物中の(葉状体及び胞子嚢)細胞は(株により異な
るが)約60μmまでのより大きな直径をもつことが見
出され得る。
Collection of a number of suitable heterotrophic strains,
Isolation and selection may involve the following methods. Suitable water samples and organisms can generally be collected, preferably from shallow saline habitats subject to wide temperature and salinity variability. These habitats include ocean tide pools, estuaries (rivers) and inland saline ponds, springs, playa and lakes. Specific examples of these collections include: 1) warm salt water springs, such as along the Colorado River at Glenwood Springs, Colorado, or along the western edge of the Stansbury Mountains, Utah; Playas, such as Goshen Playa, near Goshen, Utah; 3) Sea tide pools, such as in the Bardrox area of La Jolla, California; 4) Estuaries, such as the Chiajuana Estuary, in San Diego County, California. is there. Particular efforts are made to include some living plant matter and naturally occurring debris (degrading plant and animal matter) along with the water sample. The sample is then refrigerated until returning to the laboratory. Water sample 15 ~
After shaking for 30 seconds, for example, 1 to 10 ml is pipetted or partially poured into the filter unit to minimize the sampling error. The filter unit contains two types of filters. 1) a sterile Whatman # 4 filter (trademark, Whatman, Clifton, NJ) on top; and 2) a 1.0 μm pore size polycarbonate filter below the Whatman filter. The purpose of the first (upper) filter is to remove all particles of about 25 μm or larger in size, and generally only single cell type material permeates over a 1.0 μm polycarbonate filter Can. The first filter significantly reduces the number of mold colonies that subsequently grow in culturing polycarbonate filters at higher temperatures, increasing the chances of other colonies growing. Mold spores are very abundant in seashore and inland saltwater, and mold colonies can quickly cover the agar plate unless screened for. A 1.0 μm sized polycarbonate filter was chosen to allow most of the bacteria to pass through to the filtrate. The purpose of using a sandwich-type filter design is to select at least some of the cells in the range of about 1 μm to about 25 μm in diameter among unicellular organisms (in fermentation systems for large-scale production, Organisms that can potentially grow easily). Further growth of these unicellular organisms can be promoted by culturing polycarbonate filters on agar plates. Competition between organisms growing on the filters facilitates the isolation of competitive, robust strains of unicellular microorganisms. The unicellular aquatic microorganisms selected by the above-described method exhibit a range of cell sizes depending on the growth conditions and stages of the growth cycle. Most cells in culture have a diameter ranging from about 1 μm to about 25 μm. However,
Cells (thallus and sporangia) in culture can be found to have a larger diameter (up to about 60 μm), depending on the strain.

【0023】ろ過ののち、ポリカーボネートフィルター
を塩水培養基を含む寒天プレート上に置く。この培養基
は、グルコース、種々のでんぷん、糖蜜、粉砕コーン等
の炭水化物のような有機性炭素源、硝酸塩、尿素、アン
モニウム塩、アミノ酸のような同化性有機もしくは無機
窒素源;酵素エキス、ビタミン及びコーン浸漬液の一種
以上に含まれる微生物生育因子;有機もしくは無機の同
化性リン源;並びに重炭酸塩のようなpH緩衝剤を含有
している。微生物生長因子は、菌類や藻類を含む単細胞
微生物のヘテロトロピックな生長を促進する未だ特定さ
れていない化合物である。寒天プレートは暗所にて25
〜35℃(30℃が好ましい)で培養することができ、
2〜4日後に、多数のコロニーがフィルター上に出現す
る。目的の生物を1プレートあたり1〜5コロニー回収
することは珍しくない。酵母のコロニーは色(しばしば
ピンク色である)またはその形態のいずれかによって区
別し得る。酵母コロニーは滑らかであるが、目的の生物
はざらざらしたあるいは織り目様の表面を有するコロニ
ーを形成する。目的の生物は個々の細胞をコロニーの境
界で微細顕微鏡を通して見ることができるが、酵母細胞
は小さいために区別できない。カビ及びより高級な菌類
のコロニーは、目的生物はフィラメント状ではないの
に、それらはフィラメント状であるので、目的生物と区
別し得る。透明なあるいは白色のコロニーをプレートか
らつまみとり、同様の培養基組成の新しいプレート上に
再ストリークし得る。大部分の目的生物は透明あるいは
白色であるが、いくつかは、キサントフィル色素の存在
により橙色あるいは赤色であり、同様に選択と再ストリ
ークに適している。新しいプレートは同様の条件下(好
ましくは30℃)で培養することができ、2〜4日の培
養期間で単一のコロニーをつまみとることができる。そ
の後、単一コロニーをつまみとり、例えば寒天プレート
中と同じ有機添加物(寒天をのぞいて)を含む液体培養
基50ml中へいれることができる。これらの培養物は
30℃で、空気を吹き込みながら、例えば回転振とうテ
ーブル(100〜200rpm)上で2〜4日間培養し得
る。培養物が最高密度にまで達したと思われるときに、
20〜40mlの培養物を次いで遠心分離あるいは他の
適切な方法で収穫し、例えば凍結させて保存することが
できる。次に、試料をガスクロストグラフィーを含む標
準的で周知の方法により分析して、その株の脂肪酸含量
を同定することができる。ω-3高度不飽和脂肪酸を含
む株をこのようにして同定することができ、これらの株
の培養物をさらなるスクリーニング用に維持し得る。
After filtration, the polycarbonate filter is placed on an agar plate containing saline. This culture medium is composed of organic carbon sources such as glucose, various starches, molasses, carbohydrates such as ground corn, assimilable organic or inorganic nitrogen sources such as nitrates, urea, ammonium salts, amino acids; enzyme extracts, vitamins and corn. It contains a microbial growth factor contained in one or more of the immersion liquids; an organic or inorganic assimilable phosphorus source; and a pH buffer such as bicarbonate. Microbial growth factors are unidentified compounds that promote heterotrophic growth of unicellular microorganisms, including fungi and algae. Agar plate is 25 in dark place
3535 ° C. (preferably 30 ° C.)
After 2-4 days, a large number of colonies appear on the filter. It is not uncommon to recover 1 to 5 colonies of a target organism per plate. Yeast colonies can be distinguished either by color (often pink) or by their morphology. Yeast colonies are smooth, but the organism of interest forms colonies with a rough or textured surface. The organism of interest can see individual cells at the border of the colony through a microscopic microscope, but yeast cells are small and indistinguishable. Mold and higher fungal colonies can be distinguished from target organisms because they are filamentous, although the target organism is not filamentous. Clear or white colonies can be picked from the plate and re-streaked onto a new plate of similar medium composition. Most target organisms are clear or white, but some are orange or red due to the presence of the xanthophyll pigment, which is equally suitable for selection and restreak. A new plate can be cultured under similar conditions (preferably at 30 ° C.), and a single colony can be picked in a culture period of 2 to 4 days. Thereafter, a single colony can be picked and placed, for example, in 50 ml of liquid culture medium containing the same organic additives (except for agar) as in agar plates. These cultures can be cultured at 30 ° C. with blowing air, for example on a rotary shaking table (100-200 rpm) for 2-4 days. When the culture seems to have reached the highest density,
20-40 ml of the culture can then be harvested by centrifugation or other suitable method and stored, for example, frozen. The sample can then be analyzed by standard and well-known methods, including gas clostography, to identify the fatty acid content of the strain. Strains containing ω-3 highly unsaturated fatty acids can be identified in this way, and cultures of these strains can be maintained for further screening.

【0024】有望な株を、50mlの培養基を含む25
0mlの振とうフラスコにその株を移植することによ
り、温度許容性についてスクリーニングし得る。次い
で、これらの培養物を2日間、振とうテーブル上で、任
意の所望の温度範囲、最も実用的には、27〜48℃の
間で一つの培養物毎に3℃間隔としてインキュベートす
る。産生量を培養基1mlあたりの産生された脂肪酸の
全量で定量しうる。全脂肪酸は上記のようにガスクロマ
トグラフィーで定量できる。同様の方法を、塩分許容性
についてのスクリーニングに使用し得る。塩分許容性に
ついては、大部分の目的に対して、5〜40mmho/cmの
導電率を与える塩分濃度範囲が適当である。種々の炭素
源及び窒素源を使用する能力についてのスクリーニング
も同様に上で概要を説明した方法を用いて行うことがで
きる。ここで、炭素源及び窒素源の評価は5g/lの濃
度で行った。評価した炭素源は、グルコース、コンスタ
ーチ、粉砕コーン、じゃがいもデンプン、小麦でんぷん
及び糖蜜である。評価した窒素源は、硝酸塩、尿素、ア
ンモニウム、アミノ酸、タンパク質加水分解物、コーン
浸漬液(コーンスティープ液)、トリプトン、ペプト
ン、又はカゼインである。他の炭素源及び窒素源も使用
することができ、ユーザーが重要とする基準に基づき、
この技術分野の当業者が任意に選択しうる。
Promising strains were identified as 25 strains containing 50 ml of culture medium.
One can screen for temperature tolerance by inoculating the strain into a 0 ml shake flask. These cultures are then incubated for 2 days on a shaking table at any desired temperature range, most practically between 27-48 ° C, at 3 ° C intervals per culture. The amount of production can be quantified by the total amount of fatty acids produced per ml of culture medium. Total fatty acids can be determined by gas chromatography as described above. Similar methods can be used for screening for salt tolerance. For salinity tolerance, for most purposes, a salinity range that provides a conductivity of 5-40 mmho / cm is appropriate. Screening for the ability to use various carbon and nitrogen sources can also be performed using the methods outlined above. Here, the carbon source and the nitrogen source were evaluated at a concentration of 5 g / l. The carbon sources evaluated were glucose, starch, ground corn, potato starch, wheat starch and molasses. The nitrogen sources evaluated were nitrates, urea, ammonium, amino acids, protein hydrolysates, corn steep liquor (corn steep liquor), tryptone, peptone, or casein. Other sources of carbon and nitrogen can also be used, based on criteria that the user considers important,
Those skilled in the art can arbitrarily choose.

【0025】予想外のことに、トロウストチトリウム
(ヤブレツボカビ、Thrausochytrium)属からの種の株
が粉砕した、加水分解されていない穀物を直接発酵して
ω-3HUFAを産生することが見出された。この方法
は、そのような穀物は一般に安価な炭素源及び窒素源で
あるので、従来の発酵法に比べて有利である。さらに、
この方法を実施しても、ω-3HUFAの量のような、
藻類の有益な特性を損なうような影響を与えない。
Unexpectedly, it has been found that a strain of a species from the genus Thrausochytrium produces fermentation of ground, unhydrolyzed grain directly to produce ω-3HUFA. Was. This method is advantageous over conventional fermentation methods because such cereals are generally cheap carbon and nitrogen sources. further,
Even if this method is carried out, such as the amount of ω-3HUFA,
Does not affect the beneficial properties of the algae.

【0026】穀物の直接発酵を用いる本方法は、制限な
く、トウモロコシ、モロコシ、米、オート麦、ライ麦、
及びアワを含む任意の種類の穀物について有用である。
しかしながら、少なくとも粗く粉砕した穀物を用いるこ
とが好ましく、さらには、小麦粉状のコンシステンシー
をもつまでに粉砕した穀物がより好ましい。この方法
は、さらに、安価な炭素/窒素源として、その他に、非
加水分解コーンシロップ、もしくはスチラーゲ(stilla
ge)のような農産上発酵上の副産物、トウモロコシをア
ルコールに発酵する際の不要産物を用いることをも包含
する。
The method using direct fermentation of cereals is not limited to corn, sorghum, rice, oats, rye,
And any kind of cereal, including millet.
However, it is preferred to use at least coarsely ground cereals, more preferably cereals ground to a flour-like consistency. This method further provides a low-cost source of carbon / nitrogen, as well as non-hydrolyzed corn syrup or stilla.
ge), the use of by-products in agricultural production and fermentation, and unnecessary products in fermenting corn to alcohol.

【0027】もう一つの好ましい方法においては、ω-
3HUFAは、加水分解された上述の穀物及び不要産物
の発酵によって、トロウストチトリウムもしくはシゾチ
トリウムにより産生し得ることが見出された。そのよう
な穀物及び不要産物は酸加水分解又は酵素加水分解のよ
うな当業者に公知の任意の方法により加水分解し得る。
別の態様は混合加水分解処理である。この方法において
は、粉砕穀物を当業者に公知の任意の温和な酸処理方法
に従って、温和な酸条件下でまず部分的に加水分解す
る。続いて、部分的に加水分解した粉砕穀物をさらに、
当業者に公知の任意の酵素法に従って、酵素プロセスに
より加水分解する。この好ましい方法においては、アミ
ラーゼ、アミログルコシダーゼ、α- もしくはβ-グル
コシダーゼのような酵素又はこれらの酵素の混合物が用
いられる。得られる加水分解生成物を、次いで、本発明
において炭素源及び窒素源として使用する。
In another preferred method, ω-
It has been found that 3HUFA can be produced by Troost or Schizochytrium by fermentation of the above-mentioned hydrolyzed grains and unwanted products. Such cereals and waste products can be hydrolyzed by any method known to those skilled in the art, such as acid hydrolysis or enzymatic hydrolysis.
Another embodiment is a mixed hydrolysis treatment. In this method, the ground cereal is first partially hydrolyzed under mild acid conditions according to any mild acid treatment method known to those skilled in the art. Subsequently, the partially hydrolyzed crushed cereal was further
Hydrolysis by an enzymatic process according to any enzymatic method known to the person skilled in the art. In this preferred method, enzymes such as amylase, amyloglucosidase, α- or β-glucosidase or mixtures of these enzymes are used. The resulting hydrolysis products are then used in the present invention as carbon and nitrogen sources.

【0028】上で概要を説明した収集法及びスクリーニ
ング法を用いて、単細胞の菌類及び藻類の株のうち、ω
-3高度不飽和脂肪酸含量を灰分を含まない全細胞の乾
燥重量(afdw)の32%まで含有し、かつ、15〜48
℃の温度範囲で増殖し、極めて低い塩分濃度の培養基中
で成長するものを単離し得る。非常に高いω-3株の多
くは増殖が大変遅い。上記の方法で単離され、速い増殖
と、ω-3高度不飽和脂肪酸を良好に産生し、かつその
含量の多い株は、ω-3高度不飽和脂肪酸含量が約15
%afdw程度までである。本発明の方法による株の成長
は、満足すべき成長が進行する任意の温度。例えば約1
5℃〜48℃、好ましくは25〜36℃で達成し得る。
培養基は一般に、もし酸の添加やバッファーによってp
Hを調節しないならば、発酵の間によりアルカリ性とな
る。株は4.0〜11.0のpH範囲で増殖するが、好ま
しい範囲は約5.5〜8.5である。
Using the collection and screening methods outlined above, single-cell fungal and algae strains of ω
-3 contains up to 32% of the ashless total cell dry weight (afdw) of the polyunsaturated fatty acid content and 15-48
One that grows in the temperature range of ° C. and grows in cultures with very low salinity can be isolated. Many very high ω-3 strains grow very slowly. A strain which is isolated by the above-described method, produces fast growth and produces ω-3 polyunsaturated fatty acids well, and has a high content thereof has an ω-3 polyunsaturated fatty acid content of about 15%.
% Up to about afdw. The growth of the strain according to the method of the invention is at any temperature at which satisfactory growth proceeds. For example, about 1
It can be achieved at 5C to 48C, preferably 25C to 36C.
The culture medium is generally adjusted by adding acid or buffer.
If H is not regulated, it will be more alkaline during fermentation. The strain grows in the pH range from 4.0 to 11.0, with the preferred range being about 5.5 to 8.5.

【0029】増殖を大容量の容器及びタンク中で行う場
合には、凍結防止剤、ジメチルスルホキシド(DMS
O)もしくはグリセリンを用いて−70℃で保存した培
養物又は傾斜培養物からのアリコートをこのブロス培養
物に移植することによって、栄養ブロス培地中に栄養移
植物を調製することが好ましい。若い、活発な栄養移植
物が確保されたときに、それを無菌的により大きい生産
タンク又は発酵槽に移すことができる。栄養移植物が調
製される培養基は、その株が良好に増殖する限り、細胞
の大規模生産に用いるものと同じであっても、異なって
いてもよい。
When the growth is carried out in a large volume container or tank, the antifreezing agent, dimethyl sulfoxide (DMS) is used.
It is preferred to prepare a vegetative transplant in a nutrient broth medium by transferring an aliquot from a culture or a gradient culture stored at -70 ° C with O) or glycerin into this broth culture. When a young, active nutritional implant is secured, it can be aseptically transferred to a larger production tank or fermenter. The culture medium from which the vegetative transplant is prepared may be the same or different from that used for large-scale production of cells, as long as the strain grows well.

【0030】本発明者は、上記の方法で単離され、スク
リーニングされたトロウストチトリアレ目の単細胞株
(ω-3脂肪酸を含有する)は、エマーソン(1950)とS
chneide(1976)によって予見されたように、数世代後
には栄養増殖を停止するという制限された増殖を一般に
示すことを見出した。しかしながら、本発明者は、比較
的高濃度の(例えば、KH2PO4>0.2g/l)に維持
するか及び/又は酵母エキスもしくはコーン浸漬液
(0.2g/l以上)のような栄養補助物(菌類成長因子
の源)を加えることよって、連続的なこれらの単細胞菌
類の培養増殖が維持できることを見出した。液体培地中
で2〜3世代を越えて増殖を維持する能力を、本明細書
中で持続増殖と表現する。群として、トロウストチトリ
ド属の株は、シゾチトリウム属の株よりも、リン酸塩の
添加に対してより好ましい形で応答するようであり、後
者はリン酸塩の必要がより少ないと思われる。菌類成長
因子を供給する栄養補助剤に関して、コーン浸漬液を、
酵母エキスの代りとすることができ、ある種の株におい
ては、培地中で株の高密度化を達成するのにより優れた
効果を有する。コーン浸漬液及び酵母エキスは、細胞が
成長するのに必要な一種以上の成長因子を含んでいる。
成長因子は、現在のところ解明されていないが、それは
酵母エキスおよびコーン浸漬液の成分であり、これらの
よく知られた栄養補助物のどちらかで十分である。50
%に近い炭素変換効率(培養基に添加した100gの有
機性炭素当たりの生成した細胞乾燥重量のg数)が、こ
の方法を用いて容易に達成できる。
The present inventors have determined that a single cell line of the order Thraustochytriales (containing ω-3 fatty acids) isolated and screened by the method described above was obtained from Emerson (1950) and S.
As foreseen by chneide (1976), it was found that after several generations it generally showed limited growth, stopping vegetative growth. However, the inventor has found that maintaining relatively high concentrations (eg, KH 2 PO 4 > 0.2 g / l) and / or using yeast extract or corn steep liquor (> 0.2 g / l) It has been found that by adding a nutritional supplement (a source of fungal growth factor), continuous culture growth of these unicellular fungi can be maintained. The ability to maintain growth for more than a few generations in liquid media is referred to herein as sustained growth. As a group, Troost Titolide strains appear to respond in a more favorable manner to phosphate addition than Schizochytrium strains, the latter appearing to require less phosphate . For nutraceuticals that supply fungal growth factors, corn steeped liquid
It can replace yeast extract and, in certain strains, has a better effect in achieving densification of the strain in the medium. Corn soak and yeast extract contain one or more growth factors necessary for the cells to grow.
Although growth factors are currently unknown, they are components of yeast extract and corn steep liquor, and either of these well-known nutritional supplements is sufficient. 50
% Carbon conversion efficiency (g of cell dry weight produced per 100 g of organic carbon added to the culture medium) can be easily achieved using this method.

【0031】成長の指数増殖期に細胞を収穫することに
よって、高タンパク質で、高ω-3高度不飽和脂肪酸の
微生物産物を得ることができる。有意により高い脂質と
ω-3高度不飽和脂肪酸の産物を望む場合には、栄養制
限下で、好ましくは窒素制限下で適切な期間、好ましく
は6〜24時間、培養を行い得る。培養物を窒素を含ま
ない培養基に移すか、あるいは、好ましくは指数増殖期
の後期に窒素が不足するように、生育培養基の最初の窒
素含量を調節しうる。誘導期間を短く、通常は6〜24
時間とする限り、窒素の制限は、ω-3高度不飽和脂肪
酸を高レベルで維持しながら全脂質の産生を促進する。
培養のこの段階、つまり培養物分布がその最高細胞密度
に到達した段階は、定常期として知られている。誘導期
間の長さは、使用した株に応じて、温度を上げるか下げ
ることによって調整できる。さらに、細胞を高い炭素/
窒素比の培養基中で、連続的な形で培養でき、高脂質含
量(及び高ω-3含量)の細胞バイオマスを連続的に生
産することが可能となる。上記したスクリーニング法に
より単離したヘテロトロピック微生物の単細胞株は、三
種のω-3高度不飽和脂肪酸、すなわちC20:5w3、
C22:5w3及びC22:6w3を高濃度で含有し、C
20:4w6を極めて低い濃度で含む傾向にある。これ
らの脂肪酸の比率は、培養条件と使用した株によって変
動しうる。C20:5w3とC22:6w3の比率は約
1:1〜1:30の範囲をとりうる。C22:5w3とC
22:6w3の比率は1:12から、ほんの痕跡量のC2
2:5w3までになりうる。C22:5w3を含まない株
では、C20:5w3とC22:6w3の比率は約1:1
から1:10をとり得る。付加的な高度不飽和脂肪酸、
C22:5w6が先行技術の株のすべてを含むいくつか
の株により産生される(C22:6w3脂肪酸と1:4の
比率まで)。しかしながら、C22:5w6脂肪酸は、C
20:4w6脂肪酸に逆変換されるため、食事療法用の
脂肪酸としては望ましくないものと考えられている。本
発明で説明したスクリーニング方法は、しかしながら、
ω-6高度不飽和脂肪酸(C20:4w6もしくはC2
2:5w6)を全く(又は1%未満しか)含まないいく
つかの株の単離を容易にする。
By harvesting cells during the exponential phase of growth, a high protein, high ω-3 high unsaturated fatty acid microbial product can be obtained. If significantly higher lipids and products of ω-3 polyunsaturated fatty acids are desired, cultivation can be performed under nutrient restriction, preferably under nitrogen restriction, for a suitable period, preferably 6 to 24 hours. The culture may be transferred to a nitrogen-free medium, or the initial nitrogen content of the growth medium may be adjusted, preferably to provide a nitrogen deficiency late in the exponential phase. Short induction period, usually 6-24
As far as time is concerned, nitrogen restriction promotes total lipid production while maintaining high levels of ω-3 polyunsaturated fatty acids.
This stage of culture, when the culture distribution reaches its maximum cell density, is known as the stationary phase. The length of the induction period can be adjusted by increasing or decreasing the temperature, depending on the strain used. In addition, cells can be converted to high carbon /
It can be cultivated in a continuous form in a culture medium having a nitrogen ratio, and it is possible to continuously produce a cell biomass having a high lipid content (and a high ω-3 content). The single cell line of the heterotrophic microorganism isolated by the screening method described above contains three ω-3 polyunsaturated fatty acids, ie, C20: 5w3,
Containing high concentrations of C22: 5w3 and C22: 6w3,
20: 4w6 at very low concentrations. The ratio of these fatty acids can vary depending on the culture conditions and the strain used. The ratio of C20: 5w3 to C22: 6w3 can range from about 1: 1 to 1:30. C22: 5w3 and C
The ratio of 22: 6w3 is 1:12, so only trace amounts of C2
It can be up to 2: 5w3. In the strain without C22: 5w3, the ratio of C20: 5w3 to C22: 6w3 is about 1: 1.
From 1:10. Additional polyunsaturated fatty acids,
C22: 5w6 is produced by several strains, including all of the prior art strains (up to a ratio of C22: 6w3 fatty acid to 1: 4). However, C22: 5w6 fatty acids are
It is considered undesirable as a dietary fatty acid because it is converted back to 20: 4w6 fatty acids. The screening method described in the present invention, however,
ω-6 polyunsaturated fatty acids (C20: 4w6 or C2
2: 5w6) to facilitate the isolation of some strains that contain no (or less than 1%).

【0032】本方法で生産されるもののような、微生物
産物中のHUFAは、酸化条件に曝されると、より望ま
しくない不飽和脂肪酸または飽和脂肪酸に変換され得
る。しかしながら、ω-3HUFAの飽和は、β-カロテ
ン、ビタミンEおよびビタミンCのような合成抗酸化剤
または天然由来の抗酸化剤を微生物産物に加えることに
よって減少または防止することができる。
HUFA in microbial products, such as those produced by the present method, can be converted to less desirable unsaturated or saturated fatty acids when exposed to oxidizing conditions. However, saturation of ω-3 HUFA can be reduced or prevented by adding synthetic or naturally occurring antioxidants such as β-carotene, vitamin E and vitamin C to the microbial product.

【0033】BHT,BHA,TBHQまたはエトキシ
キュインのような合成抗酸化剤またはトコフェロールの
ような天然の抗酸化剤を、収穫後細胞を加工している間
に産物に加えることによって、食品または食餌製品に添
加することができる。このように添加される抗酸化剤の
量は、例えば、製品処方、包装法、および所望の棚寿命
のようなその後の用途から要求される程度によって決め
られる。
A food or feed product by adding a synthetic antioxidant such as BHT, BHA, TBHQ or ethoxycuin or a natural antioxidant such as tocopherol to the product after processing the cells after harvesting. Can be added. The amount of antioxidant thus added is determined by the degree required by subsequent applications, such as, for example, product formulation, packaging, and desired shelf life.

【0034】天然由来の抗酸化剤の濃度は、指数関数的
増殖の間よりもむしろ定常段階で発酵物を収穫するこ
と、低温で発酵にストレスをかけること、および/また
は培養基の溶存酸素濃度を高く維持することによって調
整できる。さらに、天然由来の抗酸化剤の濃度は、温
度、塩分濃度、および栄養分濃度のような培養条件を変
化させることによって調節することができる。そのう
え、L-トリプトファンもしくはL-フェニルアラニンの
ようなビタミンEの生合成前駆体を、摂取とそれに引き
続くビタミンEへの変換のために発酵培養基に添加でき
る。あるいは、抗酸化剤と共同して酸化を防止する化合
物(例えば、アスコルビン酸、クエン酸、リン酸)を収
穫の前に細胞によって取り込まれるために発酵物に加え
ることができる。さらに、痕跡量の金属、とくに二種以
上の価数状態で存在し、適した酸化還元電位を持つもの
(例えば、銅、鉄、マンガン、コバルト、ニッケル)の
濃度は、加工細胞中でHUFAの自動酸化を生じさせる
その可能性を最も小さくするように、最高の増殖のため
に必要な最小限に維持すべきである。
[0034] The concentration of naturally occurring antioxidants may be determined by harvesting the fermentate at a stationary stage rather than during exponential growth, stressing the fermentation at low temperatures, and / or reducing the dissolved oxygen concentration of the culture medium. Can be adjusted by keeping it high. In addition, the concentration of naturally occurring antioxidants can be adjusted by changing culture conditions such as temperature, salinity, and nutrient concentrations. In addition, a biosynthetic precursor of vitamin E, such as L-tryptophan or L-phenylalanine, can be added to the fermentation medium for ingestion and subsequent conversion to vitamin E. Alternatively, compounds that prevent oxidation in combination with antioxidants (eg, ascorbic acid, citric acid, phosphoric acid) can be added to the fermentation for uptake by cells prior to harvesting. Furthermore, the concentration of trace amounts of metals, especially those that exist in more than one valence state and have suitable redox potentials (eg, copper, iron, manganese, cobalt, nickel), can increase the concentration of HUFA in processed cells. It should be kept to the minimum required for maximum growth, so as to minimize its potential to cause autoxidation.

【0035】収穫した細胞のバイオマスから抽出し得る
他の産物としては、タンパク質、炭水化物、ステロイ
ド、カロテノイド、キサントフィル、および酵素(例え
ば、プロテアーゼ)が挙げられる。ω-6脂肪酸を高レ
ベルで産生する株も単離されている。そのような株は、
ω-6脂肪酸を生産するのに有用であり、この脂肪酸は
プロスタグランジンや他のエイコサノイドの化学的な合
成に有用な原料である。全脂肪酸の25%以上をω-6
脂肪酸として産生する株が本明細書に記載の方法によっ
て単離されている。
Other products that can be extracted from the harvested cell biomass include proteins, carbohydrates, steroids, carotenoids, xanthophylls, and enzymes (eg, proteases). Strains that produce high levels of ω-6 fatty acids have also been isolated. Such a strain is
Useful for producing ω-6 fatty acids, which are useful raw materials for the chemical synthesis of prostaglandins and other eicosanoids. More than 25% of total fatty acids are ω-6
Strains producing as fatty acids have been isolated by the methods described herein.

【0036】収穫したバイオマスは、(例えば、噴霧乾
燥、トンネル乾燥、真空乾燥、もしくは類似の方法)で
乾燥し、その肉あるいは産物が人間によって消費される
任意の動物用の餌または食品補助物として使用できる。
同様に、抽出したω-3高度不飽和脂肪酸は餌または食
品補助物として使用できる。あるいは、収穫され、洗浄
したバイオマスを直接(乾燥せずに)餌の補助物として
使用できる。その棚寿命を延ばすために、湿ったバイオ
マスを酸性化(約pH=3.5〜4.5)し、および/ま
たは殺菌しあるいは瞬間的加熱して酵素を不活化し、そ
の後、真空下または非酸化性雰囲気(例えば、窒素また
は二酸化炭素)下で缶詰、瓶詰あるいは包装できる。
「動物」という用語は動物界に属する任意の生物を意味
し、それから鳥肉、シーフード、牛肉、豚肉、羊肉が得
られる任意のものを制限なく包含する。シーフードは、
限定されないが、魚、海老、及び貝から得られる。「産
物」という用語は、そのような動物から得られる肉以外
の任意の産物を包含し、これらに制限されないが、卵や
他の産物を含む。これらの動物に与えると、収穫したバ
イオマス中のω-3HUFAまたは抽出したω-3HUF
Aは、これらの動物の肉、卵、あるいはその他の産物に
取り込まれ、それらのω-3HUFA含量が増大する。
The harvested biomass is dried (eg, spray-dried, tunnel-dried, vacuum-dried, or the like) and used as food or food supplement for any animal whose meat or product is consumed by humans. Can be used.
Similarly, the extracted ω-3 polyunsaturated fatty acids can be used as feed or food supplements. Alternatively, the harvested and washed biomass can be used directly (without drying) as a food supplement. To extend its shelf life, the wet biomass is acidified (approximately pH = 3.5-4.5) and / or sterilized or flash heated to inactivate the enzyme and then either under vacuum or Canned, bottled or packaged under a non-oxidizing atmosphere (eg, nitrogen or carbon dioxide).
The term "animal" means any organism belonging to the animal kingdom and includes without limitation any meat from which chicken, seafood, beef, pork, mutton is obtained. Seafood is
Obtained from, but not limited to, fish, shrimp, and shellfish. The term "product" encompasses any product other than meat obtained from such animals, including but not limited to eggs and other products. When fed to these animals, the ω-3HUFA in the harvested biomass or the extracted ω-3HUF
A is incorporated into the meat, eggs, or other products of these animals, increasing their ω-3 HUFA content.

【0037】異なった動物では、所望のω-3HUFA
含量を達成するのに様々な要件があることに注意すべき
である。例えば、反芻動物では、動物がω-3HUFA
を消化吸収する前に反芻胃の菌叢によって分解もしくは
飽和されることからこの不飽和脂肪酸を保護するため
に、ω-3HUFA用にある種のカプセル化手法が必要
となる。ω-3HUFAは、反芻胃中で消化できない
(又は消化が遅い)タンパク質(例えばゼアイン)ある
いは他の物質でオイルもしくは細胞をコーティングする
ことによって「保護」できる。これにより、脂肪酸は反
芻動物の第一胃を損傷を受けることなく通過しうる。細
胞もしくは油をコーティングする前に、タンパク質や他
の「保護」物質を溶媒に溶解する。細胞は、保護剤でコ
ーティングする前に、ペレット化しうる。高い食餌変換
率(例えば、4:1〜6:1)を有する動物は、低い食餌
変換率(2:1〜3:1)の動物と同等のω-3HUFA
の取り込みを達成するのにより高い濃度のω-3HUF
Aを必要とするであろう。餌投与法は、収穫したバイオ
マスもしくは抽出したω-3HUFAを所望の結果をう
るために与えなくてはならない動物の生活期間を考慮し
て、さらに最適化しうる。
In different animals, the desired ω-3 HUFA
It should be noted that there are various requirements to achieve the content. For example, in ruminants, the animal is ω-3HUFA
To protect this unsaturated fatty acid from being degraded or saturated by the rumen flora before digestion and absorption of it, certain encapsulation procedures for ω-3 HUFA are required. ω-3 HUFA can be “protected” by coating the oil or cells with proteins (eg, zeain) or other substances that are indigestible (or slow digesting) in the rumen. This allows fatty acids to pass through the rumen of the ruminant without damage. Before coating the cells or oil, the proteins and other "protecting" substances are dissolved in a solvent. Cells may be pelleted before coating with a protective agent. Animals with a high dietary conversion (eg, 4: 1-6: 1) have an omega-3 HUFA equivalent to animals with a low dietary conversion (2: 1-3: 1).
Higher concentration of ω-3HUF to achieve uptake of
A would be needed. The feeding regime can be further optimized in view of the animal's life span in which harvested biomass or extracted omega-3 HUFA must be provided to achieve the desired result.

【0038】大部分の餌の投与において、収穫した細胞
の油脂含量は約25〜50%afdwであり、他の成分はタ
ンパク質及び炭水化物である。タンパク質は、評価した
数種の株がすべて必須アミノ酸を持っているので、細胞
の栄養物として有意に有益であり得、栄養的にバランス
のとれたタンパク質と考えられる。
In most dietary applications, the fat content of the harvested cells is about 25-50% afdw, and the other components are proteins and carbohydrates. The protein can be significantly beneficial as a nutrient for cells, as the several strains evaluated all have essential amino acids and are considered to be nutritionally balanced proteins.

【0039】好ましい方法では、ω-3HUFAを含有
する新たに収穫され洗浄された細胞(ベルトろ過、回転
ドラムろ過、遠心分離などで収穫)は、収穫した細胞ペ
ーストの水含量を水分40%以下に減らすために、任意
の乾燥粉砕穀物と混合することができる。例えば、トウ
モロコシを用いることができ、このような混合によっ
て、細胞ペースト/トウモロコシ混合物を、通常の押出
し方法を使用して、直接押出すことが可能となる。押出
し温度と圧力は、押出し生成物における細胞破砕の程度
(すべて完全細胞から100%破砕された細胞まで)を
変えるために調節することができる。この方法での細胞
の押出しは、穀物中の抗酸化剤のいくつかが脂肪酸を酸
化から保護し、押出されたマトリックスもまた酸素が脂
肪酸に容易に到達することからの保護に役立つので、ω
-3HUFA含量を大きく減少させることはないと考え
られる。合成のもしくは天然の抗酸化剤もまた、押出し
前に細胞ペースト/穀物混合物に加えることができる。
細胞ペースト/穀物混合物の直接押出しによって、乾燥
時間とコストを大きく削減することができ、また、細胞
破砕の程度によって、ω-3HUFAの生物学的利用度
を調節できるようになる。望ましい細胞破砕の程度は、
酸化の許容レベル(細胞破砕が進めば、酸化もおそらく
増大する)及び押出し物質を消費する動物による生物学
的利用度の要求される程度を含めた様々な因子に依存す
る。
In a preferred method, freshly harvested and washed cells containing ω-3 HUFA (harvested by belt filtration, rotary drum filtration, centrifugation, etc.) reduce the water content of the harvested cell paste to less than 40% moisture. To reduce, it can be mixed with any dry ground grain. For example, corn can be used, and such mixing allows the cell paste / corn mixture to be extruded directly using conventional extrusion methods. Extrusion temperatures and pressures can be adjusted to vary the degree of cell disruption (all from whole cells to 100% disrupted cells) in the extruded product. Extrusion of cells in this manner is advantageous because some of the antioxidants in the grain protect the fatty acids from oxidation, and the extruded matrix also helps protect oxygen from reaching the fatty acids easily.
It is believed that the -3HUFA content is not significantly reduced. Synthetic or natural antioxidants can also be added to the cell paste / cereal mixture before extrusion.
Direct extrusion of the cell paste / cereal mixture can greatly reduce drying time and cost, and the degree of cell disruption can control the bioavailability of ω-3 HUFA. The desired degree of cell disruption is
It depends on a variety of factors, including the permissible level of oxidation (probably increased oxidation as cell disruption proceeds) and the required degree of bioavailability by the animal consuming the extruded material.

【0040】上述の方法によって単離される単細胞菌株
はすぐに凝集し、沈澱する。このプロセスは、培地のp
Hを7.0以下に調整することによって促進しうる。こ
の方法によって、簡単に1〜2分以内に細胞濃度を6倍
にすることができる。従って、この方法は、収穫前に細
胞を予備濃縮するため、あるいは窒素制限の前に極めて
高密度にまで細胞を濃縮するために使用しうる。(脂質
産生を高めるための)窒素制限は、従って、さらに小さ
い反応器中で行いうるし、あるいはいくつかの反応器か
らの細胞を一つの反応器に集約しうる。
The single cell strain isolated by the above-described method immediately aggregates and precipitates. This process depends on the medium
It can be promoted by adjusting H to 7.0 or less. By this method, the cell concentration can be easily increased 6 times within 1 to 2 minutes. Thus, this method can be used to pre-enrich cells before harvesting, or to enrich cells to very high densities before nitrogen limitation. Nitrogen limitation (to increase lipid production) can therefore be done in smaller reactors or can combine cells from several reactors into one reactor.

【0041】培養基から微生物細胞を回収するにあたっ
て、多くの方法を使用しうる。好ましい回収プロセスで
は、その方法で生産される細胞は、ろ過もしくは遠心分
離のような従来法での分離によって培養基から回収され
る。その後、細胞を洗浄し;凍結、凍結乾燥、もしくは
噴霧乾燥し;次いで加工食品または食餌製品に添加する
前に(酸素が存在しないようにするために)二酸化炭素
もしくは窒素のような非酸化性気体雰囲気下で貯蔵しう
る。
In recovering the microbial cells from the culture medium, many methods can be used. In a preferred recovery process, the cells produced by the method are recovered from the culture medium by conventional separation, such as filtration or centrifugation. The cells are then washed; frozen, lyophilized, or spray-dried; and then a non-oxidizing gas such as carbon dioxide or nitrogen before addition to the processed food or dietary product (to eliminate oxygen). May be stored under atmosphere.

【0042】ω-3高度不飽和脂肪酸を含有する細胞脂
質はまた、任意の適切な手段、例えば超臨界液体抽出あ
るいは、クロロホルム、ヘキサン、塩化メチレン、メタ
ノール等の溶媒で抽出し、ついで抽出物を減圧下で蒸発
して濃縮脂質材料を得ることによって、微生物細胞から
抽出することもできる。この調製物中のω-3高度不飽
和脂肪酸はさらに、脂質を加水分解し、ついで、尿素付
加もしくは分別蒸留(Schlenk, 1954)、カラムクロマ
トグラフィー(Kates, 1986)のような伝統的な方法を
用いて 、あるいは超臨界液体分別法(Hunter, 1987)
によって高度不飽和分を濃縮し得る。また、細胞を破砕
もしくは溶解し、脂質を植物油もしくは他の食用油で抽
出することもできる(Borowitzka とBorowitzka, 198
8)。抽出油は、植物油の精製に日常的に使用されている
周知のプロセスで精製できる(例えば、化学的精製また
は物質的精製)。これらの精製プロセスにより、食用油
として使用もしくは販売する前に、抽出油から不純物が
除去される。精製プロセスは、抽出油のガム質除去、漂
白、ろ過、脱臭及び磨きという一連のプロセスから成
る。精製後、油は直接食餌もしくは食品添加物として使
用して、ω-3HUFAに富む製品を製造することがで
きる。あるいは、油を下記のようにさらに加工、精製
し、ついで上述の用途や、薬学的用途に使用し得る。
Cellular lipids containing ω-3 polyunsaturated fatty acids can also be extracted by any suitable means, for example, by supercritical fluid extraction or extraction with a solvent such as chloroform, hexane, methylene chloride, methanol, and the like. It can also be extracted from microbial cells by evaporating under reduced pressure to obtain a concentrated lipid material. The ω-3 polyunsaturated fatty acids in this preparation further hydrolyze the lipids, and then are subjected to traditional methods such as urea addition or fractional distillation (Schlenk, 1954), column chromatography (Kates, 1986). Using or supercritical fluid fractionation (Hunter, 1987)
Can concentrate highly unsaturated components. Alternatively, cells can be disrupted or lysed, and lipids can be extracted with vegetable or other edible oils (Borowitzka and Borowitzka, 198).
8). The extracted oil can be refined by well-known processes routinely used for refining vegetable oils (eg, chemical or material refining). These refining processes remove impurities from the extracted oil before it is used or sold as an edible oil. The refining process consists of a series of processes: degumming, bleaching, filtering, deodorizing and polishing the extracted oil. After refining, the oil can be used directly as a feed or food additive to produce an omega-3 HUFA-rich product. Alternatively, the oil may be further processed and refined as described below, and then used for the above-mentioned and pharmaceutical uses.

【0043】好ましいプロセス方法では、高純度ω-3
HUFAまたは高純度HUFAの混合物を抽出油から容
易に濃縮できる。収穫した細胞(新鮮なもしくは乾燥し
たもの)は、超音波処理法、液体せん断破砕法(例え
ば、マントン-ゴーリンホモジナイザーのフレンチプレ
ス)、ビーズ磨砕、高圧下でのプレス法、凍結-解凍法、
凍結プレス法、あるいは細胞壁の酵素的消化法のような
周知の技術によって、破砕もしくは易浸透性にすること
ができる。破砕された細胞からの脂質は、ヘキサン、ク
ロロホルム、エーテルまたはメタノールのような溶媒も
しくは溶媒混合物を用いて抽出される。溶媒を除去し
(例えば、溶媒を回収し再使用し得る真空ロータリーエ
バポレータによって)、ついで、塩基加水分解、酸加水
分解もしくは酵素加水分解を含む、トリグリセリト類を
遊離脂肪酸もしくは脂肪酸のエステルに変換する任意の
周知の方法を用いて脂質を加水分解する。ω-3HUF
Aの分解を最少限とするために、加水分解はできる限り
低温(例えば、室温から60℃)で、しかも窒素下で行
わねばならない。加水分解が完了したのち、不ケン化物
はエーテル、ヘキサンもしくはクロロホルムのような溶
媒で抽出して除去する。その後、残りの溶液をHClの
ような酸の添加によって酸性化し、遊離脂肪酸をヘキサ
ン、エーテルもしくはクロロホルムのような溶媒中へ抽
出する。遊離脂肪酸を含む溶媒溶液を、その後、非HU
FAが結晶化するのに充分低く、HUFAが結晶化する
程は低すぎない温度に冷却する。典型的には、溶液を約
−60〜約−74℃の範囲に冷却する。結晶化した脂肪
酸(飽和脂肪酸、並びにモノ-、ジ-及びトリ-エン型脂
肪酸)は、次いで、(溶液を冷却状態に保ちながら)ろ
過、遠心分離あるいは沈積によって除去し得る。HUF
Aはろ液中(あるいは上清中)に溶解して残っている。
ろ液(あるいは上清)中の溶媒を除去すると、ω-3H
UFAまたは炭素鎖長が20以上のHUFAのいずれか
の純度が90%以上の脂肪酸混合物が得られる。精製ω
-3高度不飽和脂肪酸は、その後、食品添加物として、
人間の栄養補助物に、あるいは薬学的用途に使用するこ
とができる。これらの用途のためには、精製脂肪酸をカ
プセル化したり、直接用いたりすることができる。その
安定性を改善するために、抗酸化剤を脂肪酸に添加する
ことができる。
In a preferred process, high purity ω-3
HUFA or a mixture of high purity HUFAs can be easily concentrated from the extracted oil. Harvested cells (fresh or dried) can be obtained by sonication, liquid shearing (eg, French press with a Menton-Gaulin homogenizer), bead milling, pressing under high pressure, freeze-thaw,
Disruption or permeation can be achieved by well-known techniques such as freeze pressing or enzymatic digestion of cell walls. Lipids from the disrupted cells are extracted using a solvent or solvent mixture such as hexane, chloroform, ether or methanol. Optional to remove the solvent (eg, by vacuum rotary evaporator where the solvent can be recovered and reused) and then convert the triglycerites to free fatty acids or esters of fatty acids, including base hydrolysis, acid hydrolysis or enzymatic hydrolysis The lipids are hydrolyzed using the well-known method. ω-3HUF
In order to minimize decomposition of A, the hydrolysis should be performed at the lowest possible temperature (eg, room temperature to 60 ° C.) and under nitrogen. After hydrolysis is complete, the unsaponifiable matter is removed by extraction with a solvent such as ether, hexane or chloroform. Thereafter, the remaining solution is acidified by the addition of an acid such as HCl and the free fatty acids are extracted into a solvent such as hexane, ether or chloroform. The solvent solution containing the free fatty acids is then added to the non-HU
Cool to a temperature that is low enough for the FA to crystallize but not too low for the HUFA to crystallize. Typically, the solution is cooled to a range from about -60 to about -74C. Crystallized fatty acids (saturated fatty acids and mono-, di- and triene-type fatty acids) can then be removed by filtration, centrifugation or sedimentation (while keeping the solution cool). HUF
A remains dissolved in the filtrate (or in the supernatant).
When the solvent in the filtrate (or supernatant) is removed, ω-3H
A fatty acid mixture having a purity of 90% or more of either UFA or HUFA having a carbon chain length of 20 or more is obtained. Refined ω
-3 polyunsaturated fatty acids are then added as food additives
It can be used for human nutritional supplements or for pharmaceutical use. For these uses, the purified fatty acids can be encapsulated or used directly. Antioxidants can be added to fatty acids to improve their stability.

【0044】この方法の利点は、冷時結晶化の前に飽和
脂肪酸とモノ不飽和脂肪酸を除去するために、尿素錯体
法あるいは、超臨界二酸化炭素抽出や高速液体クロマト
グラフィーのような他の高価な抽出法を行わずにすむこ
とである。この利点は、魚油のような20にものぼる脂
肪酸を含む複雑な油(飽和、モノ-、ジ-、トリ- 及びポ
リエン型脂肪酸が連続的にふくまれており、そのままで
は一連の重なり合う結晶化温度を示す)よりもむしろ、
トロウストチトリドが産生するような単純な脂肪酸組成
からなる油(3〜4種の飽和もしくはモノ不飽和脂肪酸
と3〜4種のHUFAで、脂肪酸の2つのグループはそ
の結晶化温度がはっきりと分かれている)を原料として
精製を行うことによりもたらされる。
The advantage of this method is that it removes saturated and monounsaturated fatty acids before cold crystallization by the urea complex method or other expensive methods such as supercritical carbon dioxide extraction and high performance liquid chromatography. That is, it is not necessary to perform a simple extraction method. The advantage is that complex oils containing as many as 20 fatty acids, such as fish oils (saturated, mono-, di-, tri- and polyene-type fatty acids are continuously contained, and as such, a series of overlapping crystallization temperatures) Rather than indicating)
An oil of a simple fatty acid composition such as that produced by troast titride (3-4 saturated or monounsaturated fatty acids and 3-4 HUFAs; two groups of fatty acids have distinct crystallization temperatures. (Separated) is used as a raw material for purification.

【0045】好ましい方法においては、ω-3HUFA
に富んだ油はトロウストチトリウム属の株を培養して生
産できる。任意のいくつかの周知の方法によって、細胞
から油を抽出した後、主としてタンパク質と炭水化物か
ら成る残りの抽出(脂質を除いた)バイオマスは殺菌し
て発酵槽に戻すことができる。その中で、トロウストチ
トリウムの株は栄養源(炭素と窒素源)として直接リサ
イクルできる。細胞のバイオマスを予備加水分解または
予備消化することは必要ではない。最初に酸及び/また
は酵素処理により消化しておけば、トロウストチトリウ
ム属の抽出バイオマスは同様の方法でリサイクルでき
る。
In a preferred method, ω-3HUFA
Rich oil can be produced by cultivating a strain of Thraustochytrium. After extracting oil from the cells by any of several well-known methods, the remaining extracted (excluding lipid) biomass, consisting primarily of proteins and carbohydrates, can be sterilized and returned to the fermentor. Among them, strains of Thraustochytrium can be recycled directly as nutrient sources (carbon and nitrogen sources). It is not necessary to pre-hydrolyze or pre-digest the cell biomass. Once digested by acid and / or enzymatic treatment, the extracted biomass of Thraustochytrium can be recycled in a similar manner.

【0046】上で詳しく述べたように、全細胞バイオマ
スを、人間の摂取あるいは動物の餌のために、ω-3高
度不飽和脂肪酸含量及び加工食品の栄養価を高めるため
に、食品添加物として直接用いることができる。動物の
餌として用いた場合には、ω-3HUFAは動物の肉あ
るいは他の産物中に取り込まれる。これらの脂肪酸を含
む複合脂質はまた、溶媒で全細胞生成物から抽出でき、
薬学的もしくは栄養の目的のために及び工業的用途に、
より高濃度の形(例えば、カプセル化した形)で用いる
ことができる。本発明の他の態様では、種々の病気の処
置のために、上述のソースからのω-3HUFAを人間
に投与することを包含する。
As detailed above, whole cell biomass is used as a food additive to enhance the ω-3 polyunsaturated fatty acid content and nutritional value of processed foods for human consumption or animal feed. Can be used directly. When used as animal feed, ω-3 HUFA is incorporated into animal meat or other products. Complex lipids containing these fatty acids can also be extracted from whole cell products with solvents,
For pharmaceutical or nutritional purposes and for industrial use,
It can be used in a more concentrated form (eg, in an encapsulated form). Another aspect of the invention involves administering to a human ω-3 HUFA from the above sources for the treatment of various diseases.

【0047】本明細書中で、「処置」とは薬物を治療及
び予防のために与えることの両方を意味する。ω-3H
UFAの食餌療法上の価値は文献上広く認識されてお
り、本発明にしたがって生産されたω-3HUFAの人
間による摂取は、脳血管疾患、炎症及び/または免疫疾
患並びに癌の処置に有効である。
As used herein, "treatment" refers to both providing a drug for treatment and prophylaxis. ω-3H
The dietary value of UFA is widely recognized in the literature, and human consumption of omega-3 HUFA produced according to the present invention is effective in treating cerebrovascular disease, inflammatory and / or immune diseases, and cancer. .

【0048】本発明を実施例によりさらにくわしく説明
する。上記の選択基準に適合する種はこれまで先行技術
において記載されていない。これらの選択基準を用いる
ことによって、本発明者は、スクリーニングした約10
00のサンプルから25以上の潜在的に期待のもてる株
を単離した。American Type Culture Collection
(ATCC)の約20,500株の中で、10株が本発
明者が単離した株と同じ分類学上のグループに属するこ
とがあとになって同定された。そのCollection中で、
まだ生きているそれらの株を入手し、かつ使用して上述
の方法で単離し培養した株と比較した。この比較の結果
を下記の実施例5及び6に示す。
The present invention will be described in more detail by way of examples. Species meeting the above selection criteria have not heretofore been described in the prior art. By using these selection criteria, the inventor was able to screen about 10
More than 25 potentially promising strains were isolated from 00 samples. American Type Culture Collection
Of the approximately 20,500 strains of (ATCC), 10 were later identified as belonging to the same taxonomic group as the strains isolated by the present inventors. In that Collection,
Those strains that were still alive were obtained and used to compare to strains isolated and cultured in the manner described above. The results of this comparison are shown in Examples 5 and 6 below.

【0049】本願の原出願を出願してから、最近の進展
によりトロウストチトリドの分類の改訂があった。最新
の分類理論学者はそれらを藻類と一緒にしている。しか
しながら、依然として残されている分類学上の不確かさ
のために、それらの株をトロウストチトリドとして考え
ることが本発明の目的において最良であろう(目;トロ
ウストチトリアレ(Thraustochytriales),族;トロウ
ストチトリアセ(Thraustochytriaceae), 属;トロウス
トチトリウム(Thraustochytrium)またはシゾチトリウ
ム(Schizochytrium))。最新の分類学上の変更を以下に
概括する。
Since the filing of the original application of the present application, there has been a revision of the classification of Troost Titolide due to recent developments. Modern classification theorists combine them with algae. However, due to the taxonomic uncertainties that still remain, it would be best for the purposes of the present invention to consider these strains as troostochtolides (eye; Thraustochytriales, Thraustochytriaceae, genus; Thraustochytrium or Schizochytrium). The latest taxonomic changes are summarized below.

【0050】本明細書中に開示し、クレームした単細胞
微生物のすべての株はトロウストチトリド目のメンバー
である。トロウストチトリド(ヤブレツボカビ類)は数
奇な分類上の歴史をもつ海の有核生物である。トロウス
トチトリドの分類学上の位置についての問題は、最近、
Moss(1986)、とBahnweb とJackle(1986)、及びと
Chamberlain とMoss(1988)によって概括されてい
る。便宜上、トロウストチトリドは最初、分類学者によ
って、藻菌類(藻類様菌類)の中の他の無色のべん毛菌
類と共に位置づけられた。しかしながら、藻菌類の名
は、結局は分類学上の地位から脱落し、トロウストチト
リドは卵藻類の中にとどまった(二べん毛べん毛菌
類)。卵藻類はヘテロコント藻類に関係づけられると最
初仮定され、ついにはBarr(1983)によりまとめられ
た広汎な超微細構造また生化学的な研究からこの仮定が
支持された。卵藻類は事実、Leedal(1974)と他の藻
類学者によって、ヘテロコント藻類の一部であるとして
受け入れられた。しかしながら、それらのヘテロトロピ
ックな性質に起因して便宜的に、卵藻類とトロウストチ
トリドは、藻類学者(藻類を研究する学者)よりも、菌
類学者(菌類を研究する学者)によって多く研究されて
きた。
All strains of the unicellular microorganisms disclosed and claimed herein are members of the order Thraustochytrid. Thraustochytrids (Thysanoptera: Thraustochytrids) are marine eukaryotes with a strange taxonomic history. The question of the taxonomic position of Troost Titolide has recently been
Moss (1986), and Bahnweb and Jackle (1986), and Chamberlain and Moss (1988). For convenience, Troost Titolide was initially positioned by taxonologists along with other colorless flagellate fungi in algae (algae-like fungi). However, the name of the algae eventually dropped out of taxonomic status, and troost titride remained in the egg algae (Nippugella). Oocytes were initially hypothesized to be related to heterocompetes, and extensive ultrastructural and biochemical studies summarized by Barr (1983) supported this assumption. Egg algae were in fact accepted by Leedal (1974) and other algaeologists as being part of the heterocone algae. However, expediently due to their heterotrophic nature, egg algae and troost titride are studied more by mycologists (scholars studying fungi) than by algaeologists (scholars studying algae). Have been.

【0051】他の分類学的な観点から、革新的な生物学
者の間で、有核生物がどのようにして発生したかについ
て、考え方での二つの一般的な学派が生まれた。一つの
理論では、一連の内部共生を通して膜結合性オルガネラ
の外因性の起源を提案している(Margulis(1970);例
えば、ミトコンドリアはバクテリヤの内部共生に由来
し、クロロプラストは卵藻類に、また、フラケラはスピ
ロヘータに由来)。他の理論は、オートジーンプロセス
を経て、原核生物の先祖の非膜結合性システムから膜結
合性オルガネラが徐々に発生したことを示唆している
(Cavalier-Smith 1975)。この両者の革新的生物学者の
グループは、しかしながら、卵藻類とトロウストチトリ
ドを菌類から除き、それらを褐色植物界の褐色藻類に
(Calvalier-Smith 1981)、あるいはプロトクチスタ(P
rotoctista)界のすべての藻類の中に(Margulis とSag
an 1985)位置づけている。
From another taxonomic point of view, among the innovative biologists, two general schools of ideas have emerged on how nucleated organisms arise. One theory proposes an exogenous source of membrane-bound organelles through a series of endosymbiosis (Margulis (1970); for example, mitochondria are derived from endosymbiosis of bacteria, chloroplasts are found in ovaries, and , Flakera is derived from spirochetes). Other theories suggest that membrane-associated organelles evolved gradually from non-membrane-associated systems of prokaryotic ancestors via the autogene process (Cavalier-Smith 1975). However, both groups of innovative biologists, however, have removed oocytes and troost titrides from the fungi and replaced them with brown algae of the brown plant kingdom (Calvalier-Smith 1981), or protoctistas (P.
rotoctista) Among all algae in the world (Margulis and Sag
an 1985).

【0052】電子顕微鏡の発達に伴い、トロウストチト
リドの2つの属、トロウストチリウムとシゾチトリウム
の遊走子の超構造についての研究(Perkins 1976;Kaz
ama1980;Barr 1981)は、トロウストチトリアセ(ヤブ
レツボカビ)は卵藻類とかなり離れた関係にあることの
良い証拠を提供している。さらに、5SリボソームRN
A配列の対応分析(多変量統計の形)を示すより最近の
遺伝子データは、トロウストチトリアレは明らかに、有
性生物中で特異なグループであって、菌類とは完全に分
離され、紅藻類及び褐藻類並びに卵藻類の仲間と最も密
接な関係にあることを示している(Mannella 他、198
7)。しかしながら最近、大部分の分類学者は卵藻類から
トロウストチトリドを除くことに同意している(Bartni
cki-Garcia, 1988)。
With the development of electron microscopy, a study on the ultrastructure of the zoospores of two genus of troostrichtolide, troustyrium and schizochytrium (Perkins 1976; Kaz)
ama 1980; Barr 1981) provide good evidence that Troost titriaceae (Thysanoptera: Thraustochytriales) is quite distantly related to egg algae. Furthermore, 5S ribosome RN
More recent genetic data showing A sequence correspondence analysis (in the form of multivariate statistics) indicate that Troost chitriales are clearly a unique group in sexual organisms, completely isolated from fungi, Algae, brown algae, and egg algae, indicating the closest relationship (Mannella et al., 198
7). Recently, however, most taxonomies have agreed to remove troost titride from egg algae (Bartni
cki-Garcia, 1988).

【0053】まとめると、Cavalier-Smith (1981, 19
83) の分類システムを使用すれば、トロウストチトリド
は4つの植物界の1つである、褐色植物界の中の褐色
(chro-mophyta)藻類に分類される。これにより、それ
らは、Eufungi 界にすべてが位置する菌類とは完全に
異なった界に位置づけられる。従って、トロウストチト
リド類の分類学的な位置は以下のようにまとめられる。 界: 褐色植物(クロモフィタ) 門: ヘテロコンタ 目: トロウストチトリアレ 族: トロウストチトリアセ(ヤブレツボカビ) 属: トロウストチトリウムまたはシゾチトリウム より上位の分類である界及び門の中での分類学的な位置
づけは不明確であるにもかかわらず、トロウストチトリ
ドは、そのメンバーを依然として、トロウストチトリア
レ目の中に分類可能な区別しうる特徴的なグループとし
て存在している。
In summary, Cavalier-Smith (1981, 19
Using the classification system of 83), troost titride is classified as a brown (chro-mophyta) algae in the brown plant kingdom, one of four plant kingdoms. This places them in a completely different kingdom from fungi that are all located in the kingdom Eufuguni. Therefore, the taxonomic position of troost titrides is summarized as follows. Genus: brown plant (chromophyta) phylum: heteroconta eyes: troost chitriale tribe: troost titriaceae (genus Thraustochytriales) genus: taxonomic within the genus and phyla, which is a higher class than troost titorium or Schizochytrium Despite its unclear position, Troost titride still exists as a distinctive distinctive group of its members, which can be classified in the order Troost titria.

【0054】ω-3高度不飽和脂肪酸は、人間及び動物
の双方にとって、栄養として重要な脂肪酸である。現
在、市販されている唯一のこれらの脂肪酸源は魚油から
のものである。しかしながら、魚油を食品もしくは餌の
添加物あるいは補助物として用いる場合には、いくつか
の重大な問題が存在する。第一の、そして最も重大なも
のとして、魚油は強烈な魚臭及び魚味を有し、そのまま
では食用製品にマイナスの影響を与えることなく加工食
品に添加物として加えることはできない。このことは、
動物の食品または餌の添加物としてのその多くの用途に
おいても同様である。例えば、本発明者や他の人々によ
る実験で、魚油を多く含む餌を数日以上与えると、産卵
めんどりはその餌を直ちに嫌いになることが明らかとな
っている。魚油は非常に不安定であり、すぐに腐敗臭が
するようになり、これにより餌のおいしさ及び栄養価が
減少してしまう。
Ω-3 polyunsaturated fatty acids are nutritionally important fatty acids for both humans and animals. Currently, the only source of these fatty acids that is commercially available is from fish oil. However, there are some significant problems when using fish oils as food or feed additives or supplements. First and most importantly, fish oils have an intense fishy odor and taste and cannot be added as such to processed foods without adversely affecting edible products. This means
The same is true for its many uses as an additive to animal food or feed. For example, experiments by the present inventors and others have shown that spawning hens immediately hate the diet when fed a diet rich in fish oil for more than a few days. Fish oil is very unstable and soon becomes putrid odor, which reduces the palatability and nutritional value of the food.

【0055】第二に、魚油は一般に20〜30%のω-
3HUFAしか含んでいない。海の幼魚及び海老の餌中
に望ましいω-3HUFA含量はその乾燥重量の5〜1
0%程度でありうる。5〜10%のω-3HUFAを含
む好適な合成食料を構成するためには、15〜30%が
魚油の食料を必要とする。このような合成食料は、これ
らの幼い生物にとって、おいしさ、消化性、あるいは安
定性のいずれかの点で最適のものではない(Sargent
他、1989)。人間の栄養という観点では、魚油中の他の
70〜80%の脂肪酸は飽和脂肪酸及びω-6脂肪酸で
あり、人間にとって健康に悪影響を及ぼしうる。魚油か
ら純粋なω-3脂肪酸を単離するプロセスを含むとコス
トがかかり、得られる純粋な形の脂肪酸は極めて高価
(200〜1000ドル/g)なものとなり、食品や餌
の添加物として使用するにはあまりにも高価すぎる(Si
gma Chemical, Co., 1988; CalBiochem Co., 1988)。
Second, fish oils generally have 20-30% ω-
Contains only 3HUFA. Desirable ω-3 HUFA content in marine juvenile and shrimp diets is 5 to 1% of its dry weight.
It can be as low as 0%. To constitute a suitable synthetic food containing 5-10% omega-3 HUFA, 15-30% requires a fish oil food. Such synthetic foods are not optimal for these young organisms in terms of taste, digestibility, or stability (Sargent
Et al., 1989). In terms of human nutrition, the other 70-80% of the fatty acids in fish oil are saturated fatty acids and ω-6 fatty acids, which can adversely affect human health. Including the process of isolating pure ω-3 fatty acids from fish oil is costly and the pure form of the resulting fatty acids can be very expensive ($ 200-1000 / g) and used as an additive in food and feed Too expensive (Si
gma Chemical, Co., 1988; CalBiochem Co., 1988).

【0056】第三に、農産物産業で現在使用されている
大部分の餌は穀物をベースとする餌であり、そのままで
はω-3HUFA含量は比較的低い。最近の海産物の調
査において、水産養殖場で製造された魚及び海老は、一
般に、野性の捕獲された魚や海老のω-3HUFA含量
の1/3〜1/2しか有していないことが明らかとなっ
ている(Pigott, 1989)。水産養殖生物は、多くが、そ
のマイルドさ、魚臭がしないことのゆえに賞賛されてい
るが、その食品の魚油含量を増加させることは、魚の味
のする製品としてしまう点で、有効なことではない。
Third, most baits currently used in the agricultural industry are cereal-based baits, which have relatively low ω-3 HUFA content. Recent surveys of marine products have revealed that fish and shrimps produced in aquaculture generally have only one-third to one-half the ω-3 HUFA content of wild-caught fish and shrimps. (Pigott, 1989). Aquaculture organisms are often praised for their mildness and lack of fishy odor, but increasing the fish oil content of their food is not as effective as a fish-tasting product. Absent.

【0057】上述した問題の結果として、ω-3HUF
Aの別の(魚由来でない)源を開発することが重要な課
題として存在する。
As a result of the above problem, ω-3HUF
Developing another (non-fish-derived) source of A exists as a significant challenge.

【0058】本発明の微生物産物は、食品あるいは餌の
補助物として使用でき、従来の源に比べて優れた利点を
有するω-3高度不飽和脂肪酸のより良い源を提供す
る。この微生物産物を添加した食料で養われた家禽は、
ω-3高度不飽和脂肪酸を体組織や卵に取り込む。この
卵は、全く魚臭がしないし、魚の味もしない。また、黄
身の色にも変化は全くない。家禽は、魚油添加食餌のと
きのようには、その添加食餌を食べることを止めない。
本発明の微生物産物を添加した餌は、通常の棚寿命をも
ち、数日間室温で放置しても腐敗臭を発しない。本発明
にしたがって、飼育された家禽の卵及び肉は、ω-6脂
肪酸含量は低く、魚臭は全くしないままで、ω-3高度
不飽和脂肪酸源として、人間の栄養物に有用である。
The microbial products of the present invention can be used as food or feed supplements and provide a better source of ω-3 polyunsaturated fatty acids with significant advantages over conventional sources. Poultry raised on food supplemented with this microbial product,
Incorporates ω-3 highly unsaturated fatty acids into body tissues and eggs. This egg has no fishy odor and no fishy taste. Also, there is no change in the color of the yolk. Poultry does not stop eating its supplemental diet as it does on a fish oil supplemented diet.
The bait to which the microbial product of the present invention is added has a normal shelf life and does not emit putrid odor even when left at room temperature for several days. In accordance with the present invention, bred poultry eggs and meat are useful in human nutrition as a source of ω-3 highly unsaturated fatty acids, while having a low ω-6 fatty acid content and no fishy odor.

【0059】本発明の微生物産物は、また、水産養殖で
生産された魚、海老、及び他の産物に対するω-3高度
不飽和脂肪酸源としても価値がある。産物は餌に補助物
として直接添加することができ、あるいは水産養殖産物
によって消費するための塩水海老、又は他の生きた餌生
物に食べさせることもできる。このような補助物を用い
ることによって、養殖によってもたらされる食味上の利
点を保持し、一方ω-6脂肪酸含量が減少した付加的な
健康上の利点を伴った野性の魚のような高いω-3高度
不飽和脂肪酸含量を有する改良された製品を、魚や海老
養殖業者が市場に出すことが可能となる。
The microbial products of the present invention are also valuable as sources of ω-3 highly unsaturated fatty acids for fish, shrimp, and other products produced in aquaculture. The product can be added directly to the diet as a supplement, or it can be fed to salted shrimp or other live prey for consumption by aquaculture products. By using such supplements, high ω-3, such as wild fish, with the additional health benefits of reduced ω-6 fatty acid content, while retaining the taste benefits provided by aquaculture. Improved products with a high unsaturated fatty acid content can be marketed by fish and shrimp farmers.

【0060】[0060]

【実施例1】収集とスクリーニング 浅い、内陸部の塩水池から150mlの水試料を収集
し、滅菌したポリエチレン瓶に保存した。水試料ととも
に、いくらかの生きた植物材料と天然由来の破片(分解
しつつある植物および動物分)が含まれるように特に努
力した。実験室に戻るまで、試料を氷上においた。実験
室で、水試料を15〜30秒振とうし、以下の2つのタ
イプのフィルターを有するフィルターユニットに、1〜
10mlの試料をピペットでとり注入した。2つのフィ
ルターは、 1)上部に、孔経約25μmで、直径47mm
の滅菌したワットマン#4フィルター及び 2)ワットマ
ンフィルターの下に、孔経約1.0μmで直径47mmのポ
リカーボネートフィルターである。フィルターの公称孔
径をこのように少し変えることによって、ポリカーボネ
ートフィルター上に集められた細胞の大きさが約1.0
μm〜約25μmの範囲となる。
Embodiment 1Collection and screening  Collect 150ml water sample from shallow, inland saltwater pond
And stored in sterile polyethylene bottles. With water sample
With some living plant material and naturally occurring debris (degraded
(Plants and animals that are growing).
Strengthened. Samples were kept on ice until returning to the laboratory. Experiment
In the chamber, shake the water sample for 15 to 30 seconds, and
1 to the filter unit having a filter of Ip
A 10 ml sample was pipetted and injected. Two files
Luther, 1) At the top, about 25μm in diameter, 47mm in diameter
Sterile Whatman # 4 filter and 2) Whatman
Under the filter, a hole with a hole of about 1.0 μm and a diameter of 47 mm
It is a carbonate filter. Nominal hole of filter
By slightly changing the diameter in this way, polycarbonate
The size of the cells collected on the
μm to about 25 μm.

【0061】ワットマンフィルターは取り出して捨て
た。ポリカーボネートフィルターをペトリ皿中の個体F
-1培養基上においた。この培養基は、1リットル当り
以下のものを含んでいた:海水(人口海水を使用でき
る)600ml,蒸留水400ml,寒天10g,グルコ
ース1g,タンパク質加水分解物1g,酵母エキス0.2
g,0.1MKH2PO4 2ml,ビタミン溶液(A-vit
s),(100ml/lのチアミン、0.5mg/lのビオチ
ン、及び0.5mg/lのシアノコバラミンを含む)1m
l,微量金属混合物5ml(PII金属、1リットル当
り、Na2EDTA 6.0g、FeCl3・6H2O 0.29
g、H3BO3 6.84g、MnCl2・4H2O 0.86g、
ZnCl2 0.06g、CoCl2・6H2O 0.29g、(N
iSO4・H2O 0.052g、CuSO4・5H2O 0.00
2g、と Na2MoO4・2H2O 0.005g、並びに50
0mgづつのストレプトマイシン硫酸塩及びペニシリン
G。寒天プレートは暗所、30℃でインキュペートし
た。2〜4日後、無数のコロニーがフィルター上に出現
した。単細胞菌類(酵母を除く)のコロニーをプレート
から取り出して、同様組成の新しい培養基プレート上に
再ストリークした。無色または白色の細胞からなるすべ
てのコロニーを取り出すように特に注意を払った。新し
いプレートを30℃でインキュベートし、2〜4日のイ
ンキュベート期間の後に、単一コロニーを取り出した。
単一コロニーを取りだし、次いで寒天プレート中と同じ
有機分増強物を含む50mlの液体培養基にいれた。こ
の培養基を回転振とうテーブル(100〜200rpm)
上、30℃で2〜4日間インキュベートした。培養物が
最大密度に到達したと思われたときに、20〜40ml
の培養物を収穫し、遠心にかけ、そして凍結した。その
後、試料を標準的なよく知られたガスクロマトグラフィ
ー法(例えば、Lepage とRey、1984)によって分析
し、その株の脂肪酸含量を同定した。これにより、ω-
3高度不飽和脂肪酸を含む株を同定し、これの株の培養
物をさらにスクリーニングにかけた。
The Whatman filter was removed and discarded. Solid F in Petri dish with polycarbonate filter
-1 was placed on a culture medium. The culture medium contained the following per liter: 600 ml of seawater (we can use artificial seawater), 400 ml of distilled water, 10 g of agar, 1 g of glucose, 1 g of protein hydrolyzate, 0.2 g of yeast extract.
g, 0.1 MKH 2 PO 4 2 ml, vitamin solution (A-vit
s), 1 m (containing 100 ml / l thiamine, 0.5 mg / l biotin, and 0.5 mg / l cyanocobalamin)
1, 5 ml of trace metal mixture (PII metal, 6.0 g of Na 2 EDTA, 0.29 of FeCl 3 .6H 2 O per liter)
g, H 3 BO 3 6.84g, MnCl 2 · 4H 2 O 0.86g,
0.06 g of ZnCl 2 , 0.29 g of CoCl 2 .6H 2 O, (N
iSO 4 · H 2 O 0.052g, CuSO 4 · 5H 2 O 0.00
2 g, and 0.005 g of Na 2 Mo 4 .2H 2 O, and 50
0 mg of streptomycin sulfate and penicillin G. The agar plate was incubated at 30 ° C. in the dark. After 2 to 4 days, countless colonies appeared on the filter. Colonies of unicellular fungi (excluding yeast) were removed from the plates and restreaked on fresh medium plates of similar composition. Particular care was taken to pick out all colonies consisting of colorless or white cells. New plates were incubated at 30 ° C and single colonies were picked after an incubation period of 2-4 days.
Single colonies were picked and then placed in 50 ml broth containing the same organic enhancers as in the agar plates. Rotating and shaking the culture medium (100-200 rpm)
And incubated at 30 ° C. for 2-4 days. When the culture appears to have reached maximum density,
Cultures were harvested, centrifuged and frozen. The sample was then analyzed by standard well-known gas chromatography methods (eg, Lepage and Rey, 1984) to identify the fatty acid content of the strain. Thus, ω-
Strains containing the three highly unsaturated fatty acids were identified and cultures of these strains were further screened.

【0062】上記した収集法及びスクリーニング法を用
いて、150を越える単細胞菌類の株が単離された。こ
れらの株は、灰分を除いた全細胞乾燥重量の32%まで
のω-3高度不飽和脂肪酸含量を有し、15〜48℃の
範囲の温度で増殖する。1%未満の(全脂肪酸に対する
%として)望ましくないC20:4w6及びC22:5w
6高度不飽和脂肪酸を含む株も単離することができる。
これらの菌類の株は、上記した方法を用いて、同じ場所
から繰り返し単離できる。二、三の新たに単離された株
は、大変よく似た脂肪酸プロフィールを有する。幾つか
のものは同じ株の二重の単離物である可能性も現在のと
ころ否定できない。塩分許容性あるいは種々の炭素源及
び窒素源の使用能力のような他の望ましい特徴について
さらにスクリーニングすることも、同様の方法を用いて
その後行うことができる。
Using the collection and screening procedures described above, more than 150 strains of unicellular fungi were isolated. These strains have an ω-3 polyunsaturated fatty acid content of up to 32% of the total cell dry weight, excluding ash, and grow at temperatures ranging from 15 to 48 ° C. Less than 1% undesired C20: 4w6 (as% of total fatty acids) and C22: 5w
Strains containing 6 highly unsaturated fatty acids can also be isolated.
Strains of these fungi can be repeatedly isolated from the same location using the methods described above. A few newly isolated strains have very similar fatty acid profiles. It is currently undeniable that some may be double isolates of the same strain. Further screening for other desirable characteristics, such as salinity tolerance or the ability to use various carbon and nitrogen sources, can be performed subsequently using similar methods.

【0063】[0063]

【実施例2】非制限的細胞増殖の維持:リン 実施例1の方法で単離した株、トロウストチリウム sp.
U42-2(ATCC番号20891)の細胞を固体F-
培養基から取りだし、50mlの修飾FFM培養基(Fu
ller 他,1964)に接種した。この培養基は、海水 10
00ml;グルコース 1.0g;ゼラチン加水分解物 1.
0g;肝臓エキス 0.01g;酵母エキス 0.1g;PI
I金属類 5ml;1mlのB-ビタミン類溶液(Goldstei
n 他、1969);および1mlの抗生物質溶液(25g/l
のストレプトマイシン硫酸塩とペニシリンG)を含む。
1.0mlのビタミンミックス(pH7.2)は、チアミン
塩酸塩 200μg;ビオチン 0.5μg;シアノコバラ
ミン 0.05μg;ニコチン酸 100μg;パントテン
酸カルシウム 100μg;リボフラビン 5.0μg;ピ
リドキシン塩酸塩 40.0μg;ピリドキサミン二塩酸
塩 20.0μg;p-アミノ安息香酸 10μg;クロリン
塩酸塩 500μg;イノシトール 1.0mg;チミン 0.
8mg;オロチン酸 0.26mg;フォリニン酸 0.2μ
g、及び葉酸 2.5μg含む。この培養基 50mlの入っ
た250mlの三角フラスコを27℃のオービタル振と
う器(200rpm)上に2〜4日間置いた。この時点で
培養物はその最高密度に達した。この培養物の1ml
を、1リットル当り以下の処理剤の1つを余分に添加し
た修飾FFM培養基の入った新しいフラスコに移した:
1)1mlのB-ビタミンミックス; 2)1mlのA-ビタ
ミン溶液; 3)5mlのPII金属類; 4)2mlの0.
1MKH2PO2(〜28mg); 5)2、3、及び4の処
理剤の組み合わせ;並びに 6)480mgのKH2PO4
培養物の1mlを、また、余分の添加剤を含まない修飾
FFM培養基のフラスコに接種し、実験におけるコント
ロールとした。培養物を回転振とう器(200rpm)
上、27℃で48時間インキュベートした。その後、細
胞を遠心分離によって収穫し、脂肪酸をガスクロマタグ
ラフィーで定量した。その結果を図1及び表1に示す。
図1においては、収量をコントロールとの比としてプロ
ットしてあり、従ってコントロールの相対的収量は1.
0である。1〜6の処理は次の通り: 1)2×Bビタミ
ン類の濃度; 2)2×Aビタミン類の濃度; 3)2×微
量金属類の濃度; 4)2×(Bビタミン類+リン酸塩+
微量金属類)の濃度; 5)2×リン塩酸の濃度;及び
6)50ml当り24mgのリン酸塩(1リットル当り0.
48g)。1リットル当り0.48gのKH24を添加する
処理のみが、増殖の促進をもたらし、また有意に増大し
た脂肪酸収量をもたらした。
Embodiment 2Maintaining unrestricted cell growth: phosphorus  A strain isolated by the method of Example 1, Troostylium sp.
U42-2 (ATCC No. 20891) cells were transformed into solid F-
Remove from the medium and add 50 ml of modified FFM medium (Fu
ller et al., 1964). This culture medium contains seawater 10
00 ml; glucose 1.0 g; gelatin hydrolyzate 1.
0 g; liver extract 0.01 g; yeast extract 0.1 g; PI
I metals 5 ml; 1 ml of B-vitamin solution (Goldstei
n et al., 1969); and 1 ml of antibiotic solution (25 g / l)
Streptomycin sulfate and penicillin G).
1.0 ml of vitamin mix (pH 7.2) is thiamine
Hydrochloride 200 μg; biotin 0.5 μg; cyanocoba
Min 0.05 μg; Nicotinic acid 100 μg; Pantothene
Calcium acid 100 μg; riboflavin 5.0 μg;
Lidoxin hydrochloride 40.0 μg; pyridoxamine dihydrochloride
Salt 20.0 μg; p-aminobenzoic acid 10 μg; chlorin
Hydrochloride 500 μg; inositol 1.0 mg; thymine 0.
8 mg; orotic acid 0.26 mg; folinic acid 0.2 μ
g and 2.5 μg of folic acid. 50ml of this culture medium
250 ml Erlenmeyer flask with 27 ° C orbital shake
It was placed on a container (200 rpm) for 2-4 days. at this point
The culture has reached its highest density. 1 ml of this culture
And add one extra treatment agent per liter
Transferred to a new flask containing the modified FFM medium:
 1) 1 ml of B-vitamin mix; 2) 1 ml of A-vita
Min solution; 3) 5 ml of PII metals; 4) 2 ml of 0.
1MKHTwoPOTwo(-28 mg); 5) Treatment of 2, 3, and 4
6) 480 mg of KHTwoPOFour.
1 ml of culture, also modified without extra additives
Inoculate flasks of FFM medium and control
Roll. Rotating the culture with a rotary shaker (200 rpm)
And incubated at 27 ° C. for 48 hours. Then,
The cells are harvested by centrifugation and the fatty acids are
Quantified by luffy. The results are shown in FIG.
In FIG. 1, the yield is expressed as the ratio to the control.
The relative yield of the control is therefore 1.
0. The processing of 1 to 6 is as follows: 1) 2 × B Vitamins
2) Concentration of 2 × A vitamins; 3) 2 × fine
4) 2 x (B vitamins + phosphate +
5) 2x concentration of phosphoric acid; and
6) 24 mg of phosphate per 50 ml (0.1 per liter)
48g). 0.48 g of KH per literTwoOFourAdd
Treatment alone results in enhanced growth and significantly increases
Fatty acid yield.

【0064】[0064]

【表1】 [Table 1]

【0065】[0065]

【実施例3】非制限的生長の維持:PO4及び酵母エキス シゾチトリウムアグレガタム(Schizuchytrium aggrega
tum)(ATCC番号28209)の細胞を固体F-1培
養基から取り出して、50mlのFFM培養基に接種し
た。培養物を27℃の回転振とう器(200rpm)上に
置いた。3〜4日後、この培養物の1mlをそれぞれ以
下の処理剤 50mlに移した: 1)FFM培養基(コン
トロ-ルとして);及び 2)KH2PO4 250mg/l及
び酵母エキス250mg/lを添加したFFM培養基。こ
れらの培養物を27℃の回転振とう器(200rpm)上
に48時間置いた。細胞を収穫し、細胞の収量を定量し
た。処理1において、灰分を除いた乾燥重量基準で、細
胞の最終濃度は616mg/lであった。処理2では、細
胞の最終濃度は1675mg/lであり、培養基中のPO
4 及び酵母エキスの濃度の増大が促進効果を与えるこ
とを示している。
Embodiment 3Maintaining unrestricted growth: PO4 and yeast extract  Schizuchytrium aggrega
tum) (ATCC No. 28209) on a solid F-1 medium.
Remove from nutrient medium and inoculate 50ml FFM medium
Was. The culture is placed on a 27 ° C. rotary shaker (200 rpm).
placed. After 3-4 days, 1 ml of this culture was
The following treatment was transferred to 50 ml: 1) FFM medium (con
And 2) KHTwoPOFour 250mg / l
And an FFM culture medium to which 250 mg / l of yeast extract was added. This
These cultures are placed on a rotary shaker (200 rpm) at 27 ° C.
For 48 hours. Harvest cells and quantify cell yield
Was. In treatment 1, fine weight on a dry weight basis excluding ash
The final concentration of vesicles was 616 mg / l. In process 2,
The final concentration of the vesicles is 1675 mg / l,
FourIncrease in yeast and yeast extract concentration has a promoting effect.
Are shown.

【0066】[0066]

【実施例4】非制限的生長の維持:酵母エキスをコーン
浸漬液に代替 シゾチトリウム sp.S31(ATCC番号20888)
の細胞を固体F-1培養基から取りだし、50mlのM-
5培養基にいれた。この培養基は、(1リットル当り
に)、NaCl 25g;MgSO4・7H2O 5g;KCl
1g;CaCl2 200mg;グルコ-ス 5g;グルタメ-ト
5g;KH2PO4 1g;PII金属類 5ml;A-ビタ
ミン溶液 1ml;及び抗生物質溶液1mlからなってい
る。溶液のpHを7.0に調整し、溶液をフィルタ-滅菌
した。コーン浸漬液(4g/40ml;pH7.0)及び酵
母エキス(1g/40ml;pH7.0)の滅菌溶液を調製
した。M-5培養基フラスコ1セットに、次の量の酵母
エキス溶液を加えた: 1)2ml; 2)1.5ml; 3)1
ml; 4)0.5ml;及び 5)0.25ml。M-5培養基
フラスコの他の1セットには、以下の量の酵母エキス及
びコーン浸漬液を加えた: 1)2mlの酵母エキス; 2)
1.5mlの酵母エキスと0.5mlのコーン浸漬液; 3)
1.0mlの酵母エキスと1.0mlのコーン浸漬液; 4)
0.5mlの酵母エキスと1.5mlのコーン浸漬液;及び
5)2mlのコーン浸漬液。F-1培養基中の培養物1m
lを用いて各々のフラスコに接種した。それらを27℃
の回転振とう器上に48時間置いた。細胞を遠心分離器
によって収穫し、細胞の収量を(灰分を除いた乾燥重量
として)定量した。結果を表2に示す。この結果は、培
養器の0.8g/lまで酵母エキスを添加すると細胞収量
が増加することを示している。しかしながら、コーン浸
漬液の添加はさらに効果的であり、酵母エキスの添加処
理での収量の2倍という結果が得られた。コーン浸漬液
は酵母エキスに比べてより安価であるので、このこと
は、細胞の経済的な生産にとって極めて好都合である。
Embodiment 4Maintaining unrestricted growth: Yeast extract with corn
Substitute with immersion liquid  Schizochytrium sp.S31 (ATCC No. 20888)
Of cells from the solid F-1 culture medium and 50 ml of M-
Five culture media were added. This medium is (per liter
), 25 g of NaCl; MgSOFour・ 7HTwoO 5g; KCl
1 g; CaClTwo 200mg; Glucose 5g; Glutamate
 5g; KHTwoPOFour 1 g; PII metals 5 ml; A-Vita
1 ml of Min solution; and 1 ml of antibiotic solution
You. Adjust the pH of the solution to 7.0 and filter-sterilize the solution
did. Corn immersion liquid (4 g / 40 ml; pH 7.0) and yeast
Prepare sterile solution of mother extract (1g / 40ml; pH 7.0)
did. Add the following amount of yeast to one set of M-5 culture flasks.
The extract solution was added: 1) 2 ml; 2) 1.5 ml; 3) 1
4) 0.5 ml; and 5) 0.25 ml. M-5 culture medium
The other set of flasks contains the following amounts of yeast extract and
And corn immersion liquid were added: 1) 2 ml yeast extract; 2)
1.5 ml of yeast extract and 0.5 ml of corn soak; 3)
1.0 ml yeast extract and 1.0 ml corn immersion liquid; 4)
0.5 ml yeast extract and 1.5 ml corn steep solution; and
 5) 2 ml of cone immersion liquid. 1m of culture in F-1 medium
1 was used to inoculate each flask. 27 ° C
Was placed on a rotary shaker for 48 hours. Centrifuge cells
Cell yield (dry weight excluding ash)
As). Table 2 shows the results. This result is
When the yeast extract is added to 0.8 g / l of the culture vessel, the cell yield
Is increasing. However, corn soak
The addition of the pickling solution is more effective,
The result was twice the theoretical yield. Cone immersion liquid
This is cheaper than yeast extract,
Is very advantageous for economical production of cells.

【0067】[0067]

【表2】 [Table 2]

【0068】[0068]

【実施例5】ATCC株(従来から知られていた株)に
比べて、実施例1の方法で単離された株の高度不飽和脂
肪酸含量が多いこと。 実施例1に記載された方法に従って選択された、151
の新たに単離された株のバッテリーを指数増殖期の後期
にサンプリングし、気液クロマトグラフィーにより、高
度不飽和脂肪酸含量を定量的に分析した。すべての株
は、細胞が最高の収量を与える、M1培養基あるいは液
体FFM培養基のいずれかの中で増殖させた。さらに、
五つの先に単離されていたトロウストチリウムまたはシ
ゾチトリウム種を、American Type Culture Collec
tion から得、この機関から生きた状態で得られるすべ
ての株の代表とした。T.オウレウム(ATCC番号2
8210)、T.オウレウム(ATCC番号3430
4)、T.ロゼウム(ATCC番号28210)、T.スト
ライチューム(ATCC番号34473)と S.アグレ
ガチューム(ATCC番号28209)。これらの株は
すべて従来の培養基中で成長を示し、一般にM5培養基
及びFFM培養基を含む本発明の培養基中でより向上し
た増殖を示す(実施例2)。既知の株のそれぞれの脂肪
酸産生は、本発明の培養基中で株のより向上した成長に
基づいて、上述のように、測定した。
Embodiment 5ATCC shares (formerly known strains)
In comparison, the highly unsaturated fat of the strain isolated by the method of Example 1
High fatty acid content.  151 selected according to the method described in Example 1
The battery of newly isolated strains in late exponential phase
Sampled by gas-liquid chromatography.
The unsaturated fatty acid content was quantitatively analyzed. All strains
Means that the cells give the highest yield,
Grow in any of the somatic FFM media. further,
Five previously isolated troustyrium or thirst
Zochithotrium species were purchased from American Type Culture Collec
Everything that can be obtained from this institution and alive from this institution
Representative of all strains. T. aureum (ATCC No. 2
8210), T. aureum (ATCC No. 3430)
4), T. roseum (ATCC No. 28210), T. strike
Lightum (ATCC No. 34473) and S. Agre
Gatum (ATCC No. 28209). These strains
All show growth in conventional media and are generally M5 media
And in the culture medium of the present invention containing FFM culture medium.
(Example 2). Fat of each known strain
Acid production leads to improved growth of the strain in the culture medium of the present invention.
And measured as described above.

【0069】脂肪酸のピ-クは構造既知の純粋化合物を
用いて同定した。全脂肪酸の重量%としての定量は、ク
ロマトグラフのピークの積分によって行った。同定した
化合物は、パルミチン酸(C16:0)、C20:4w6
とC22:1(使用したシステムではピークが分離しな
かった)、C20:5w3、C22:5w6、C22:5w
3及びC22:6w3であった。通常低分子量脂肪酸で
ある残余は、「他の脂肪酸」のカテゴリーの中に一括し
て含ませた。全ω-3脂肪酸は、20:5w3、22:5
w3及び22:6w3の総和として計算した。全ω-6脂
肪酸は、20:4/22:1ピークと22:5w6ピ-クの
総和として計算した。
The peak of the fatty acid was identified using a pure compound having a known structure. Quantification of the total fatty acids as% by weight was performed by integration of the chromatographic peaks. The compounds identified were palmitic acid (C16: 0), C20: 4w6
And C22: 1 (peaks were not separated in the system used), C20: 5w3, C22: 5w6, C22: 5w
3 and C22: 6w3. Residues, which are usually low molecular weight fatty acids, were included in the "Other fatty acids" category. Total ω-3 fatty acids are 20: 5w3, 22: 5
Calculated as the sum of w3 and 22: 6w3. Total ω-6 fatty acids were calculated as the sum of the 20: 4/22: 1 peak and 22: 5w6 peak.

【0070】結果を表3〜4に示し、また図2〜4に示
した。表3から、多くの数の株が本発明の方法で単離す
ることができ、また多くの数の株が幾つかの重要な基準
において従来公知の株よりも優れている。例えば、10
2の株が全脂肪酸の少なくとも7.8重量%のC20:5
w3を産生し、この脂肪酸の%は従来公知のどの株より
も高い。株23B(ATCC番号20892)及び12
B(ATCC番号20890)がそのような株の例であ
る。本発明の30の株が、従来公知のどの株よりも多
い、全脂肪酸の少なくとも68重量%をω-3脂肪酸と
して産生した。株23B(ATCC番号20892)が
そのような株の一例である。本発明の76の株が人間の
食品成分として望ましくないと考えられるω-6脂肪酸
として、全脂肪酸の10重量%未満を産生し、この量は
従来公知のどの株よりも少ない。株23B(ATCC番
号20892)及び12B(ATCC番号20890)
がそのような株の例である。さらに、従来公知のどの株
よりも多い、全脂肪酸の25重量%以上をω-6脂肪酸
として産生する本発明の株が35ある。このような株は
食品用途には役立たないが、ω-6脂肪酸を原料とする
エイコサノイドの化学合成用に餌として有用である。
The results are shown in Tables 3 and 4 and in FIGS. From Table 3, a large number of strains can be isolated by the method of the invention, and a large number of strains outperform previously known strains in some important criteria. For example, 10
2 strains have at least 7.8% by weight of total fatty acids of C20: 5
w3, and the percentage of this fatty acid is higher than any previously known strain. Strains 23B (ATCC No. 20892) and 12
B (ATCC No. 20890) is an example of such a strain. Thirty strains of the present invention produced at least 68% by weight of total fatty acids as omega-3 fatty acids, more than any previously known strain. Strain 23B (ATCC number 20892) is an example of such a strain. Seventy-six strains of the present invention produce less than 10% by weight of total fatty acids as omega-6 fatty acids, which are considered undesirable as human food components, which is lower than any previously known strain. Strains 23B (ATCC No. 20892) and 12B (ATCC No. 20890)
Is an example of such a strain. In addition, there are 35 strains of the present invention that produce at least 25% by weight of total fatty acids as omega-6 fatty acids, which is greater than any previously known strain. Although such strains are useless for food applications, they are useful as feed for chemical synthesis of eicosanoids from ω-6 fatty acids.

【0071】さらに、デ-タから、本発明の多くの株が
全ω-3脂肪酸のうち高比率をC22:6w3として産生
することを示している。表4では、表2で示した48の
株を、従来公知の株と比較して、C20:5w3、C2
2:5w3及びC22:6w3の それぞれを全ω-3含量
の重量%で示している。15の株が、従来公知のどの株
よりも多い、全ω-3脂肪酸の少なくとも94%をC2
2:6w3として有していた。株S8(ATCC番号2
0889)がそのような株の一例であった。18の株
が、従来公知のどの株よりも多い、全ω-3脂肪酸の少
なくとも28重量%を C20:5w3として有してい
た。株12B(ATCC番号20890)がそのような
株の一例であった。
Further, the data indicate that many strains of the present invention produce a high proportion of total ω-3 fatty acids as C22: 6w3. In Table 4, the 48 strains shown in Table 2 were compared with the conventionally known strains in comparison with C20: 5w3, C2
Each of 2: 5w3 and C22: 6w3 is indicated by weight% of the total ω-3 content. Fifteen strains had at least 94% of the total omega-3 fatty acids in C2
2: 6w3. Strain S8 (ATCC No. 2
0889) was an example of such a strain. Eighteen strains had at least 28% by weight of total ω-3 fatty acids as C20: 5w3, more than any previously known strain. Strain 12B (ATCC number 20890) was an example of such a strain.

【0072】図2は、67%より多いω-3脂肪酸(全
脂肪酸の%として)及び、10.6%未満のω-6脂肪酸
(全脂肪酸の%として)を有する、実施例1の方法で単
離した一連の株を示している。すべての従来公知の株
は、67%未満のω-3脂肪酸(全脂肪酸の%として)
及び10.6%より多いω-6(全脂肪酸の%として)を
有していた。
FIG. 2 shows the method of Example 1 with more than 67% ω-3 fatty acids (as% of total fatty acids) and less than 10.6% ω-6 fatty acids (as% of total fatty acids). A series of isolated strains is shown. All previously known strains have less than 67% omega-3 fatty acids (as% of total fatty acids)
And greater than 10.6% ω-6 (as% of total fatty acids).

【0073】図3は、67%より多いω-3脂肪酸(全
脂肪酸の%として)及び7.5%より多いC20:5w3
(全脂肪酸の%として)を有する、実施例1の方法で単
離した一連の株を示している。すべての従来公知の株
は、67%未満のω-3脂肪酸(全脂肪酸の%として)
及び7.8%未満のC20:5w3(全脂肪酸の%とし
て)を有していた。
FIG. 3 shows that more than 67% of ω-3 fatty acids (as% of total fatty acids) and more than 7.5% of C20: 5w3
1 shows a series of strains isolated by the method of Example 1 having (as% of total fatty acids). All previously known strains have less than 67% omega-3 fatty acids (as% of total fatty acids)
And less than 7.8% C20: 5w3 (as% of total fatty acids).

【0074】[0074]

【表3】 [Table 3]

【表4】 [Table 4]

【表5】 [Table 5]

【表6】 [Table 6]

【表7】 [Table 7]

【0075】[0075]

【表8】 [Table 8]

【表9】 [Table 9]

【表10】 [Table 10]

【0076】[0076]

【実施例6】ATCC株(従来公知の株)に比べて、実
施例1の方法で単離した株が向上された成長速度を示す
こと。 シゾチトリウム sp.S31(ATCC番号2088
8)、シゾチリウム sp.S8(ATCC番号2088
9)、トロウストチリウム sp.S42、トロウストチリ
ウム sp.U42-2、トロウストチトリウム sp.S42
とU30(すべて実施例1の方法で単離)及びトロウス
トチトリウム、オウレウム(ATCC番号28211)
及びシゾチトリウム、アグレガタム(ATCC番号28
209)(従来公知の株)を固体F-1培養基からとり、
M-5培養基50mlに入れた。この培養基は(1リット
ル当りで)、酵母エキス 1g;NaCl 25g;MgSO4
・7H2O5g;KCl 1g;CaCl2 200mg;グル
コース 5g;グルタミン 5g;KH2PO4 1g;PII
金属類 5ml;A-ビタミン溶液 1ml;抗生物質 1m
lからなっていた。溶液のpHを7.0に調節し、溶液を
ろ過して滅菌した。オービタル振とう器(200rpm,
27℃)上で3日間増殖した後、各々の培養物1〜2m
lを他のフラスコのM-5培養基に移し、2日間振とう
器上に置いた。次いで培養物(1〜2ml)をM-5培養
基の入った他のフラスコの移し、振とう器上に1日置い
た。この方法により、すべての培養物が増殖の指数期に
あることを確実なものとした。これらの後期培養物を、
次いで、各々の株についてM-5培養基のはいった2つ
の250mlフラスコに接種するのに用いた。その後、
これらのフラスコを25℃と30℃で振とう器上に置
き、それらの光学密度の変化をベックマンDB-G分光
光度計(660nm,1cm光路長)でモニターした。光学
密度の読取りは、0,6,10,14,17.25,2
0.25及び22.75の各時間に行った。次いで、指数
増殖速度(倍化/日)を、Sorokin(1973)の方法によ
って、光学密度のデータから算出した。結果を表5に示
し、また(25℃での株U30の増殖に対して正規化し
て)図5に示す。データから、実施例1の方法で単離し
た株は、従来公知のATCC株に比べて、持続的な増殖
に必須の最適リン酸濃度においてすら、25℃及び30
℃の両方で、はるかに大きい増殖速度を有していること
が明かである。冷たい南極海の水から単離したトロウス
トチトリアレ目の株は、30℃では増殖しないことが判
る。
Embodiment 6Compared to ATCC strains (known strains),
Strain isolated by the method of Example 1 shows improved growth rate
thing.  Schizochytrium sp.S31 (ATCC No. 2088)
8), Schizotylium sp. S8 (ATCC No. 2088)
9), Troostillium sp. S42, Troost chili
U. sp. U42-2, Troost Titrium sp. S42
And U30 (all isolated by the method of Example 1) and Trous
Totitrium and aureum (ATCC No. 28211)
And Schizochytrium, Aggregatam (ATCC No. 28
209) (a conventionally known strain) was taken from a solid F-1 culture medium,
It was placed in 50 ml of M-5 culture medium. This medium is (1 liter
Per g of yeast extract, 1 g of yeast extract; 25 g of NaCl;Four
・ 7HTwoO5g; KCl 1g; CaClTwo 200 mg; guru
Course 5g; Glutamine 5g; KHTwoPOFour 1 g; PII
Metals 5 ml; A-vitamin solution 1 ml; antibiotics 1 m
l. The pH of the solution was adjusted to 7.0 and the solution was
Filtered and sterilized. Orbital shaker (200rpm,
27 ° C.) for 3 days, then 1-2 m of each culture
1 to another flask in M-5 medium and shake for 2 days
Placed on a bowl. The culture (1-2 ml) is then cultured in M-5.
Transfer the other flask containing the group and place it on a shaker for one day.
Was. This method ensures that all cultures are in the exponential phase of growth.
It was certain that there was. These late cultures are
Then, for each strain, add two M-5 culture media.
Used to inoculate a 250 ml flask. afterwards,
Place these flasks on a shaker at 25 ° C and 30 ° C.
And the change in their optical density is measured by Beckman DB-G spectroscopy.
Monitoring was performed with a photometer (660 nm, 1 cm optical path length). Optics
Density readings are 0, 6, 10, 14, 17.25, 2
Performed each time at 0.25 and 22.75. Then the index
The growth rate (doubling / day) was determined by the method of Sorokin (1973).
Thus, it was calculated from the optical density data. The results are shown in Table 5.
(Normalized for growth of strain U30 at 25 ° C.)
FIG. 5). From the data, isolated by the method of Example 1.
Strains have a sustained growth compared to previously known ATCC strains.
Even at the optimal phosphoric acid concentration essential for
Have a much higher growth rate at both ° C
Is clear. Trousers isolated from cold Antarctic waters
It was found that the strains of the order Candida do not grow at 30 ° C.
You.

【0077】[0077]

【表11】 [Table 11]

【0078】[0078]

【実施例7】ATCC株(従来技術の株)に比べて、実
施例1の方法で単離した株がより良好な産生特性(増殖
及び脂質誘起)を示すこと。 シゾチトリウム sp.S31(ATCC番号2088
8)、シゾチトリウム sp.S8(ATCC番号2088
9)(両方とも実施例1の方法で単離)、及びトロウス
トチトリウム オウレウム(ATCC番号2821
1)、シゾチトリウムアグレガタム(ATCC番号28
209)(従来技術の株)の細胞を固体F-1培養基か
ら取り、50mlのM-5培養基(実施例5参照)に入れ
た。容器のpHを7.0に調整し、溶液をろ過滅菌した。
オ-ビタル振とう器(200rpm,27℃)上で3日間増
殖させた後、各々の培養物の1〜2mlをM-5培養基の
入った他のフラスコの移し、2日間振とう器上に置い
た。次いで、これらの培養物それぞれの灰分を除いた乾
燥重量を素早く測定し、3.29mgの各培養物を50ml
のM-5培養基を含む2つの250ml三角フラスコにピ
ペットで入れた。これらのフラスコを回転振とう器(2
00rpm,27℃)上に置いた。24時間後、各培養物
の20mlづつを遠心分離し、上清を捨て、グルタメー
ト(窒素源)を含まない50mlのM-5培養基を含む2
50mlの三角フラスコに細胞を移した。フラスコを振
とう器上に再び置き、さらに12時間経た後、サンプリ
ングして、灰分を除いた乾燥重量を測定し、またLepag
e とRoy(1984)の方法により脂肪酸含量を定量した。
結果を(従来公知の株、ATCC番号28211の収量
を基に正規化して)図6に示す。この結果から、実施例
1の方法で単離した株は、従来技術のATCC株より
も、指数増殖と窒素制限(脂質誘起のため)の組み合せ
の下、同じ時間の間に、灰分を除いた乾燥重量で2〜3
倍多く産生することが認められる。さらに、本発明の株
では、全脂肪酸及びω-3脂肪酸の収量が向上し、株S
31(ATCC番号20888)では、従来技術のAT
CC株に比べてω-3脂肪酸を3〜4倍多く産生した。
Embodiment 7Compared to ATCC stock (prior art stock),
The strain isolated by the method of Example 1 has better production characteristics (growth)
And lipid-induced).  Schizochytrium sp.S31 (ATCC No. 2088)
8), Schizochytrium sp. S8 (ATCC No. 2088)
9) (both isolated by the method of Example 1), and Trous
Totrium Thorium (ATCC No. 2821)
1), Schizochytrium aggregatam (ATCC No. 28)
209) The cells of (prior art strain) were transformed into solid F-1 medium.
And place in 50 ml of M-5 medium (see Example 5)
Was. The pH of the container was adjusted to 7.0, and the solution was sterilized by filtration.
Increased for 3 days on an orbital shaker (200 rpm, 27 ° C)
After inoculation, 1-2 ml of each culture was added to M-5 medium.
Transfer the other flask and place it on a shaker for 2 days
Was. Then, each of these cultures was dried to remove the ash.
Quickly measure dry weight and add 3.29 mg of each culture to 50 ml
Into two 250 ml Erlenmeyer flasks containing the M-5 culture medium.
Put in pets. Rotate these flasks on a rotary shaker (2
00 rpm, 27 ° C.). After 24 hours, each culture
, Centrifuge 20 ml each and discard the supernatant.
2 containing 50 ml of M-5 medium without nitrogen (nitrogen source)
The cells were transferred to a 50 ml Erlenmeyer flask. Shake the flask
Put it on the bowl again, and after another 12 hours,
To determine the dry weight, excluding ash,
The fatty acid content was determined by the method of e and Roy (1984).
The results (yield of conventionally known strain, ATCC No. 28211)
FIG. From these results, the example
The strain isolated by the method 1 is different from the prior art ATCC strain.
Also a combination of exponential growth and nitrogen restriction (for lipid induction)
Under the same time, with the dry weight excluding ash,
It is found to produce twice as much. Further, the strain of the present invention
The yield of total fatty acids and ω-3 fatty acids was improved,
31 (ATCC No. 20888), the conventional AT
It produced 3-4 times more ω-3 fatty acids than the CC strain.

【0079】[0079]

【実施例8】実施例1の方法で単離した株による向上し
た塩分許容性と脂肪酸産生 シゾチトリウム sp.S31(ATCC番号20888)
とトロウストチトリウム sp.U42-2(ATCC番号
20891)(両方とも実施例1の方法で単離し、スク
リーニングした)、及びS.アグレガタム(ATCC番号
28209)とT.オウレウム(ATCC番号2821
0)(American type Culture Collectionより入手)
の4種のトロウストチトリウムの株を固体F-1培養基
から取り、回転振とう器(200rpm)上、27℃で3〜
4日間インキュベートした。ある範囲の異なった塩分濃
度の培養基を、M培養基塩類(NaCl,25g/l;M
gSO4・7H2O,5g/l;KCl,1g/l;CaC
2,200mg/l)を以下のように希釈して調整し
た。 1)100%(w/v M培養基塩類; 2)80%
(v/v)M培養基塩類、20%(v/v)蒸留水; 3)
60%(v/v)M培養基塩類、40%(v/v)蒸留
水; 4)40%(v/v)M培養基塩類、60%(v/
v)蒸留水; 5)20%(v/v)M培養基塩類、80
%(v/v)蒸留水; 6)15%(v/v)M培養基塩
類、85%(v/v)蒸留水; 7)10%(v/v)M培
養基塩類、90%(v/v)蒸留水; 8)7%(v/v)
M培養基塩類、93%(v/v)蒸留水; 9)3%(v/
v)M培養基塩類、97%(v/v)蒸留水; 10)1.
5%(v/v)M培養基塩類、98.5%(v/v)蒸留
水)。以下の栄養物を処理物に加えた(1リットル当
り):グルコース 5g;グルタメート5g;酵母エキス
1g;(NH42SO4 200mg;NaHCO3 200m
g;KH2PO 4 1g/l;PII金属類 5ml;A-ビタ
ミン溶液 1ml;及び抗生物質溶液2ml。これらの処
理物のそれぞれ50mlにF-1培養基中で増殖している
細胞1mlを接種した。これらの培養物をオ-ビタル振と
う器(200rpm)上に置き、27℃で48時間維持し
た。細胞を遠心分離器によって収穫し、脂肪酸をガスク
ロマトグラフィーで定量した。結果を図7に示す。実施
例1の方法で単離したトロウストチトリウム sp.U42
-2(ATCC番号20891)は、T.オウレウム(A
TCC番号28210)の産生した脂肪酸のほぼ2倍、
またS.アグレガタム(ATCC番号28209)の産
生した脂肪細胞酸量の8倍以上を産生することができ
る。さらに、U42-2は、試験した塩分範囲の上限に
おいて、より広い塩分許容量を有すると思われる。やは
り実施例1の方法で単離したシゾチトリウム sp.S31
(ATCC番号20888)は、従来公知のATCC株
に比べて、より多い脂肪酸収量(従来公知のATCC株
の収量の2.5〜10倍)及び極めて広い範囲の塩分濃
度許容性を示した。そのうえ、シゾチトリウム sp.S3
1(ATCC番号20888)は極めて低い塩分濃度で
最も良く成長する。この性質は、塩水の金属製反応器へ
の腐食作用及び、塩水の廃棄に伴う問題の両方の理由
で、工場的生産を考えた場合に重要な経済的な利点をも
たらす。
Embodiment 8Improved by the strain isolated by the method of Example 1
Salt tolerance and fatty acid production  Schizochytrium sp.S31 (ATCC No. 20888)
And Troost Titrium sp.U42-2 (ATCC number
20891) (both are isolated by the method of Example 1 and
Leaning) and S. aggregatam (ATCC number
28209) and T. aureum (ATCC No. 2821)
0) (obtained from American type Culture Collection)
Of the four strains of Thraustochytrium in solid F-1 culture medium
And on a rotary shaker (200 rpm) at 27 ° C for 3 ~
Incubated for 4 days. A range of different salinities
Of the culture medium was treated with M medium salts (NaCl, 25 g / l; M
gSOFour・ 7HTwoO, 5 g / l; KCl, 1 g / l; CaC
lTwo, 200 mg / l) and adjust as follows:
Was. 1) 100% (w / v M culture base salts; 2) 80%
(V / v) M culture salts, 20% (v / v) distilled water; 3)
60% (v / v) M culture salts, 40% (v / v) distillation
Water; 4) 40% (v / v) M culture salt, 60% (v / v)
v) distilled water; 5) 20% (v / v) M culture salt, 80
% (V / v) distilled water; 6) 15% (v / v) M culture salt
, 85% (v / v) distilled water; 7) 10% (v / v) M medium
Nutrient salts, 90% (v / v) distilled water; 8) 7% (v / v)
M medium, 93% (v / v) distilled water; 9) 3% (v / v)
v) M culture salts, 97% (v / v) distilled water; 10) 1.
5% (v / v) M culture salt, 98.5% (v / v) distillation
water). The following nutrients were added to the processed material (1 liter
R): Glucose 5g; Glutamate 5g; Yeast extract
1 g; (NHFour)TwoSOFour 200 mg; NaHCOThree 200m
g; KHTwoPO Four 1 g / l; PII metals 5 ml; A-Vita
1 ml of a min solution; and 2 ml of an antibiotic solution. These processes
50 ml of each substance grown in F-1 medium
1 ml of cells was inoculated. These cultures were orbital shaked.
Place on a centrifuge (200 rpm) and maintain at 27 ° C. for 48 hours.
Was. Cells are harvested by centrifugation and fatty acids are
Quantification was by chromatography. FIG. 7 shows the results. Implementation
Thraustochytrium sp. U42 isolated by the method of Example 1
-2 (ATCC No. 20891) is T. aureum (A
TCC No. 28210), almost twice the fatty acids produced,
The production of S. aggregatam (ATCC No. 28209)
Can produce more than 8 times the amount of fat cells produced
You. In addition, U42-2 is at the upper end of the tested salinity range.
Would have a wider salt tolerance. Yaha
Schizochytrium sp. S31 isolated by the method of Example 1
(ATCC No. 20888) is a conventionally known ATCC strain.
Fatty acid yield (ATCC strain known in the art)
2.5 to 10 times the yield of) and a very wide range of salt concentrations
Degree tolerance was shown. Besides, Schizochytrium sp.S3
1 (ATCC No. 20888) at very low salinity
Grow best. This property is important for saltwater metal reactors.
For both the corrosive action of the seawater and the problems associated with the disposal of salt water
Also has important economic advantages when considering factory production.
Sprinkle.

【0080】[0080]

【実施例9】培養/低塩分濃度 250mlの三角フラスコ中のM/10-5培養基の50
mlを、寒天傾斜培養物から取ったシゾチトリウム sp.
S31(ATCC番号20888)のコロニーで接種し
た。このM/10-5培養基は、脱イオン水 1000m
l,NaCl 2.5g,MgSO4・7H2O 0.5g,KC
l 0.1g,CaCl2 0.02g,KH2PO4 1.0g,
酵母エキス 1.0g,グルコ-ス 5.0g,グルタミン酸
5.0g,NaHCO3 0.2g,PII微量金属類 5m
l,ビタミンミックス 2ml,及び抗生物質ミックス
2mlを含有している。培養物は30℃で回転振とう器
(200rpm)上でインキュベートした。2日後、培養物
は、中程度の密度であり、活発に増殖していた。この活
発に増殖している培養物の20mlを、グルコ-スとグル
タメートの濃度を40g/リットル(M/10-40培養
基)とした以外は同じ培養基1700mlを含む2リッ
トルの発酵槽に接種するのに使用した。発酵槽は30℃
に保ち、1vol/vol/minでエアレーションし、300r
pmで撹拌した。48時間後、発酵槽中の細胞濃度は2
1.7g/lとなった。細胞を遠心分離して収穫し、冷凍
し、窒素下に保存した。
Embodiment 9Culture / low salinity  50 of M / 10-5 medium in a 250 ml Erlenmeyer flask
ml of Schizochytrium sp. taken from the agar slant culture.
S31 (ATCC No. 20888) colony
Was. This M / 10-5 culture medium has 1000 m of deionized water.
1, NaCl 2.5 g, MgSOFour・ 7HTwoO 0.5g, KC
l 0.1 g, CaClTwo 0.02 g, KHTwoPOFour 1.0g,
Yeast extract 1.0 g, glucose 5.0 g, glutamic acid
5.0 g, NaHCOThree 0.2 g, PII trace metals 5 m
l, vitamin mix 2ml, and antibiotic mix
Contains 2 ml. The culture is a rotary shaker at 30 ° C.
(200 rpm). 2 days later, culture
Had a moderate density and were actively growing. This activity
Add 20 ml of the growing culture to glucose and glue.
Tamate concentration of 40 g / liter (M / 10-40 culture
2 liters containing 1700 ml of the same culture medium except that
Used to inoculate torr fermenters. Fermenter at 30 ℃
And aeration at 1vol / vol / min, 300r
Stirred at pm. After 48 hours, the cell concentration in the fermentor was 2
It became 1.7 g / l. Harvest cells by centrifugation and freeze
And stored under nitrogen.

【0081】全脂肪酸含量及びω-3脂肪酸含量はガス
クロマトグラフィーにより測定した。最終生成物の全脂
肪酸含量は、灰分を除いた乾燥重量で29.0%であっ
た。微生物産物のω-3高度不飽和脂肪酸含量(C20:
5w3,C22:5w3及びC 22:6w3)は灰分を
除いた乾燥重量の15.6%であった。試料の灰分含量
は7.0%であった。
The total fatty acid content and the ω-3 fatty acid content were measured by gas chromatography. The total fatty acid content of the final product was 29.0% by dry weight, excluding ash. Ω-3 highly unsaturated fatty acid content of microbial products (C20:
5w3, C22: 5w3 and C22: 6w3) were 15.6% of the dry weight excluding ash. The ash content of the sample was 7.0%.

【0082】[0082]

【実施例10】実施例5に記した種々の株の増殖及び脂
肪酸産生のガスクロマトグラフィーでの分析によって、
脂肪酸分布の違いが明かとなった。本発明の株は、従来
入手可能な株よりも、より少ない種類の脂肪酸を合成し
た。分離すべき不純物が少ないので、脂肪酸分散が小さ
なことは好都合である。食品補助物としての目的のため
にも、望ましくない脂肪酸を摂取する可能性が減るの
で、脂肪酸の種類が少ないことは好都合である。表6
は、ATCC記号で表示した従来公知の株及び種々の本
発明の株について、全脂肪酸の1重量%を越える濃度で
存在する高度不飽和脂肪酸の種類の数を示している。
Example 10 By gas chromatography analysis of the growth and fatty acid production of the various strains described in Example 5,
The difference in fatty acid distribution became apparent. The strains of the present invention synthesized fewer types of fatty acids than previously available strains. A small fatty acid dispersion is advantageous because there are few impurities to be separated. For the purpose of food supplements, a reduced variety of fatty acids is advantageous, as it reduces the possibility of ingesting unwanted fatty acids. Table 6
Indicates the number of types of polyunsaturated fatty acids present at concentrations exceeding 1% by weight of total fatty acids for the conventionally known strains and the various strains of the present invention indicated by the ATCC symbol.

【0083】[0083]

【表12】 [Table 12]

【0084】[0084]

【実施例11】回 収 250mlの三角フラスコ中のM5培養基50mlを、寒
天傾斜培地から取ったシゾチトリウム sp.S31(AT
TC番号20888)の1つのコロニーで接種した。M
/5培養基は、脱イオン水 1000ml,NaCl 2
5.0g,MgSO4・7H2O 5.0g,KCl 1.0g,C
aCl2 0.2g,KH2PO4 1.0g,酵母エキス 1.0
g,グルコース 5.0g,グルタミン酸 5.0g,NaHC
3 0.2g,PII微量金属類 5ml,ビタミンミック
ス 2ml,及び抗生物質ミックス2mlを含有する。培
養物は30℃で回転振とう器(200rpm)上でインキ
ュベートした。2日後、培養物は、中程度の密度とな
り、活発に増殖していた。この活発に増殖している培養
物の20mlを、グルコ-スとグルタメートの濃度を40
g/リットル(M/20培養基)に増加させたことを除
いて同じ培養基1000mlを含む1リットルの発酵槽
に接種するのに使用した。発酵槽は30℃でpH7.4に
保ち、1vol/minでエアレーションし、また400rpm
で撹拌した。48時間後、発酵槽中の細胞濃度は18.
5g/lであった。発酵槽のエアレーション及び撹拌を
止めた。2〜4分以内に、細胞は凝集し、発酵槽の底の
250mlに沈澱する。この細胞の濃縮したゾーンは7
2g/lの細胞濃度を有していた。この細胞ゾーンを、
発酵槽からサイフォンで取りだし、そして(1)窒素制
限期間のあいだ他の反応器に移すか(例えば、幾つかの
発酵槽の高度に濃縮された産生物を一緒にして)、ある
いは(2)遠心分離またはろ過によって直接収穫するこ
とができる。このように細胞を予め濃縮することによ
り、60〜80%も少ない水を細胞の回収のために処理
することになる。
Embodiment 11Collection  50 ml of the M5 medium in a 250 ml Erlenmeyer flask was
Schizochytrium sp. S31 (AT
(TC No. 20888). M
/ 5 medium is 1000 ml of deionized water, NaCl 2
5.0g, MgSOFour・ 7HTwoO 5.0 g, KCl 1.0 g, C
aClTwo 0.2 g, KHTwoPOFour 1.0 g, yeast extract 1.0
g, glucose 5.0 g, glutamic acid 5.0 g, NaHC
OThree 0.2g, PII trace metals 5ml, vitaminmick
And 2 ml of antibiotic mix. Culture
Nutrition is ink on a rotary shaker (200 rpm) at 30 ° C.
Was added. After two days, the culture is at medium density.
And actively proliferated. This actively growing culture
20 ml of the product and a concentration of glucose and glutamate of 40
g / liter (M / 20 medium)
1 liter fermenter containing 1000 ml of the same culture medium
Used for inoculation. Fermenter at pH 7.4 at 30 ° C
Keep aeration at 1vol / min and 400rpm
And stirred. After 48 hours, the cell concentration in the fermentor was 18.
It was 5 g / l. Fermentation tank aeration and agitation
stopped. Within two to four minutes, the cells clump together and form the bottom of the fermenter.
Settle to 250 ml. The concentrated zone of this cell is 7
It had a cell concentration of 2 g / l. This cell zone,
Siphon out of fermenter and (1) nitrogen control
Transfer to another reactor for a limited time (for example, some
Together with the highly concentrated products of the fermenter)
Or (2) harvest directly by centrifugation or filtration.
Can be. By pre-concentrating the cells in this way,
60-80% less water for cell recovery
Will do.

【0085】[0085]

【実施例12】種々の炭素源及び窒素源の利用 250mlの三角フラスコ中のM5培養基50mlを寒天
傾斜培養物から取ったシゾチトリウム sp.S31(AT
CC番号20888)またはトロウストチトリウム sp.
U42-2(ATCC番号20891)の1つのコロニ
ーで接種した。M5培養基は2mlのビタミンミックス
と2mlの抗生物質ミックスを除いて実施例4に記載し
たものと同じである。培養物を回転振とう器上(200
rpm)、30℃でインキュベートした。2日後、培養物は
中程度の密度となり、活発に増殖していた。この培養物
を、グルコースの代りに(5g/lで)次の1つのも
の:デキストリン、ソルビトール、フルクトース、ラク
トース、マルトース、スクロース、コーンスターチ、小
麦デンプン、じゃがいもデンプン、粉砕コ-ン;あるい
はグルタメートの代りに(5g/lで)次の1つのも
の:ゲリゼート、ペプトン、トリプトン、カゼイン、コ
ーン浸漬液、尿素、ナイトレート、アンモニウム、ホエ
ーまたはコーングルテンミール、と置き換えたM5培養
基の入ったフラスコに接種するのに用いた。培養物を回
転振とう器(200rpm,27℃)上で48時間インキ
ュベートした。種々の有機基質上での増殖を示す、相対
的な培養物濃度を表7〜8に示す。
Embodiment 12Utilization of various carbon and nitrogen sources  Transfer 50 ml of M5 medium in a 250 ml Erlenmeyer flask to agar.
Schizochytrium sp. S31 (AT
CC number 20888) or Troost thorium sp.
One colony of U42-2 (ATCC number 20891)
Inoculated. M5 medium is 2ml vitamin mix
And described in Example 4 except for 2 ml of the antibiotic mix.
Is the same as The culture is placed on a rotary shaker (200
rpm) at 30 ° C. Two days later, the culture
It had a medium density and was actively growing. This culture
With one of the following instead of glucose (at 5 g / l)
Of: dextrin, sorbitol, fructose, lacquer
Toast, maltose, sucrose, cornstarch, small
Wheat starch, potato starch, ground corn; or
Is one of the following (in 5 g / l) instead of glutamate
A: Gerizate, Peptone, Tripton, Casein, Ko
Immersion liquid, urea, nitrate, ammonium, whey
Or corn gluten meal
It was used to inoculate the flask containing the group. Times the culture
Ink for 48 hours on a shaker (200 rpm, 27 ° C)
Was added. Relative, showing growth on various organic substrates
Typical culture concentrations are shown in Tables 7-8.

【0086】[0086]

【表13】 [Table 13]

【0087】[0087]

【表14】 [Table 14]

【0088】[0088]

【実施例13】エビのω-3HUFA含量を増大させる
ためのトロウストチトリドベースの餌補助物の給餌 トロウストチトリウム sp.12B(ATCC番号208
90)の細胞性バイオマスを、25℃でM-5培養基
(実施例6参照)中、振とうフラスコ中で生産した。ト
ロウストチトリウム sp.S31(ATCC番号2088
8)の細胞性バイオマスは27℃でM-5/10培養基
(実施例9参照)中、振とうフラスコの中で生産した。
各々の株の細胞を遠心分離により収穫した。ペレットを
一回蒸留水で洗浄し、ついで再遠心して50%固形分ペ
ーストを製造した。得られたペーストを海水に再懸濁
し、その後、餌補助物としておとなの塩水エビ飼育物に
与えた。この塩水エビは、それまでは農産廃棄物製品で
飼育したものであり、その結果そのω-3HUFA含量
は極めて低く、全脂肪酸のほんの1.3〜2.3%であっ
た(自然界で捕らえた塩水エビは、平均して全脂肪酸の
6〜8%のω-3HUFAを有している)。この塩水エビ
(2〜3/ml)を海水で満たした1リットルのビーカ
ー中に入れ、エアレーションと飼育物を混合するために
エアーストーンを用いた。餌補助物を加えたのち、塩水
エビのサンプルを周期的に収穫し、洗浄し、そしてその
脂肪酸含量をガスクロマトグラフィーによって測定し
た。結果を図8〜図9に示す。トロウストチトリドベー
スの餌補助物を仕上げ餌として与えると、塩水エビのω
-3含量を、株12Bを与えたときは5時間以内に、ま
た株S31を与えたときは11時間以内に野性の塩水エ
ビの含量と同じにまで増加することができる。塩水エビ
のω-3HUFA含量は、これらの餌補助物を24時間
までに与えると、野性のものの含量をはるかに越えさせ
ることができる。さらに、これらの餌補助物は、自然界
で捕らえた塩水エビ中では通常微量レベルにすぎないと
報告されているDHA含量を著しく増大させる。
Embodiment 13Increases ω-3 HUFA content in shrimp
Of troost titride-based bait supplements for food  Thraustochytrium sp. 12B (ATCC No. 208
90) of the cellular biomass at 25 ° C. in M-5 medium
(See Example 6), produced in shake flasks. G
Roast Titrium sp.S31 (ATCC No. 2088)
8) Cellular biomass at 27 ° C in M-5 / 10 culture medium
Medium (see Example 9), produced in shake flasks.
Cells of each line were harvested by centrifugation. Pellets
Wash with single distilled water, then centrifuge again to remove 50% solids
Manufactured. Resuspend the obtained paste in seawater
After that, as a feed supplement,
Gave. This saltwater shrimp was previously an agricultural waste product
Bred and, as a result, its ω-3 HUFA content
Is very low, only 1.3-2.3% of the total fatty acids
(On average, saltwater shrimp caught in nature
6-8% ω-3 HUFA). This saltwater shrimp
(2 to 3 / ml) 1 liter beaker filled with seawater
To mix the aeration and the feed
Air stone was used. After adding food supplements, salt water
Shrimp samples are harvested periodically, washed and then
Fatty acid content is determined by gas chromatography.
Was. The results are shown in FIGS. Troasted chicken tribe
When the bait supplement is given as the finishing bait, the saltwater shrimp ω
-3 content within 5 hours when strain 12B is given,
Wild strain water within 11 hours
It can be increased to the same as the content of bi. Saltwater shrimp
Ω-3HUFA content of these dietary supplements for 24 hours
Up to far beyond the content of the wild
Can be In addition, these food supplements are
In the saltwater shrimp caught in
Significantly increases the reported DHA content.

【0089】[0089]

【実施例14】ω-3HUFAに富んだ卵を産卵めんど
りに産ませるためのトロウストチトリドベースの餌補助
物の給餌 トロウストチトリウム sp.S31(ATCC番号208
88)の細胞性バイオマスを27℃でM-5/10培養
基(実施例9参照)中、10リットルの発酵槽中で生産
した。トロウストチトリウム sp.S31(ATCC番号
20888)の細胞を遠心分離で収穫し、一旦蒸留水で
洗浄し、再遠心分離して50%固形分ペーストを製造し
た。その後、この細胞ペーストを次の2つの方法の一つ
で処理した:1)冷凍すること;または 2)粉砕コーン
と混合して70%固形分ペーストを製造し、次いで90
〜120℃で押出し、風乾する。得られた乾燥生成物を
次に粉砕し、ω-3HUFA含量を分析し、さらに産卵
するめんどりに1日当り400mgのω-3HUFAとな
るレベルで飼料に混合した(400mgのω-3HUFA
/100gの飼料)。産まれた卵を約45日にわたって
サンプリングレ、ガスクロマトグラフィーでω-3HU
FAについて分析した。200〜425mg ω-3HUF
A/卵の鶏卵がω-3補助物DE養わられためんどりに
よって産卵された(5000mg脂肪酸卵に正規化した濃
度)。調理すると、これらの卵は全く魚臭を呈さなかっ
た。コントロールのめんどりは約20mg ω-3HUFA
/卵を含む卵を産卵した。コントロール群とω-3補助
物を与えためんどりとによって産卵された卵の数に有意
な差はなかった。餌補助物とコントロール食品とで得ら
れた卵の黄味の色にも変りは全くなかった。
Embodiment 14Egg laying egg which is rich in ω-3HUFA
Troost Titolide-based feeding aid for litter
Feeding things  Thraustochytrium sp.S31 (ATCC No. 208
88) M-5 / 10 culture of the cellular biomass at 27 ° C
In a 10 liter fermentor (see Example 9)
did. Thraustochytrium sp.S31 (ATCC number
20888) cells are harvested by centrifugation and once with distilled water.
Wash and re-centrifuge to produce 50% solids paste
Was. The cell paste is then used in one of two ways:
Treated with: 1) frozen; or 2) ground corn
To produce a 70% solids paste,
Extrude at ~ 120 ° C and air dry. The resulting dried product is
Next, crush, analyze ω-3 HUFA content, and spawn
400 mg of ω-3 HUFA per day
(400 mg of ω-3HUFA)
/ 100 g feed). Laid eggs for about 45 days
Ω-3HU by sampling and gas chromatography
The FA was analyzed. 200-425mg ω-3HUF
A / Egg chicken is fed with ω-3 supplement DE
The eggs were laid (concentration normalized to 5000 mg fatty acid eggs)
Every time). When cooked, these eggs have no fishy odor
Was. The control hen is about 20mg ω-3HUFA
/ Eggs including eggs were laid. Control group and ω-3 assistance
Significant in the number of eggs laid by feeding hens
There was no significant difference. Obtained with feed supplements and control foods
There was no change in the yellow color of the egg.

【0090】[0090]

【実施例15】高純度品の製造(>90%純度のω-3
HUFAあるいは>90%純度のHUFA脂肪酸混合
物) トロウストチトリウム sp.S31(ATCC番号208
88)の細胞性バイオマスは10リットルの発酵槽中、
27℃でM-5/10培養基(実施例9参照)中で生産
した。この株の細胞を遠心分離によって収穫した。約5
gの細胞ペーストを、0.5mmガラスビーズで1/2を満
たしたビーズビータービーズミルの350mlのステン
レススチール粉砕チャンバーに入れた。その容積の残り
を試薬グレードのMeOHで満たし、細胞を2回、3分
間均質化した。ビーズミル操作のあいだ、ステンレスス
チールチャンバーを付属の氷浴で冷却状態に保った。
Embodiment 15Production of high-purity products (> 90% pure ω-3
HUFA or> 90% pure HUFA fatty acid mixture
object)  Thraustochytrium sp.S31 (ATCC No. 208
88) Cellular biomass in a 10 liter fermenter
Produced at 27 ° C in M-5 / 10 medium (see Example 9)
did. Cells of this strain were harvested by centrifugation. About 5
g cell paste, fill half with 0.5mm glass beads
350ml stainless steel from a bead beater bead mill
Placed in a less steel grinding chamber. The rest of that volume
Is filled with reagent grade MeOH and cells are washed twice for 3 minutes
While homogenizing. During the bead mill operation, stainless steel
The teal chamber was kept cool with an attached ice bath.

【0091】破砕した細胞の溶液をフラスコに注ぎ、そ
の中へクロロホルムと2M NaCl水溶液を加えて最終
溶液がおよそ1:1:0.9(クロロホルム:MeOH:
水)となるようにした。その後、溶液を分液ロートに注
ぎ、数回振り混ぜて脂質がクロロホルム層に移動するの
を促進した。数分間で溶液が分離した後、クロロホルム
層をフラスコに集め、新たなクロロホルムを分液ロート
に加えて抽出を繰り返した。その後、このクロロホルム
層を分液ロートから抜き出して2つのクロロホルム層を
一緒にした。次いで、クロロホルムを、40℃で操作さ
れる回転真空蒸発装置を用いて除去(及び回収)した。
残った脂質の一部(300mg)を取り出し、150mgテ
フロン(登録商標)張りのネジ蓋つき瓶中で、50ml
のメタノール性NaOH(0.3N NaOH 10mlをメ
タノールで100mlに希釈したもの)で、60℃にて
6時間加水分解した。その後、非加水分解性物質(ステ
ロイド類、炭化水素類など)を、分液ロートで、50m
lづつの石油エーテルで2回層分離し、エーテル層をそ
の都度捨てることにより除去した。次いで、残った溶液
を3mlの6NHClを加えて酸性とし、遊離脂肪酸を
50mlの石油エーテルで2回抽出した。遊離脂肪酸を
含むエーテル溶液の5mlを3つの13mm×100mm試
験管に入れ、窒素気流下に溶液に吹き入れてエーテルを
除去した。その後、2mlのエーテル、ヘキサンまたは
アセトンを1つの管に加え、蓋をしてドライアイス-エ
タノール溶液中(−72〜−74℃)に置き、非HUF
A脂肪酸を結晶化させた。結晶化が完結した考えられる
ときに、培養管を、細かい紛末状のドライアイスで満た
した50mlのポリカーボネートの遠心管中に入れた。
次いで、これらの管を−10℃に冷却した遠心装置に置
き、10,000rpmに3〜5分間遠心した。その後、上
清をパスツールピペットで各々の管からすばやく抜き取
り、きれいな培養管に入れた。溶媒を窒素を吹き付けて
上清から除去した。次いで、脂肪酸を、窒素下にテフロ
ン張りのネジ蓋をした管の中で、メタノール性H2SO4
(96mlのMeOH中、4mlのH2SO4)中100℃
で1時間メチル化した。脂肪酸メチルエステルを次いで
ガスクロマトグラフィー(HP5890ガスクロマトグ
ラフ、スペルコSP2330カラム;カラム温度=20
0℃;検出器及び注入部温度=250℃;キャリヤーガ
ス=窒素)で定量した。得られた脂肪酸混合物の組成
は、(エーテル)93.1% HUFA − 23.4% C
22:5n-6 +69.7% 22:6n-3;(ヘキサ
ン)91.5% HUFA − 66.8% 22:6n-3
+ 22.1% 22:5n-6 + 2.6% 20:5n-
3;(アセトン)90.0% HUFA − 65.6% 2
2:6n-3 + 21.8n-6 + 2.6%20:5n-
3。
A solution of the crushed cells was poured into a flask, and chloroform and a 2M aqueous solution of NaCl were added thereto to make a final solution of about 1: 1: 0.9 (chloroform: MeOH:
Water). The solution was then poured into a separatory funnel and shaken several times to facilitate the transfer of lipids to the chloroform layer. After the solution was separated within a few minutes, the chloroform layer was collected in a flask, fresh chloroform was added to a separating funnel, and the extraction was repeated. Thereafter, the chloroform layer was extracted from the separating funnel, and the two chloroform layers were combined. The chloroform was then removed (and recovered) using a rotary vacuum evaporator operating at 40 ° C.
A part (300 mg) of the remaining lipid was taken out, and 50 ml was placed in a 150 mg Teflon (registered trademark) -lined bottle with a screw cap.
Of methanolic NaOH (10 ml of 0.3N NaOH diluted to 100 ml with methanol) at 60 ° C. for 6 hours. Then, non-hydrolyzable substances (steroids, hydrocarbons, etc.) are added to the separation funnel for 50m.
The layers were separated twice with 1 petroleum ether and the ether layer was removed by discarding in each case. The remaining solution was then acidified by adding 3 ml of 6N HCl and the free fatty acids were extracted twice with 50 ml of petroleum ether. Five ml of an ether solution containing free fatty acids was placed in three 13 mm × 100 mm test tubes, and the ether was removed by blowing the solution under a stream of nitrogen. Thereafter, 2 ml of ether, hexane or acetone was added to one tube, capped and placed in a dry ice-ethanol solution (-72 to -74 ° C), and the non-HUF
The A fatty acid crystallized. When the crystallization was considered complete, the culture tubes were placed in 50 ml polycarbonate centrifuge tubes filled with fine powdered dry ice.
The tubes were then placed in a centrifuge cooled to -10 ° C and centrifuged at 10,000 rpm for 3-5 minutes. Thereafter, the supernatant was quickly removed from each tube with a Pasteur pipette and placed in a clean culture tube. The solvent was removed from the supernatant by blowing nitrogen. The fatty acids were then placed in a tube with a Teflon-lined screw cap under nitrogen in methanolic H 2 SO 4.
100 ° C. in (96 ml of MeOH, 4 ml of H 2 SO 4 )
For 1 hour. The fatty acid methyl ester was then subjected to gas chromatography (HP5890 gas chromatograph, Spelco SP2330 column; column temperature = 20).
0 ° C .; detector and injection part temperature = 250 ° C .; carrier gas = nitrogen). The composition of the resulting fatty acid mixture is 93.1% (ether) HUFA-23.4% C
22: 5n-6 + 69.7% 22: 6n-3; (hexane) 91.5% HUFA-66.8% 22: 6n-3
+ 22.1% 22: 5n-6 + 2.6% 20: 5n-
3; (acetone) 90.0% HUFA-65.6% 2
2: 6n-3 + 21.8n-6 + 2.6% 20: 5n-
3.

【0092】>90%のω-3HUFAを含む脂肪酸混
合物を、12B(ATCC番号20890)のようなト
ロウストチトリドの株の収穫したバイオマスについて上
記の方法を行うことによって得ることができる。
A mixture of fatty acids containing> 90% ω-3 HUFA can be obtained by performing the above-mentioned method on the harvested biomass of a strain of Troost titride, such as 12B (ATCC No. 20890).

【0093】一般的な備考 本発明の方法に従って単離した以下の新規株を本明細書
中で開示し、クレームした生物の例として、the Ameri
can Type Culture Collection(ATCC)、メリーラ
ンド州ロックビルに寄託した。 株 ATCC番号 寄託日 シゾチトリウム S31 20888 8/8/88 シゾチトリウム S8 20889 8/8/88 シゾチトリウム 12B 20890 8/8/88 トロウストチトリウム U42-2 20891 8/8/88 シゾチトリウム 23B 20892 8/8/88
[0093]General remarks  The following novel strains isolated according to the method of the present invention
Examples of the organisms disclosed and claimed in
can Type Culture Collection (ATCC), Melilla
Deposited in Rockville, Rand. Strain ATCC No. Deposit date Schizochytrium S31 20888 8/8/88 Schizochytrium S8 20889 8/8/88 Schizochytrium 12B 20890 8/8/88 Thraustochytrium U42-2 20891 8/8/88 Schizochytrium 23B 2089288/88/88

【0094】本発明は、特定の微生物株について開示さ
れているが、本明細書中に開示した教示に従って得られ
るまたは用いうるすべての方法及び株を包含するもので
あり、当業者に熟知のそのような置換、変形、最適化は
すべて本発明に包含される。
Although the present invention has been disclosed for a particular microbial strain, it is intended to cover all methods and strains obtained or usable in accordance with the teachings disclosed herein, which are well known to those skilled in the art. Such substitutions, modifications, and optimizations are all included in the present invention.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 トロウストチトリウム sp.UT42-2(A
TCC番号20891)を試験株として用いての、種々
の培養基補足剤の脂肪酸収量への影響を示す棒グラフで
ある。上記の株は本発明の選択方法に従って単離した。
実験方法は実施例2に記載する。縦軸:補足剤なしのF
FM培養基であるコントロールを基準とした脂肪酸収
量。横軸: 1)2x「B」−ビタミンミックス、 2)2
x「A」ビタミンミックス、 3)2xPI金属類、 4)
28mg/l KH2PO4、 5) 2)と 3) と 4)の組合
せ処理、及び 6)480mg/l KH2PO4、の特定的
な添加。
FIG. 1. Troost Titrium sp.UT42-2 (A
Figure 4 is a bar graph showing the effect of various media supplements on fatty acid yield using TCC number 20891) as a test strain. The above strains were isolated according to the selection method of the present invention.
The experimental method is described in Example 2. Vertical axis: F without supplement
Fatty acid yield based on FM culture medium control. Horizontal axis: 1) 2x "B"-vitamin mix, 2) 2
x "A" vitamin mix, 3) 2xPI metals, 4)
28 mg / l KH 2 PO 4 , 5) Combination treatment of 2) and 3) and 4), and 6) Specific addition of 480 mg / l KH 2 PO 4 .

【図2】 高度不飽和脂肪酸産生量をグラフで示したも
のであり、□は本発明で新たに単離した株について示
し、★は先に単離されていた株について示す。各点はあ
る株を示し、各点の位置は、ω-3高度不飽和脂肪酸の
全脂肪酸中の重量%(横軸)及びω-6脂肪酸である脂
肪酸全ての重量%(縦軸)により決定される。本発明の
株のみが、全脂肪酸の10.6%(w/w)未満がω-6
であり、全脂肪酸の67%以上がω-3である点にプロ
ットされた。表4からのデータ。
FIG. 2 is a graph showing the amount of polyunsaturated fatty acid production, where □ indicates a strain newly isolated in the present invention, and ★ indicates a previously isolated strain. Each point indicates a certain strain, and the position of each point is determined by the weight% (horizontal axis) of the total fatty acids of ω-3 polyunsaturated fatty acids and the weight% (vertical axis) of all fatty acids which are ω-6 fatty acids. Is done. Only strains of the present invention have less than 10.6% (w / w) of total fatty acids at ω-6
And plotted at the point where at least 67% of the total fatty acids were at ω-3. Data from Table 4.

【図3】 高度不飽和脂肪酸産生量をグラフで示したも
のであり、□は本発明で新たに単離した株について示
し、★は先に単離されていた株について示す。各点はあ
る株を示し、各点の位置は、ω-3高度不飽和脂肪酸の
全脂肪酸中の重量%(横軸)及びエイコサペンタエン酸
(EPA C20:5w3)(縦軸)である全脂肪酸の重
量%より決定される。本発明の株のみが、全脂肪酸の6
7%(w/w)以上がω-3であり、全脂肪酸の7.8%
(w/w)以上がC20:5w3である点にプロットさ
れる。
FIG. 3 is a graph showing the amount of polyunsaturated fatty acid production, where □ indicates a strain newly isolated in the present invention, and ★ indicates a previously isolated strain. Each point represents a certain strain, and the position of each point is the total fatty acid weight% (horizontal axis) of the total fatty acids of ω-3 polyunsaturated fatty acids and eicosapentaenoic acid (EPA C20: 5w3) (vertical axis). Is determined from the weight% of Only the strain of the present invention has 6
More than 7% (w / w) is ω-3, 7.8% of total fatty acids
(W / w) is plotted at the point where C20: 5w3.

【図4】 ω-3高度不飽和脂肪酸組成をグラフで示し
たものであり、□は本発明で新たに単離した株について
示し、★は先に単離されていた株について示す。各点は
別々の株を示す。横軸上の値はC20:5w3である全
ω-3高度不飽和脂肪酸の重量比率であり、縦軸上の値
はC22:6w3である全ω-3高度不飽和脂肪 酸の重
量比率である。本発明の株だけが、C20:5w3の重
量比率28%以上か、あるいはC22:6ω3の重量比
率93.6%以上のいずれかを示す点にプロットされ
た。
FIG. 4 is a graph showing the composition of ω-3 polyunsaturated fatty acids, in which □ indicates a strain newly isolated in the present invention, and ★ indicates a previously isolated strain. Each point represents a separate strain. The value on the horizontal axis is the weight ratio of total ω-3 polyunsaturated fatty acids of C20: 5w3, and the value on the vertical axis is the weight ratio of total ω-3 polyunsaturated fatty acids of C22: 6w3. . Only the strains of the present invention were plotted at points showing either a weight ratio of C20: 5w3 of 28% or more, or a weight ratio of C22: 6ω3 of 93.6% or more.

【図5】 本発明の新たに単離された種々の株及びこれ
までに単離されていた株の、25℃及び30℃での増殖
を示すグラフである。増殖速度は25℃でのU-30株
の成長速度を基準として規格化して示してある。先に単
離されていた株は、そのATCCの受託番号で示してい
る。1日あたりの細胞数倍化についての数値データを表
5に示す。
FIG. 5 is a graph showing the growth of various newly isolated strains of the present invention and previously isolated strains at 25 ° C. and 30 ° C. The growth rate is shown normalized to the growth rate of the U-30 strain at 25 ° C. The previously isolated strain is indicated by its ATCC accession number. Table 5 shows the numerical data on the number of cell doublings per day.

【図6】 窒素制限によって誘導した後の、細胞での全
産生量のグラフである。灰分を除いた乾燥重量、全脂肪
酸及びω-3高度不飽和脂肪酸のそれぞれを、図示した
ように、28211株の対応する値を基準にして規格し
てプロットした。すべての株はATCCの受託番号によ
って同定している。
FIG. 6 is a graph of total production in cells after induction by nitrogen limitation. The ash-free dry weight, total fatty acids and ω-3 polyunsaturated fatty acids were each plotted, as shown, normalized to the corresponding values of the 28211 strain. All strains are identified by ATCC accession numbers.

【図7】 横軸上に示した塩分濃度を含む培養基中で増
殖後の、脂肪酸収量のグラフである。示した株は、新た
に単離したS31株(ATCC番号20888)(■)
とU42-2株(ATCC 20891)(+)、及びすべ
てに単離されていた株であるATCC番号28211
(*)とATCC番号28209(□)である。脂肪酸
収量は、試験した塩分濃度範囲においてS31株(AT
CC番号20888)が示した平均増殖速度に基づい
て、適当な値を1.00として規格化した相対収量でプ
ロットしている。
FIG. 7 is a graph of the fatty acid yield after growth in culture media containing the salt concentration shown on the horizontal axis. The indicated strain is a newly isolated S31 strain (ATCC No. 20888) (■)
And U42-2 strain (ATCC 20891) (+), and ATCC No. 28211, a strain that had been isolated in all cases.
(*) And ATCC No. 28209 (□). Fatty acid yields were determined for the S31 strain (AT
Based on the average growth rate indicated by CC No. 20888), the relative yield is plotted with the appropriate value being 1.00.

【図8】 実施例1の方法で単離したトロウストチトリ
ド株(ATCC番号20890)で飼育した、塩水エ
ビ、Artemia salina 中の全脂質のω-3高度不飽和脂
肪酸含量の増加を示すグラフである。EPA=C20:
5w3;DHA=C22:6w3。
FIG. 8 is a graph showing an increase in the ω-3 polyunsaturated fatty acid content of total lipids in a saltwater shrimp, Artemia salina, bred with a troost titride strain (ATCC No. 20890) isolated by the method of Example 1. It is. EPA = C20:
5w3; DHA = C22: 6w3.

【図9】 実施例1の方法で単離したトロウストチトリ
ド株(ATCC番号20888)で飼育した塩水エビ、
Artemia salina 中の全脂質のω-3高度不飽和脂肪酸
含量の増加を示すグラフである。EPA=C20:5w
3;DHA=C2 2:6w3。文 献 Ainsworth, G.C. (1973) "Introduction and keys to
the higher taxa."In: The Fungi. An Advanced Treat
ise. Vol. 4B, G.C. Ainsworthet al. (eds.), Academi
c Press, New York, pp. 107. Bahnweg, G. & Jackle, I. (1986) "A new approach t
o taxonomy of theThraustochytriales and Lybrinthul
ales." In: The Biology ofMarine Fungi, S.T. Moss
(ed.), Cambridge University Press,London, pp. 131
-140. Barr, J.S. (1981) "The phylogenetic and taxonomic
implications offlagellar rootlet morphology among
zoosporic fungi." BioSystems14: 359-370. Barr, J.S. (1983) "The zoosporic grouping of plan
t pathogens."In: Zoosporic Plant Pathogens: a mo
dern perspective, S.T.Buczacki (ed.), Academic Pre
ss, pp. 43-83. Bartnicki-Garcia, S. (1988) "THe cell wall: a cru
cial structure infungal evolution." In: Evolutio
nary Biologyof the Fungi,A.D.M. Rayner et al. (ed
s.), Cambrindge University Press,pp. 389-403. CalBiochem Co. (1987). Biochemical/Immunochemical
Catalog. BehringDiagnostics, La Jolla, Californi
a. Cavalier-Smith, T. (1975) "The origin of nuclei a
nd of eukaryoticcells." Nature 256: 463-468. Cavalier-Smith, T. (1983) "A 6-kingdom classifica
tion and a unifiedphylogeny." In: Endocytobiolog
y II: Intracellular Space asOligogenetic System,
H.E.A. Schenk and W. Schwemmler (eds.),De Gruyter
(Berlin), pp. 1207-1034. Chamberlain, A.H. and Moss, S.T. (1988) "The thra
ustochytrids:a protist group with mixed affinitie
s." BioSystems 21:341-349. Cerda-Olmeda, E. & Lipson, E. (1987) Phycomyces,
Cold Springs HarborLaboratory, Cold Springs Harbo
r, New York. Dick, M.W. (1973) "Saprolegniales." In: The Fun
gi. An AdvancedTreatise, Vol. 4B, G.C.Ainsworth et
al. (eds.), Academic Press,New York, pp. 113-144. Ellenbogen, B.B. et al. (1969) "Polyunsaturated f
atty acids of aquaticfungi: possible phylogenetic
significance." Comp. Biochem.Physiol. 29: 805-81
1. Emerson, R. (1950) "Current trends of experimenta
l reserch in theaquatic Phycomycetes." Ann. Rev.M
icro. 4: 169-200. Erwin, J. (1973) "Comparative biochemistry of fat
ty acids ineukaryotic microorganisms." In: Lipid
s and Biomembranes ofEukarytic Microorganisms, J.
Erwin (ed.), Academic Press,New York, pp. 41-143. Findlay, R.H. et al. (1986) "Biochemical indicato
rs of the role offungi and Thraustrochytrids in ma
ngrove detrital systems."In: The Biology of Marin
e Fungi, S.T. Moss (ed.), CambridgeUniversity Pres
s, London, pp. 91-103. Fuller, M.S. et al. (1964) "Isolation and pure cu
lture of marinePhycomycetes." Mycologia 56: 745-7
56. Gellerman, J.L. & Schlenk, H. (1979) "Methyl-dire
cted desaturation ofarachidonic to eicosapentaenoi
c acid in the fungus, Saprolegniaparasitica." Bio
chem. Biophys. Acta 573: 23-30. Goldstein, S. (1963) "Development and nutrition o
f new species ofThraustochytrium." Am. J. Bot. 5
0: 271-279. Goldstein, S. et al. (1969) "Biology of a problem
atic marine fungus,Dermocytidium sp. II. Nutritio
n and repiration." Mycologia61:468-72. Hiri, H. et al. (1980) Nucl. Acids Res. 8:5535 55
39. Hunter, J.E. (1987) "Fish oil and other omega-3 s
ources." J. Am. OilChem. Soc. 64: 1592-1596. Kates, M. (1986) Techniques of Lipidology: Isola
tion, Analysis andIdentification of Lipids, Elsevi
er, Amsterdam. Kazama, F. (1980) "The zoospore of Schizoshytrium
aggregatum. Can J.Bot. 58: 2434-2446. Kyle, D.J. (1987) "Microalgae as a source of EPA-
containing oils."Abstract of talk presented at Wor
ld Conference for Fats & Oils,Hamburg, West German
y. J. Am. Oil Chem. Soc. 64: 1251. Leedale, G. (1974) "Howmany are the kingdoms of o
rganisms." Taxon23: 261-270. Lepage, G. and Roy, C. (1984) "Improved recovery
of fatty acidthrough direct transesterification wi
thout prior extraction orpurification." J. Lipid
Res. 25: 1391-1396. Margulis, L. (1970) Origin of Eukaryotic Cells, Y
ale University Press,New Haven. Margulis, L. and Sagan, D. (1985) "Order amidst a
nimalcules: theProctoctista kingdom and its undul
ipodiated cells." BioSystems18: 141-147. Mannella, C.A. et al. (1987) "Interrelatedness of
5S RNA sequencesinvestigated by correspondence an
alysis." J. Mol. Evol. 24:228-235. Moss, S. (1986) "Biology and phylogeny of the Lab
rinthulales andThraustochytriales." In: The Biol
ogy of Marine Fungi, S.T.Moss (ed.), Cambridge Uni
versity Press, London, pp. 105-130. Perkins, F.O. (1976) "Fine structure of lower mar
ine and estuarinefungi." In: Recent Advances in
marine Mycology, E.B. GarethJones (ed.), Elek Scie
nce, pp. 279-312. Pigot, G.M. (1989), "The need to improve omega-3
content of culturedfish," World Aquaculture 20: 63
-68. Perkins, F. (1974) "Phylogenetic considerations o
f the problematicthraustochytriaceous-labrinthulid
-Dermocystidium complex based onobservations of fi
ne structure." Veroff. Inst. Meeresforsch.Bremer
h. Suppl. 5: 45-63. Pohl, P. and Zurheide, F. (1979) "Fatty acids and
lipids of marinealgae and the control of their bi
osynthesis by environmentalfactors." In: Marine
Algae in Pharmaceutical Science, H. Hoppeet al. (e
ds.), W. de Gruyter, Berlin, pp. 473-524. Poyton, R. (1970) "The charaterization of Hyalloc
hlorella marina gen.et sp. nov. a new colorless co
unterpart of Chlorella." J. Gen.Microbiol. 62: 17
1-188. Ryther, J.H. (1983) "Cultivation of macroscopic m
arine algae." In:Solar Energy Research Institute
Aguayic Species Program Review.Proc. of the March
1983 Principal Investigators Meeting.SERI/CP-231-1
946, pp. 79-88. Sargent, J. et al. (1989), "The lipids," in Fish
Nutrition, SecondEdition, J. Halver (ed.), Academi
c Press, pp. 153-218. Schlenk, H. (1954) "Urea inclusion compounds of f
atty acids." Prog.Chem. Fats and other Lipids 2:
243:267. Schneider, J. (1976) "Cultivation of Microorgnism
s. Section 3.2:Fungi." In: Marine Ecology, Vol.
3, Part 1. Cultivation,O. Kinne (ed.), Wiley Inte
rscience. Sigma Chemical Co. (1988). Catalog: Biochemical
and Organic Compoundsfor Reserch. Sigma Chemical C
o., St.Louis, Missouri. Simopoulos, A.P. et al. (1986) Health Effects of
Polyunsaturated FattyAcids in Seafoods, Academic P
ress, New York. Sorokin, C. (1973) "Growth measurements: dry wei
ght packed cellvolume, and optical density." In:
Handbook of PhycologicalMethods: Culture Methods
and Growth Measurements, J.R. Stein(ed.), Cambrid
ge University Press, Cambridge, pp. 321-343. Sparrow, F.K. (1960) Aquatic Phycomycetes. Unive
rsity of MichiganPress, Ann Arbor, pp. 37-38. Wassef, M. (1977) "Fungal lipids." Adv. Lioid Re
s. 15: 159-232. Weete, J.D. (1980) Lipid Biochemistry of Fungi an
d Other Organisms.Plenum Press,New York. Yamada, H. et al. (1987) "Production of arachidon
ic acid andeicosapentaenoic acid by microorganism
s." Abstract of talkpresented at Wold Conference
for Fats & Oils, Hamburg, WestGermany. J. Am Oil
Chem. Soc. 64: 1254.
FIG. 9: Troost chicken isolated by the method of Example 1
Salted shrimp bred in the strain (ATCC No. 20888),
Ω-3 highly unsaturated fatty acids of all lipids in Artemia salina
It is a graph which shows an increase in content. EPA = C20: 5w
3: DHA = C2 2: 6w3.Literature  Ainsworth, G.C. (1973) "Introduction and keys to
the higher taxa. "In:The Fungi. An Advanced Treat
ise. Vol. 4B, G.C.Ainsworthet al. (Eds.), Academi
c Press, New York, pp. 107. Bahnweg, G. & Jackle, I. (1986) "A new approach t
o taxonomy of theThraustochytriales and Lybrinthul
ales. "In:The Biology ofMarine Fungi, S.T.Moss
 (ed.), Cambridge University Press, London, pp. 131
-140. Barr, J.S. (1981) "The phylogenetic and taxonomic
 implications offlagellar rootlet morphology among
 zoosporic fungi. "BioSystems14: 359-370. Barr, J.S. (1983) "The zoosporic grouping of plan
t pathogens. "In:Zoosporic Plant Pathogens: a mo
dern perspective, S.T.Buczacki (ed.), Academic Pre
ss, pp. 43-83. Bartnicki-Garcia, S. (1988) "THe cell wall: a cru
cial structure infungal evolution. "In:Evolutio
nary Biologyof the Fungi, A.D.M.Rayneret al. (ed
s.), Cambrindge University Press, pp. 389-403. CalBiochem Co. (1987).Biochemical / Immunochemical
Catalog. BehringDiagnostics, La Jolla, Californi
a. Cavalier-Smith, T. (1975) "The origin of nuclei a
nd of eukaryoticcells. "Nature256: 463-468. Cavalier-Smith, T. (1983) "A 6-kingdom classifica
tion and a unifiedphylogeny. "In:Endocytobiolog
y II: Intracellular Space asOligogenetic System,
H.E.A.Schenk and W. Schwemmler (eds.), De Gruyter
(Berlin), pp. 1207-1034. Chamberlain, A.H. and Moss, S.T. (1988) "The thra
ustochytrids: a protist group with mixed affinitie
s. "BioSystemstwenty one: 341-349. Cerda-Olmeda, E. & Lipson, E. (1987)Phycomyces,
Cold Springs Harbor Laboratory, Cold Springs Harbo
r, New York. Dick, M.W. (1973) "Saprolegniales." In: The Fun
gi. An AdvancedTreatise, Vol. 4B, G.C. Ainsworthet
 al(eds.), Academic Press, New York, pp. 113-144. Ellenbogen, B.B. et al. (1969) "Polyunsaturated f
atty acids of aquaticfungi: possible phylogenetic
 significance. "Comp. Biochem.Physiol.29: 805-81
1. Emerson, R. (1950) "Current trends of experimenta
l reserch in theaquatic Phycomycetes. "Ann. Rev.M
icro.Four: 169-200. Erwin, J. (1973) "Comparative biochemistry of fat
ty acids ineukaryotic microorganisms. "In:Lipid
s and Biomembranes of Eukarytic Microorganisms, J.
Erwin (ed.), Academic Press, New York, pp. 41-143. Findlay, R.H.et al. (1986) "Biochemical indicato
rs of the role offungi and Thraustrochytrids in ma
ngrove detrital systems. "In:The Biology of Marin
e Fungi, S.T.Moss (ed.), CambridgeUniversity Pres
s, London, pp. 91-103. Fuller, M.S.et al(1964) "Isolation and pure cu
lture of marinePhycomycetes. "Mycologia56: 745-7
56. Gellerman, J.L. & Schlenk, H. (1979) "Methyl-dire
cted desaturation ofarachidonic to eicosapentaenoi
c acid in the fungus,Saprolegniaparasitica. "Bio
chem. Biophys. Acta573: 23-30. Goldstein, S. (1963) "Development and nutrition o
f new species ofThraustochytrium. "Am. J. Bot.Five
0: 271-279. Goldstein, S.et al. (1969) "Biology of a problem
atic marine fungus,Dermocytidium sp. II. Nutritio
n and repiration. "Mycologia61: 468-72. Hiri, H.et al. (1980) Nucl. Acids Res. 8: 5535 55
39. Hunter, J.E. (1987) "Fish oil and other omega-3 s
ources. "J. Am. OilChem. Soc.64: 1592-1596. Kates, M. (1986)Techniques of Lipidology: Isola
tion, Analysis and Identification of Lipids, Elsevi
er, Amsterdam.Kazama, F. (1980) "The zoospore of Schizoshytrium
 aggregatum. Can J. Bot.58: 2434-2446. Kyle, D.J. (1987) "Microalgae as a source of EPA-
containing oils. "Abstract of talk presented at Wor
ld Conference for Fats & Oils, Hamburg, West German
y. J. Am. Oil Chem. Soc.64: 1251. Leedale, G. (1974) "Howmany are the kingdoms of o
rganisms. "Taxontwenty three: 261-270. Lepage, G. and Roy, C. (1984) "Improved recovery
of fatty acidthrough direct transesterification wi
thout prior extraction orpurification. "J. Lipid
Res.twenty five: 1391-1396.Margulis, L. (1970) Origin of Eukaryotic Cells, Y
ale University Press, New Haven.Margulis, L. and Sagan, D. (1985) "Order amidst a
nimalcules: theProctoctista kingdom and its undul
ipodiated cells. "BioSystems18: 141-147. Mannella, C.A.et al. (1987) "Interrelatedness of
 5S RNA sequences invested by correspondence an
alysis. "J. Mol. Evol.twenty four: 228-235. Moss, S. (1986) "Biology and phylogeny of the Lab.
rinthulales andThraustochytriales. "In:The Biol
ogy of Marine Fungi, S.T.Moss (ed.), Cambridge Uni
versity Press, London, pp. 105-130.Perkins, F.O. (1976) "Fine structure of lower mar
ine and estuarinefungi. "In:Recent Advances in
marine Mycology, E.B.GarethJones (ed.), Elek Scie
nce, pp. 279-312.Pigot, G.M. (1989), "The need to improve omega-3
content of culturedfish, "World Aquaculture20: 63
-68. Perkins, F. (1974) "Phylogenetic considerations o
f the problematicthraustochytriaceous-labrinthulid
-Dermocystidium complex based onobservations of fi
ne structure. "Veroff. Inst. Meeresforsch.Bremer
h. Suppl.Five: 45-63. Pohl, P. and Zurheide, F. (1979) "Fatty acids and
 lipids of marinealgae and the control of their bi
osynthesis by environmentalfactors. "In:Marine
Algae in Pharmaceutical Science, H. Hoppeet al(e
ds.), W. de Gruyter, Berlin, pp. 473-524. Poyton, R. (1970) "The charaterization ofHyalloc
hlorella marina gen.et sp.nov.a new colorless co
unterpart of Chlorella. "J. Gen. Microbiol.62: 17
1-188. Ryther, J.H. (1983) "Cultivation of macroscopic m
arine algae. "In:Solar Energy Research Institute
Aguayic Species Program Review.Proc. Of the March
1983 Principal Investigators Meeting.SERI / CP-231-1
946, pp. 79-88. Sargent, J.et al. (1989), "The lipids," inFish
Nutrition, SecondEdition, J. Halver (ed.), Academi
c Press, pp. 153-218.Schlenk, H. (1954) "Urea inclusion compounds of f
atty acids. "Prog.Chem. Fats and other LipidsTwo:
243: 267. Schneider, J. (1976) "Cultivation of Microorgnism
s. Section 3.2: Fungi. "In:Marine Ecology, Vol.
3, Part 1. Cultivation, O. Kinne (ed.), Wiley Inte
rscience. Sigma Chemical Co. (1988). Catalog: Biochemical
and Organic Compounds for Reserch.Sigma Chemical C
o., St. Louis, Missouri. Simopoulos, A.P. et al. (1986)Health Effects of
Polyunsaturated FattyAcids in Seafoods, Academic P
ress, New York. Sorokin, C. (1973) "Growth measurements: dry wei
ght packed cellvolume, and optical density. "In:
 Handbook of PhycologicalMethods: Culture Methods
and Growth Measurements, J.R. Stein (ed.), Cambrid
ge University Press, Cambridge, pp. 321-343.Sparrow, F.K. (1960)Aquatic Phycomycetes. Unive
rsity of MichiganPress, Ann Arbor, pp. 37-38. Wassef, M. (1977) "Fungal lipids." Adv. Lioid Re
s.Fifteen: 159-232. Weete, J.D. (1980)Lipid Biochemistry of Fungi an
d Other Organisms.Plenum Press, New York. Yamada, H.et al. (1987) "Production of arachidon
ic acid andeicosapentaenoic acid by microorganism
s. "Abstract of talkpresented at Wold Conference
for Fats & Oils, Hamburg, WestGermany. J. Am Oil
Chem. Soc.64: 1254.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C12N 1/12 C12N 1/12 A B C 1/14 1/14 A B C //(C12P 7/64 (C12P 7/64 C12R 1:89) C12R 1:89) (C12P 7/64 (C12P 7/64 C12R 1:645) C12R 1:645) ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C12N 1/12 C12N 1/12 A B C 1/14 1/14 A B C // (C12P 7/64 (C12P 7/64 C12R 1:89) C12R 1:89) (C12P 7/64 (C12P 7/64 C12R 1: 645) C12R 1: 645)

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 有機性炭素源、同化しうる窒素、海水の
塩分濃度よりも低い塩分濃度、および少なくとも約15
℃の温度からなる培養基中で、トロウストチトリウム属
およびシゾチトリウム属を除くトロウストチトリアレ目
の微生物から選択され、ω-3高度不飽和脂肪酸を効率
よく生産し得る微生物を培養することを含む、ω-3高
度不飽和脂肪酸の製造方法。
1. An organic carbon source, assimilable nitrogen, a salinity below seawater salinity, and at least about 15
Cultivating a microorganism selected from microorganisms of the order Thraustochytriales, excluding Thraustochytrium and Schizochytrium, and capable of efficiently producing ω-3 polyunsaturated fatty acids, in a culture medium having a temperature of 0 ° C. Method for producing ω-3 polyunsaturated fatty acid.
【請求項2】 さらに、ω-3高度不飽和脂肪酸もしく
はトロウストチトリウム属およびシゾチトリウム属を除
くトロウストチトリアレ目の微生物から選択され、ω-
3高度不飽和脂肪酸を効率よく生産し得る微生物の収穫
後の加工の間に、BHT,BHA,TBHQ,エトキシ
キュイン、β-カロテン、ビタミンEおよびビタミンC
からなる群より選択される化合物を、ω-3高度不飽和
脂肪酸もしくはトロウストチトリウム属およびシゾチト
リウム属を除くトロウストチトリアレ目の微生物から選
択され、ω-3高度不飽和脂肪酸を効率よく生産し得る
微生物に添加することを含む、請求項1に記載の方法。
2. The method of claim 2, further comprising selecting from ω-3 polyunsaturated fatty acids or microorganisms of the order Thraustochytriale excluding the genera Thraustochytrium and Schizochytrium;
3 During post-harvest processing of microorganisms capable of producing polyunsaturated fatty acids efficiently, BHT, BHA, TBHQ, ethoxycuin, β-carotene, vitamin E and vitamin C
A compound selected from the group consisting of: ω-3 polyunsaturated fatty acids or microorganisms of the order Thraustochytriale except genus Thraustochytrium and Schizochytrium, which efficiently produces ω-3 polyunsaturated fatty acids. 2. The method of claim 1, comprising adding to the resulting microorganism.
【請求項3】 さらに、トロウストチトリウム属および
シゾチトリウム属を除くトロウストチトリアレ目の微生
物から選択され、ω-3高度不飽和脂肪酸を効率よく生
産し得る微生物から脂質を抽出することを含む、請求項
1に記載のω-3高度不飽和脂肪酸の製造方法。
Further comprising extracting lipids from a microorganism selected from the microorganisms of the order Thraustochytriales excluding the genera Trous thythotrium and Schizochytrium and capable of efficiently producing ω-3 highly unsaturated fatty acids; A method for producing an ω-3 polyunsaturated fatty acid according to claim 1.
【請求項4】 上記の抽出において、 a) 微生物細胞を破砕して破砕細胞を得、 b) 破砕細胞から脂質混合物を溶媒抽出し、 c) 脂質混合物を加水分解し、さらに、 d) 上記脂質混合物中で非高度不飽和脂肪酸を冷却結晶
化する ステップを含む、請求項3に記載の方法。
4. In the above extraction, a) disrupting microbial cells to obtain disrupted cells; b) solvent extracting the lipid mixture from the disrupted cells; c) hydrolyzing the lipid mixture; 4. The method of claim 3, comprising cooling and crystallizing the non-highly unsaturated fatty acids in the mixture.
【請求項5】 ATCC番号20888のシゾチトリウ
ム、ATCC番号20889のシゾチトリウム、ATC
C番号20890のトロウストチトリウム、ATCC番
号20891のトロウストチトリウム、ATCC番号2
0892のトロウストチトリウムのいずれかから誘導さ
れる、トロウストチトリウム属およびシゾチトリウム属
を除くトロウストチトリアレ目に属する変異株たる微生
物であって、ω-3高度不飽和脂肪酸を産出し得るもの
で、広範な温度範囲、特に約15℃〜48℃の間で生育
でき、広範な塩分レベル、特に例えば5〜40mmho/cm
の間の電導率をもたらす塩分レベルのような低い塩分レ
ベルで生育でき、そして、フィラメント状ではない微生
物からなる群から選択される単細胞微生物。
5. Schizochytrium of ATCC No. 20888, Schizochytrium of ATCC No. 20889, ATC
Thraustochytrium with C number 20890, Thraustochytrium with ATCC number 20891, ATCC number 2
0892, which is a mutant strain belonging to the order Thraustochytriales other than the genera Thraustochytrium and Schizochytrium, which is capable of producing ω-3 highly unsaturated fatty acids. Can grow over a wide temperature range, especially between about 15 ° C. and 48 ° C., and have a wide range of salinity levels, for example,
A unicellular microorganism that is capable of growing at low salinity levels, such as a salinity level that results in a conductivity between, and is selected from the group consisting of non-filamentous microorganisms.
【請求項6】a) (i) ATCC番号20888のシゾ
チトリウムから誘導される、トロウストチトリウム属お
よびシゾチトリウム属を除くトロウストチトリアレ目に
属する変異株たる微生物であって、ω-3高度不飽和脂
肪酸を産出し得るもので、広範な温度範囲、特に約15
℃〜48℃の間で生育でき、広範な塩分レベル、特に例
えば5〜40mmho/cmの間の電導率をもたらす塩分レベ
ルのような低い塩分レベルで生育でき、そして、フィラ
メント状ではない微生物; (ii) ATCC番号20889のシゾチトリウムから誘
導される、トロウストチトリウム属およびシゾチトリウ
ム属を除くトロウストチトリアレ目に属する変異株たる
微生物であって、ω-3高度不飽和脂肪酸を産出し得る
もので、広範な温度範囲、特に約15℃〜48℃の間で
生育でき、広範な塩分レベル、特に例えば5〜40mmho
/cmの間の電導率をもたらす塩分レベルのような低い塩
分レベルで生育でき、そして、フィラメント状ではない
微生物; (iii) ATCC番号20890のトロウストチトリウ
ムから誘導される、 トロウストチトリウム属およびシゾチトリウム属を除く
トロウストチトリアレ目に属する変異株たる微生物であ
って、ω-3高度不飽和脂肪酸を産出し得るもので、広
範な温度範囲、特に約15℃〜48℃の間で生育でき、
広範な塩分レベル、特に例えば5〜40mmho/cmの間の
電導率をもたらす塩分レベルのような低い塩分レベルで
生育でき、そして、フィラメント状ではない微生物; (iv) ATCC番号20891のトロウストチトリウム
から誘導される、トロウストチトリウム属およびシゾチ
トリウム属を除くトロウストチトリアレ目に属する変異
株たる微生物であって、ω-3高度不飽和脂肪酸を産出
し得るもので、広範な温度範囲、特に約15℃〜48℃
の間で生育でき、 広範な塩分レベル、特に例えば5〜40mmho/cmの間の
電導率をもたらす塩分レベルのような低い塩分レベルで
生育でき、そして、フィラメント状ではない微生物; (v) ATCC番号20892のトロウストチトリウム
から誘導される、トロウストチトリウム属およびシゾチ
トリウム属を除くトロウストチトリアレ目に属する変異
株たる微生物であって、ω-3高度不飽和脂肪酸を産出
し得るもので、広範な温度範囲、特に約15℃〜48℃
の間で生育でき、 広範な塩分レベル、特に例えば5〜40mmho/cmの間の
電導率をもたらす塩分レベルのような低い塩分レベルで
生育でき、そして、フィラメント状ではない微生物;か
らなる群から選択される微生物、またはこれらから抽出
された脂質と、 b) 食用物質とを含む、食用製品。
6. a) (i) a microorganism which is derived from Schizochytrium of ATCC No. 20888 and is a mutant strain belonging to the genus Thraustochytrium and the genus Thraustochytriale excluding the genus Schizochytrium, wherein the strain is ω-3 highly unsaturated. It can produce fatty acids and has a wide temperature range, especially about 15
Microorganisms capable of growing between 0 ° C. and 48 ° C., capable of growing at low salinity levels, such as salinity levels resulting in a wide range of salinity, for example, between 5 and 40 mmho / cm, and not being filamentous; ii) a microorganism derived from Schizochytrium of ATCC No. 20889, which is a mutant strain belonging to the order Thraustochytriale except genus Thraustochytrium and Schizochytrium, which is capable of producing ω-3 highly unsaturated fatty acids; It can grow over a wide temperature range, especially between about 15 ° C. and 48 ° C., and has a wide range of salinity levels, especially for example 5-40 mmho.
microorganisms that can grow at low salinity levels, such as salinity levels that result in a conductivity of between 0.5 / cm and non-filamentous; and (iii) derived from ATCC No. 20890 Thraustochytrium, Thraustochytrium and Schizochytrium. A microorganism which is a mutant strain belonging to the order Thraustochytriales except for the genus, which can produce ω-3 polyunsaturated fatty acids, and which can grow in a wide temperature range, particularly between about 15 ° C. to 48 ° C.,
Microorganisms that can grow at low salinity levels, such as those that provide a wide range of salinity, especially conductivity between 5 and 40 mmho / cm, and are not filamentous; (iv) from ATCC no. A derived microorganism, which is a mutant strain belonging to the order Thraustochytriale excluding the genera Thraustochytrium and Schizochytrium, which is capable of producing ω-3 polyunsaturated fatty acids and has a wide temperature range, particularly about 15 ° C. ° C to 48 ° C
Microorganisms that are capable of growing between a wide range of salinity levels, especially low salinity levels such as those that provide a conductivity of, for example, between 5 and 40 mmho / cm, and are not filamentous; (v) ATCC numbers A microorganism belonging to the order of the Thraustochytriales except Thraustochytrium and Schizochytrium, which is derived from the Tauostitolium of 20892, and is capable of producing ω-3 polyunsaturated fatty acids. Temperature range, especially about 15 ° C to 48 ° C
Microorganisms that can grow between a wide range of salinity levels, especially low salinity levels such as those that provide a conductivity of, for example, between 5 and 40 mmho / cm, and are not filamentous. An edible product comprising microorganisms to be isolated, or lipids extracted therefrom; and b) edible substances.
JP2000297654A 1989-11-17 2000-09-28 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid Expired - Lifetime JP4187133B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43909389A 1989-11-17 1989-11-17
US580,778 1990-09-11
US07/580,778 US5130242A (en) 1988-09-07 1990-09-11 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US439,093 1990-09-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51571090A Division JP3669372B2 (en) 1989-11-17 1990-11-05 Heterotropic process for producing microbial products containing high concentrations of omega-3 highly unsaturated fatty acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006042778A Division JP4247442B2 (en) 1989-11-17 2006-02-20 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid

Publications (2)

Publication Number Publication Date
JP2001149087A true JP2001149087A (en) 2001-06-05
JP4187133B2 JP4187133B2 (en) 2008-11-26

Family

ID=27031913

Family Applications (6)

Application Number Title Priority Date Filing Date
JP51571090A Expired - Lifetime JP3669372B2 (en) 1989-11-17 1990-11-05 Heterotropic process for producing microbial products containing high concentrations of omega-3 highly unsaturated fatty acids
JP2000297654A Expired - Lifetime JP4187133B2 (en) 1989-11-17 2000-09-28 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid
JP2006042778A Expired - Lifetime JP4247442B2 (en) 1989-11-17 2006-02-20 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid
JP2008018408A Expired - Lifetime JP4418930B2 (en) 1989-11-17 2008-01-30 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid
JP2009023481A Withdrawn JP2009089717A (en) 1989-11-17 2009-02-04 Process for heterotrophic production of microbial products with high concentration of omega-3 highly unsaturated fatty acid
JP2010071830A Pending JP2010136730A (en) 1989-11-17 2010-03-26 PROCESS FOR HETEROTROPHIC PRODUCTION OF MICROBIAL PRODUCT WITH HIGH CONCENTRATION OF omega-3 HIGHLY UNSATURATED FATTY ACID

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51571090A Expired - Lifetime JP3669372B2 (en) 1989-11-17 1990-11-05 Heterotropic process for producing microbial products containing high concentrations of omega-3 highly unsaturated fatty acids

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2006042778A Expired - Lifetime JP4247442B2 (en) 1989-11-17 2006-02-20 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid
JP2008018408A Expired - Lifetime JP4418930B2 (en) 1989-11-17 2008-01-30 Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid
JP2009023481A Withdrawn JP2009089717A (en) 1989-11-17 2009-02-04 Process for heterotrophic production of microbial products with high concentration of omega-3 highly unsaturated fatty acid
JP2010071830A Pending JP2010136730A (en) 1989-11-17 2010-03-26 PROCESS FOR HETEROTROPHIC PRODUCTION OF MICROBIAL PRODUCT WITH HIGH CONCENTRATION OF omega-3 HIGHLY UNSATURATED FATTY ACID

Country Status (12)

Country Link
US (1) US5130242A (en)
EP (1) EP0512997B1 (en)
JP (6) JP3669372B2 (en)
AT (1) ATE156520T1 (en)
AU (1) AU657259B2 (en)
CA (1) CA2072978C (en)
DE (1) DE69031223T2 (en)
DK (1) DK0512997T3 (en)
ES (1) ES2106736T3 (en)
GR (1) GR3025200T3 (en)
HK (1) HK1001922A1 (en)
WO (1) WO1991007498A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063886A1 (en) * 2005-11-30 2007-06-07 Nagase Chemtex Corporation Method for producing phospholipid containing polyvalent unsaturated fatty acid, and phospholipid containing polyvalent unsaturated fatty acid obtained by such method

Families Citing this family (276)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130242A (en) * 1988-09-07 1992-07-14 Phycotech, Inc. Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US20060094089A1 (en) * 1988-09-07 2006-05-04 Martek Biosciences Corporation Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US6451567B1 (en) * 1988-09-07 2002-09-17 Omegatech, Inc. Fermentation process for producing long chain omega-3 fatty acids with euryhaline microorganisms
US5340742A (en) 1988-09-07 1994-08-23 Omegatech Inc. Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids
US5985348A (en) * 1995-06-07 1999-11-16 Omegatech, Inc. Milk products having high concentrations of omega-3 highly unsaturated fatty acids
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ES2049025T3 (en) * 1990-03-12 1994-04-01 Einar Sola PROCESS TO ENRICH THE FAT WITH POLYINSATURATED FATTY ACIDS AND PHOSPHOLIPIDS, AND THE USE OF SUCH ENRICHED FAT.
ZA92452B (en) * 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
JP3354582B2 (en) * 1991-09-30 2002-12-09 サントリー株式会社 Method for producing omega-9 polyunsaturated fatty acid and lipid containing the same
US6410281B1 (en) 1992-07-10 2002-06-25 Omegatech, Inc. Reducing corrosion in a fermentor by providing sodium with a non-chloride sodium salt
JP2558050B2 (en) * 1993-02-18 1996-11-27 イセ食品株式会社 Chicken feed
JPH078215A (en) * 1993-04-30 1995-01-13 Kawasaki Steel Corp Marine microalgal food raw material containing docosahexaenoic acid and its production
AU7053494A (en) * 1993-06-04 1995-01-03 Martek Biosciences Corporation Method of treating coronary vascular disease using docosahexaenoic acid
EP2140863A1 (en) * 1993-06-09 2010-01-06 Martek Biosciences Corporation Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of neurological disorders
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5583019A (en) * 1995-01-24 1996-12-10 Omegatech Inc. Method for production of arachidonic acid
DE69637953D1 (en) 1995-04-17 2009-07-30 Nat Inst Of Advanced Ind Scien HIGHLY UNSATURATED FATTY ACID-PRODUCING MICRO-ORGANISMS AND METHOD FOR PRODUCING HIGH-UNSATURATED FATTY ACIDS THROUGH THE USE OF THESE MICRO-ORGANISMS
US20080175953A1 (en) * 1995-06-07 2008-07-24 Martek Biosciences Corporation Process for the Heterotrophic Production of Microbial Products with High Concentrations of Omega-3 Highly Unsaturated Fatty Acids
GB9514649D0 (en) * 1995-07-18 1995-09-13 Zeneca Ltd Extraction of triglycerides from microorganisms
EP2251411A3 (en) * 1996-03-28 2011-10-12 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US6166230A (en) * 1996-05-15 2000-12-26 Gist-Brocades B.V. Sterol extraction with polar solvent to give low sterol, high triglyceride, microbial oil
DE19629433A1 (en) * 1996-07-22 1998-01-29 Hoechst Ag Preparation containing omega-3 fatty acids from microorganisms as a prophylactic or therapeutic agent against parasitic diseases in animals
WO1998003671A1 (en) * 1996-07-23 1998-01-29 Nagase Biochemicals, Ltd. Process for preparing docosahexaenoic acid and docosapentaenoic acid
US6566583B1 (en) * 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
AU748220C (en) * 1997-08-01 2003-02-27 Martek Biosciences Corporation DHA-containing nutritional compositions and methods for their production
CA2301040C (en) * 1997-08-14 2007-11-06 Omegatech Inc. A method for increasing incorporation efficiency of omega-3 highly unsaturated fatty acid in poultry meat
TR200003712T2 (en) 1998-06-17 2001-04-20 Dsm N.V. Microbial arachidonic acid (ARA) for use in the feed of marine animals
US6166231A (en) * 1998-12-15 2000-12-26 Martek Biosciences Corporation Two phase extraction of oil from biomass
US8003772B2 (en) 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
US7211418B2 (en) * 1999-01-14 2007-05-01 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US20070244192A1 (en) * 1999-01-14 2007-10-18 Martek Biosciences Corporation Plant seed oils containing polyunsaturated fatty acids
US7271315B2 (en) 1999-01-14 2007-09-18 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US7247461B2 (en) * 1999-01-14 2007-07-24 Martek Biosciences Corporation Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
US7217856B2 (en) * 1999-01-14 2007-05-15 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
AUPP887399A0 (en) * 1999-02-24 1999-03-25 Bartlett Grain Pty Ltd Animal feed formulae for the nutritional enrichment of foodstuffs
KR20000067595A (en) * 1999-04-29 2000-11-25 정봉환 Production of dha (docosahexaenoic acid) from food wastes or agricultural and livestock farming wastes
GB9916537D0 (en) 1999-07-14 1999-09-15 Univ Hull Culture of microorganisms for the synthesis of a polyunsaturated fatty acid
US6762203B2 (en) * 1999-08-03 2004-07-13 Kao Corporation Oil composition
AU7551100A (en) * 1999-09-27 2001-04-30 Algal Ltd. Vegetarian foodstuff
KR100338193B1 (en) * 1999-12-13 2002-05-24 김광양 New kind of protista schizochytrium sp. Sπ-2(KCTC 0694BP) and a method of cultivation
US6395778B1 (en) 2000-01-11 2002-05-28 Omegatech, Inc. Process for making an enriched mixture of polyunsaturated fatty acid esters
EP2295594B1 (en) * 2000-01-19 2018-04-04 DSM IP Assets B.V. Solventless extraction process
ATE374531T1 (en) * 2000-01-28 2007-10-15 Martek Biosciences Corp ENHANCED PRODUCTION OF LIPIDS CONTAINING POLYUNSATURATED FATTY ACIDS BY HIGH DENSITY CULTURES OF EUCARIOTIC MICROBE IN FERMENTATION DEVICES
US6783951B2 (en) * 2000-02-24 2004-08-31 Long, Ii Thomas Veach Process for production of carotenoids, xanthophylls and apo-carotenoids utilizing eukaryotic microorganisms
EP1276885B1 (en) * 2000-04-21 2007-09-12 Martek Biosciences Corporation Trophic conversion of obligate phototrophic algae through metabolic engineering
EP1780283A1 (en) 2000-04-21 2007-05-02 Martek Biosciences Corporation Trophic conversion of obligate photographic algae through metabolic engineering
ES2168971B1 (en) * 2000-07-19 2003-11-01 Antibioticos Sau BETA-CAROTENE PRODUCTION PROCEDURE.
EP1178118A1 (en) * 2000-08-02 2002-02-06 Dsm N.V. Isolation of microbial oils
US6635451B2 (en) 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
BR0205508A (en) * 2001-01-25 2005-05-03 Abbott Lab Desaturase genes and their uses
GB2377455A (en) * 2001-02-09 2003-01-15 Univ Hull Method of culturing crypthecodinium cohnii
DE60138602D1 (en) * 2001-03-09 2009-06-18 Nestle Sa An oil containing long-chain polyunsaturated fatty acids from biomass, process of manufacture, food, food composition, cosmetic or pharmaceutical composition containing the same
TWI426127B (en) * 2001-04-16 2014-02-11 Dsm Ip Assets Bv Pufa polyketide synthase systems and uses thereof
TWI324181B (en) * 2001-04-16 2010-05-01 Martek Biosciences Corp Product and process for transformation of thraustochytriales microorganisms
US6716460B2 (en) * 2001-05-14 2004-04-06 Martek Biosciences Corporation Method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
AU2002323409A1 (en) * 2001-08-24 2003-03-10 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
EP1304029A1 (en) 2001-10-19 2003-04-23 Dsm N.V. PUFAs in eggs
CA2471211A1 (en) * 2002-01-04 2003-07-17 Ivax Research, Inc. Drug delivery system for sustained delivery of glipizide
AU2003223852A1 (en) 2002-02-28 2003-09-09 Wolf-Dieter Juelich Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
JP4088097B2 (en) 2002-04-26 2008-05-21 サントリー株式会社 Method for producing highly unsaturated fatty acid-containing lipid
EP1503715A4 (en) 2002-05-03 2005-07-06 Martek Biosciences Corp High-quality lipids and methods for producing by enzymatic liberation from biomass
US7202067B2 (en) * 2002-05-14 2007-04-10 Martek Biosciences Corporation Carotene synthase gene and uses therefor
EP2368445A1 (en) 2002-06-18 2011-09-28 Martek Biosciences Corporation Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same
CN101837135B (en) 2002-06-19 2014-09-24 帝斯曼知识产权资产管理有限公司 Pasteurisation process for microbial cells and microbial oil
CA2499501A1 (en) 2002-09-27 2004-04-08 Martek Biosciences Corporation Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
EP1558237A4 (en) * 2002-09-27 2007-01-17 Martek Biosciences Corp Improved glycemic control for prediabetes and/or diabetes type ii using docosahexaenoic acid
JP4280158B2 (en) * 2002-12-27 2009-06-17 富士フイルム株式会社 Microorganisms capable of producing docosahexaenoic acid and use thereof
JP2007502601A (en) * 2003-08-15 2007-02-15 グレイン プロセシング コーポレーション Method for dissociating cells
MX271416B (en) * 2003-10-02 2009-10-30 Martek Biosciences Corp Production of high levels of dha in microalgae using modified amounts of chloride and potassium.
DE10352838A1 (en) 2003-11-10 2005-07-07 Nutrinova Nutrition Specialties & Food Ingredients Gmbh A method of cultivating microorganisms of the genus Thraustochytriales using an optimized low salt medium
AU2004290052B2 (en) * 2003-11-12 2008-12-04 Corteva Agriscience Llc Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
DE102004022015A1 (en) * 2004-05-03 2005-12-01 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Fish food for aqua farms based on fermented polyunsaturated fatty acids
DK1776450T3 (en) * 2004-08-12 2010-06-21 Nippon Suisan Kaisha Ltd Process for polyunsaturated fatty acid production using novel cell preservation technique
US7678931B2 (en) * 2004-10-22 2010-03-16 Martek Biosciences Corporation Process for preparing materials for extraction
US7300965B2 (en) 2004-12-29 2007-11-27 Weyerhaeuser Company Mixed polymer network
CA2611324C (en) * 2005-06-07 2017-02-14 Ocean Nutrition Canada Limited Eukaryotic microorganisms for producing lipids and antioxidants
AU2006265801B2 (en) * 2005-07-01 2011-07-14 Martek Biosciences Corporation Polyunsaturated fatty acid-containing oil product and uses and production thereof
WO2007005727A2 (en) * 2005-07-01 2007-01-11 Martek Biosciences Corporation Microwaveable popcorn and methods of making
EP1976973B1 (en) * 2005-12-29 2010-07-21 ABL Biotechnologies Ltd. Novel strain of schizochytrium limacinum useful in the production of lipids and extracellular polysaccharides and process thereof
KR101524398B1 (en) * 2006-03-15 2015-06-04 디에스엠 아이피 어셋츠 비.브이. Polyunsaturated Fatty Acid Production in Heterologous Organisms Using PUFA Polyketide Synthase Systems
TW200806184A (en) * 2006-04-11 2008-02-01 Martek Biosciences Corp Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same
KR100700486B1 (en) * 2006-05-03 2007-03-28 대상 주식회사 Microorganism producing omega-3 unsaturated fatty acid and processes for preparing omega-3 unsaturated fatty acid using the same
EP2034973B2 (en) 2006-06-22 2022-01-19 DSM IP Assets B.V. Encapsulated labile compound compositions and methods of making the same
US20080026109A1 (en) * 2006-06-29 2008-01-31 Martek Biosciences Corporation Sweetened Oil Compositions and Methods of Making
EP2043970B1 (en) * 2006-07-05 2018-04-18 Centre National De La Recherche Scientifique (C.N.R.S.) Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding
CN101981201A (en) * 2006-08-01 2011-02-23 加拿大海洋营养食品有限公司 Oil producing microbes and methods of modification thereof
BRPI0714732A2 (en) 2006-08-29 2014-09-23 Martek Biosciences Corp Use of DPA (n-6) Oils in Infant Formula
US8088614B2 (en) * 2006-11-13 2012-01-03 Aurora Algae, Inc. Methods and compositions for production and purification of biofuel from plants and microalgae
DE102008015239A1 (en) 2007-03-20 2008-09-25 Georg Fritzmeier Gmbh & Co. Kg Process for the production of polyunsaturated fatty acids
BRPI0811967B1 (en) * 2007-06-01 2023-01-17 Terravia Holdings, Inc MICROALGAE CHLORELLA OR PROTOTHECA AND METHOD FOR THE PRODUCTION OF MICROBIAL LIPIDS
US8652814B2 (en) 2007-06-04 2014-02-18 National University Corporation Hokkaido University Method for production of DHA-containing phospholipid through microbial fermentation
WO2008155410A1 (en) * 2007-06-21 2008-12-24 Novozymes A/S Production of lipids containing poly-unsaturated fatty acids
MX2010000263A (en) * 2007-06-29 2010-03-11 Martek Biosciences Corp Production and purification of esters of polyunsaturated fatty acids.
KR101650680B1 (en) * 2007-08-31 2016-08-23 디에스엠 아이피 어셋츠 비.브이. Polyunsaturated fatty acid-containing solid fat compositions and uses and production thereof
US8148559B1 (en) 2007-08-31 2012-04-03 Clemson University Research Foundation Supercritical fluid explosion process to aid fractionation of lipids from biomass
JP2010538642A (en) 2007-09-12 2010-12-16 マーテック バイオサイエンシーズ コーポレーション Biological oil and its production and use
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US7989195B2 (en) * 2008-02-20 2011-08-02 Washington State University Research Foundation Heterotrophic algal high cell density production method and system
EP2105506A1 (en) 2008-03-26 2009-09-30 Lonza Ag Process for preparing oils containing PUFAs employing microorganisms of the order Labyrinthulomycota
CN104561150A (en) 2008-04-09 2015-04-29 索拉兹米公司 Direct chemical modification of microbial biomass and microbial oils
US20110076379A1 (en) * 2008-06-13 2011-03-31 Means Michael M High omega saturated fat free meat products
EP2145942A1 (en) * 2008-07-15 2010-01-20 Lonza Ltd. Method for isolating oils from cells and biomasses
US20100022393A1 (en) * 2008-07-24 2010-01-28 Bertrand Vick Glyphosate applications in aquaculture
US20100028484A1 (en) * 2008-07-30 2010-02-04 Gs Cleantech Corporation Methods for producing lipids from ethanol production co-products by introducing lipid producing microorganisms
US20100297331A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Reduced Fat Foods Containing High-Lipid Microalgae with Improved Sensory Properties
US20100297323A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Gluten-free Foods Containing Microalgae
US20100303989A1 (en) * 2008-10-14 2010-12-02 Solazyme, Inc. Microalgal Flour
US20100303961A1 (en) * 2008-10-14 2010-12-02 Solazyme, Inc. Methods of Inducing Satiety
US20100297325A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Egg Products Containing Microalgae
US20100297292A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Reduced Pigmentation Microalgae Strains and Products Therefrom
US20100297296A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Healthier Baked Goods Containing Microalgae
US20100303957A1 (en) * 2008-10-14 2010-12-02 Solazyme, Inc. Edible Oil and Processes for Its Production from Microalgae
US20100297295A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Microalgae-Based Beverages
CN104770424A (en) * 2008-10-14 2015-07-15 索拉兹米公司 Food compositions of microalgal biomass
US20100303990A1 (en) * 2008-10-14 2010-12-02 Solazyme, Inc. High Protein and High Fiber Algal Food Materials
MX2011005629A (en) 2008-11-28 2011-09-28 Solazyme Inc Production of tailored oils in heterotrophic microorganisms.
US8940340B2 (en) * 2009-01-22 2015-01-27 Aurora Algae, Inc. Systems and methods for maintaining the dominance of Nannochloropsis in an algae cultivation system
US8143051B2 (en) * 2009-02-04 2012-03-27 Aurora Algae, Inc. Systems and methods for maintaining the dominance and increasing the biomass production of nannochloropsis in an algae cultivation system
AU2010225930B2 (en) 2009-03-16 2017-01-12 Dsm Ip Assets B.V. Protein production in microorganisms of the phylum Labyrinthulomycota
CA2755639C (en) 2009-03-19 2018-09-25 Martek Biosciences Corporation Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
CN109609562A (en) 2009-03-19 2019-04-12 帝斯曼知识产权资产管理有限公司 Thraustochytriale, aliphatic acid composition and preparation method and the usage
CN104988078B (en) * 2009-03-19 2021-07-30 帝斯曼知识产权资产管理有限公司 Thraustochytrid, fatty acid composition and preparation method and application thereof
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
US9187778B2 (en) 2009-05-04 2015-11-17 Aurora Algae, Inc. Efficient light harvesting
US8865452B2 (en) * 2009-06-15 2014-10-21 Aurora Algae, Inc. Systems and methods for extracting lipids from wet algal biomass
US8769867B2 (en) * 2009-06-16 2014-07-08 Aurora Algae, Inc. Systems, methods, and media for circulating fluid in an algae cultivation pond
US9101942B2 (en) * 2009-06-16 2015-08-11 Aurora Algae, Inc. Clarification of suspensions
US20100325948A1 (en) * 2009-06-29 2010-12-30 Mehran Parsheh Systems, methods, and media for circulating and carbonating fluid in an algae cultivation pond
US8747930B2 (en) * 2009-06-29 2014-06-10 Aurora Algae, Inc. Siliceous particles
US9932554B2 (en) 2009-09-18 2018-04-03 Phycoil Biotechnology International, Inc. Microalgae fermentation using controlled Illumination
US8765983B2 (en) * 2009-10-30 2014-07-01 Aurora Algae, Inc. Systems and methods for extracting lipids from and dehydrating wet algal biomass
US8748160B2 (en) * 2009-12-04 2014-06-10 Aurora Alage, Inc. Backward-facing step
ES2651313T3 (en) * 2009-12-28 2018-01-25 Dsm Ip Assets B.V. Recombinant traustoquids growing in xylose, and compositions, methods of preparation and uses thereof
CN107858297A (en) 2009-12-28 2018-03-30 Dsm Ip资产公司 Restructuring thraustochytriale and its composition, the Preparation method and use grown on sucrose
KR20150013667A (en) * 2010-01-19 2015-02-05 디에스엠 아이피 어셋츠 비.브이. Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
JP2013521778A (en) * 2010-03-11 2013-06-13 ビーピー・バイオフューエルズ・ユーケイ・リミテッド Method, biological oil, biofuel, unit, and organism intended for use in a compression engine
US8211308B2 (en) 2010-04-06 2012-07-03 Heliae Development, Llc Extraction of polar lipids by a two solvent method
WO2011127127A2 (en) 2010-04-06 2011-10-13 Arizona Board Of Regents For And On Behalf Of Arizona State University Extraction with fractionation of oil and co-products from oleaginous material
US8308951B1 (en) 2010-04-06 2012-11-13 Heliae Development, Llc Extraction of proteins by a two solvent method
US8211309B2 (en) 2010-04-06 2012-07-03 Heliae Development, Llc Extraction of proteins by a two solvent method
US8273248B1 (en) 2010-04-06 2012-09-25 Heliae Development, Llc Extraction of neutral lipids by a two solvent method
US8115022B2 (en) 2010-04-06 2012-02-14 Heliae Development, Llc Methods of producing biofuels, chlorophylls and carotenoids
US8313648B2 (en) 2010-04-06 2012-11-20 Heliae Development, Llc Methods of and systems for producing biofuels from algal oil
US8202425B2 (en) 2010-04-06 2012-06-19 Heliae Development, Llc Extraction of neutral lipids by a two solvent method
CN102971407A (en) 2010-04-06 2013-03-13 赫里开发公司 Methods of and systems for producing biofuels
US8475660B2 (en) 2010-04-06 2013-07-02 Heliae Development, Llc Extraction of polar lipids by a two solvent method
SG10201504197SA (en) 2010-05-28 2015-06-29 Solazyme Inc Food Compositions Comprising Tailored Oils
WO2011153246A2 (en) 2010-06-01 2011-12-08 Martek Biosciences Corporation Extraction of lipid from cells and products therefrom
ES2733134T3 (en) 2010-06-09 2019-11-27 Fermentalg Compositions comprising eicosapentaenoic acid suitable for high purification
US9023625B2 (en) * 2010-06-14 2015-05-05 Io-Mega Holding Corporation Methods for production of algae derived oils
US9028696B2 (en) 2010-07-26 2015-05-12 Sapphire Energy, Inc. Process for the recovery of oleaginous compounds from biomass
US8906236B2 (en) 2010-07-26 2014-12-09 Sapphire Energy, Inc. Process for the recovery of oleaginous compounds and nutrients from biomass
MX2013000892A (en) 2010-07-26 2013-04-03 Sapphire Energy Inc Process for the recovery of oleaginous compounds from biomass.
US20120183668A1 (en) * 2010-08-11 2012-07-19 E.I. Du Pont De Nemours And Company Aquaculture feed compositions
US9415035B2 (en) 2010-09-17 2016-08-16 Maine Natural Health Company, Inc. Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
US20130203701A1 (en) 2010-09-17 2013-08-08 Maine Natural Health, Inc. Compositions containing omega-3 oil and uses thereof
US10479969B2 (en) 2010-10-11 2019-11-19 Phycoil Biotechnology International. Inc. Utilization of wastewater for microalgal cultivation
EP2635663B1 (en) 2010-11-03 2019-05-08 Corbion Biotech, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
CN103827307A (en) 2011-02-02 2014-05-28 索拉兹米公司 Tailored oils produced from recombinant oleaginous microorganisms
US8926844B2 (en) 2011-03-29 2015-01-06 Aurora Algae, Inc. Systems and methods for processing algae cultivation fluid
US8569530B2 (en) 2011-04-01 2013-10-29 Aurora Algae, Inc. Conversion of saponifiable lipids into fatty esters
US8752329B2 (en) 2011-04-29 2014-06-17 Aurora Algae, Inc. Optimization of circulation of fluid in an algae cultivation pond
KR20140033378A (en) 2011-05-06 2014-03-18 솔라짐, 인코포레이티드 Genetically engineered microorganisms that metabolize xylose
CN102787140A (en) * 2011-05-20 2012-11-21 罗盖特兄弟公司 Method for preparing and extracting squalene by microalgae
CN102787074B (en) * 2011-05-20 2016-06-08 罗盖特兄弟公司 Produce the Microalgae new strain of squalene
US8365462B2 (en) 2011-05-31 2013-02-05 Heliae Development, Llc V-Trough photobioreactor systems
USD682637S1 (en) 2011-06-10 2013-05-21 Heliae Development, Llc Aquaculture vessel
USD679965S1 (en) 2011-06-10 2013-04-16 Heliae Development, Llc Aquaculture vessel
USD661164S1 (en) 2011-06-10 2012-06-05 Heliae Development, Llc Aquaculture vessel
US9637763B2 (en) 2011-06-23 2017-05-02 Rho Renewables, Inc. Recombinant production systems for aromatic molecules
MY180625A (en) * 2011-07-13 2020-12-03 Alltech Inc Algal lipid compositions and methods of preparing and utilizing the same
SG10201605966TA (en) 2011-07-21 2016-09-29 Dsm Ip Assets Bv Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
CN108771240A (en) 2011-07-21 2018-11-09 帝斯曼知识产权资产管理有限公司 Aliphatic acid composition
US20140323569A1 (en) * 2011-07-21 2014-10-30 Krishna Raman Microbial oils enriched in polyunsaturated fatty acids
KR20200003227A (en) 2011-11-01 2020-01-08 디에스엠 아이피 어셋츠 비.브이. Oxidatively stable polyunsaturated fatty acid containing oil
WO2013075116A2 (en) 2011-11-17 2013-05-23 Heliae Development, Llc Omega 7 rich compositions and methods of isolating omega 7 fatty acids
US9719114B2 (en) 2012-04-18 2017-08-01 Terravia Holdings, Inc. Tailored oils
SG11201406711TA (en) 2012-04-18 2014-11-27 Solazyme Inc Tailored oils
US8747916B1 (en) 2012-10-30 2014-06-10 Donald M. Smith Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health
KR101465545B1 (en) * 2012-12-28 2014-11-26 대상 주식회사 Process for culturing chlorella for increasing crude protein contents
US10023884B2 (en) 2013-01-18 2018-07-17 Kyowa Hakko Bio Co., Ltd. Microorganism producing docosahexaenoic acid and utilization thereof
US10098371B2 (en) 2013-01-28 2018-10-16 Solazyme Roquette Nutritionals, LLC Microalgal flour
EP2762008A1 (en) 2013-02-05 2014-08-06 Evonik Industries AG Improving bioavailability of valuable materials from microorganisms by use of a rotor-stator system for cell disruption
WO2014122092A1 (en) 2013-02-05 2014-08-14 Evonik Industries Ag Improving the bioavailability of useful materials from microorganisms
PT2970926T (en) 2013-03-13 2018-03-22 Dsm Nutritional Products Ag Engineering microorganisms
US9266973B2 (en) 2013-03-15 2016-02-23 Aurora Algae, Inc. Systems and methods for utilizing and recovering chitosan to process biological material
BR112015026948A8 (en) 2013-04-26 2017-10-03 Solazyme Inc "COMPOSITIONS, LUBRICANT, SURFACE, SOLVENT, CLEANING FORMULATION, RETICULABLE OR RETICULATED RUBBER COMPOSITION, TIRE STRIP, POLYURETHANE FOAM AND ITS PREPARATION METHOD
KR20230119731A (en) * 2013-06-12 2023-08-16 솔라베스트 바이오에너지 인코퍼레이티드 Methods of producing algal cell cultures and biomass, lipid compounds and compositions, and related products
EP2826384A1 (en) * 2013-07-16 2015-01-21 Evonik Industries AG Method for drying biomass
FR3009619B1 (en) 2013-08-07 2017-12-29 Roquette Freres BIOMASS COMPOSITIONS OF MICROALGUES RICH IN PROTEINS OF SENSORY QUALITY OPTIMIZED
EP3052636A2 (en) 2013-10-04 2016-08-10 Solazyme, Inc. Tailored oils
CN103911292B (en) * 2013-12-05 2016-04-06 中国科学院天津工业生物技术研究所 The schizochytrium limacinum of one strain tolerance less salt and application thereof
WO2015092546A1 (en) 2013-12-20 2015-06-25 MARA Renewables Corporation Methods of recovering oil from microorganisms
EP3082792A4 (en) 2013-12-20 2017-08-16 DSM IP Assets B.V. Processes for obtaining microbial oil from microbial cells
EP3083974A1 (en) 2013-12-20 2016-10-26 DSM Nutritional Products AG Methods of recovering oil from microorganisms
TWI646188B (en) 2013-12-20 2019-01-01 荷蘭商Dsm智慧財產有限公司 Method for obtaining microbial oil from microbial cells (4)
US10342772B2 (en) 2013-12-20 2019-07-09 Dsm Ip Assets B.V. Processes for obtaining microbial oil from microbial cells
CN106061475B (en) 2013-12-20 2022-03-25 帝斯曼知识产权资产管理有限公司 Method for obtaining microbial oil from microbial cells
WO2015116671A2 (en) 2014-01-28 2015-08-06 Dsm Ip Assets B.V. Factors for the production and accumulation of polyunsaturated fatty acids (pufas) derived from pufa synthases
US9394550B2 (en) 2014-03-28 2016-07-19 Terravia Holdings, Inc. Lauric ester compositions
AU2014393411B2 (en) * 2014-05-08 2019-01-31 Donald M. Smith Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in Omega 3's for human health
BR112017000414A2 (en) 2014-07-10 2017-11-07 Terravia Holdings Inc ketoacyl acp synthase genes and their uses
US11213048B2 (en) 2014-07-25 2022-01-04 Smallfood, Inc. Protein rich food ingredient from biomass and methods of preparation
US11122817B2 (en) 2014-07-25 2021-09-21 Smallfood Inc. Protein rich food ingredient from biomass and methods of production
WO2016050552A1 (en) 2014-10-02 2016-04-07 Evonik Degussa Gmbh Process for producing a pufa-containing biomass which has high cell stability
WO2016050559A1 (en) 2014-10-02 2016-04-07 Evonik Degussa Gmbh Process for producing a pufa-containing feedstuff by extruding a pufa-containing biomass
US11464244B2 (en) 2014-10-02 2022-10-11 Evonik Operations Gmbh Feedstuff of high abrasion resistance and good stability in water, containing PUFAs
ES2900848T3 (en) 2014-10-02 2022-03-18 Evonik Operations Gmbh Procedure for the production of a feed
KR101521274B1 (en) 2014-10-08 2015-05-22 에스케이이노베이션 주식회사 Novel microalgae aurantiochytrium sp. la3 (kctc12685bp) and method for preparing bio-oil using thereof
CN106687605B (en) 2014-10-16 2022-02-01 玛拉可再生能源公司 Semi-continuous culture method
BR112017012888A2 (en) * 2014-12-16 2018-01-09 Heliae Dev Llc mixotrophic chlorella-based composition and process for its preparation and application in plants
US10357038B2 (en) 2014-12-16 2019-07-23 Heliae Development, Llc Mixotrophic chlorella-based composition, and methods of its preparation and application to plants
US9386774B2 (en) 2014-12-16 2016-07-12 Heliae Development, Llc Application of mixotrophic chlorella for the improved yield and quality of solanaceae plants
EP3098318A1 (en) 2015-01-24 2016-11-30 Indian Oil Corporation Limited Thraustochytrid based process for treating waste effluents
AR104042A1 (en) 2015-03-26 2017-06-21 Mara Renewables Corp HIGH-DENSITY PRODUCTION OF BIOMASS AND OIL USING GLUCEROL IN GROSS
EP3318640A4 (en) 2015-07-03 2019-03-06 Kuysyu University, National University Corporation Labyrinthulid microorganism capable of producing microbial oil, microbial oil, methods respectively for producing said microorganism and for producing said microbial oil, and uses of said microorganism and said microbial oil
MX2018000502A (en) 2015-07-13 2018-09-07 Mara Renewables Corp Enhancing microalgal metabolism of xylose.
BR112017017672A2 (en) 2015-10-01 2018-07-31 Dsm Ip Assets Bv supplementary material for use in pet food.
CN108697119A (en) * 2016-01-27 2018-10-23 合成基因组股份有限公司 Contain protein material and its production method from biomass
US11197474B2 (en) * 2016-01-29 2021-12-14 Heliae Development, Llc Dried chlorella based compositions and methods for plants
CN109477079A (en) 2016-05-12 2019-03-15 帝斯曼知识产权资产管理有限公司 Increase the method for omega-3 polyunsaturated fatty acids yield in microalgae
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
US11419350B2 (en) 2016-07-01 2022-08-23 Corbion Biotech, Inc. Feed ingredients comprising lysed microbial cells
AU2017297760B2 (en) 2016-07-13 2021-09-23 Dsm Ip Assets B.V. Method of separating lipids from a lysed lipids containing biomass
EP3485027A1 (en) 2016-07-13 2019-05-22 DSM IP Assets B.V. Method for extracting a microbial oil comprising polyunsaturated fatty acids from a fermentation broth containing oleaginous microorganisms
AU2017297752B2 (en) 2016-07-13 2021-09-23 Dsm Ip Assets B.V. Method for isolating lipids from lipid-containing cells
JP6998935B2 (en) 2016-07-13 2022-01-18 エボニック オペレーションズ ゲーエムベーハー How to Separate Lipids from Dissolved Lipid-Containing Biomass
WO2018122057A1 (en) 2016-12-27 2018-07-05 Evonik Degussa Gmbh Method of isolating lipids from a lipids containing biomass
EP3562925B1 (en) 2016-12-27 2021-03-10 Evonik Operations GmbH Method of isolating lipids from a lipids containing biomass
GB201701014D0 (en) 2017-01-20 2017-03-08 Megatech Res Gmbh Composition and method of production thereof
WO2019013832A1 (en) 2017-07-12 2019-01-17 Bunge Global Innovation Llc Process for extraction of oil from algal biomass
WO2019034354A1 (en) 2017-08-17 2019-02-21 Evonik Degussa Gmbh Enhanced production of lipids by limitation of at least two limiting nutrient sources
BR112020003326A2 (en) 2017-08-17 2020-11-17 Evonik Operations Gmbh marked lipid production by limiting at least two sources of limiting nutrients
WO2019048327A1 (en) 2017-09-05 2019-03-14 Evonik Degussa Gmbh Method of separating lipids from a lysed lipids containing biomass
EP3470502A1 (en) 2017-10-13 2019-04-17 Evonik Degussa GmbH Method of separating lipids from a lysed lipids containing biomass
US10701941B2 (en) 2017-11-10 2020-07-07 Heliae Development, Llc Biomass compositions
EP3527664A1 (en) 2018-02-15 2019-08-21 Evonik Degussa GmbH Method of isolating lipids from a lipids containing biomass
WO2019121752A1 (en) 2017-12-20 2019-06-27 Evonik Degussa Gmbh Method of isolating lipids from a lipids containing biomass
WO2019122030A1 (en) 2017-12-22 2019-06-27 Dsm Ip Assets B.V. Method of separating lipids from a lysed lipids containing biomass
CA3084705A1 (en) 2017-12-22 2019-06-27 Dsm Ip Assets B.V. Oil comprising at least one polyunsaturated fatty acid having at least 20 carbon atoms (lc-pufa)
WO2019185889A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Novel use of carnosic acid
WO2019185888A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Novel use of tocopherols
EP3774757A1 (en) 2018-03-29 2021-02-17 DSM IP Assets B.V. Chroman-6-ols with an extended lipophilic side chain in position 2, their manufacture and use
WO2019185939A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Use of twin-chromanols as antioxidants in oil
WO2019185891A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Novel use of substituted chroman-6-ols
WO2019185941A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Novel use of substituted chroman-6-ols with extended lipophilic side chains
WO2019185942A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Use of tocotrienols as antioxidants
BR112020019757A2 (en) 2018-03-29 2021-03-02 Dsm Ip Assets B.V. innovative use of croman-6-oils replaced with extended lipophilic side chains
EP3772975A1 (en) 2018-03-29 2021-02-17 DSM IP Assets B.V. Novel use of substituted chroman-6-ols
WO2019185940A1 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Use of twin-chromanols as antioxidants
WO2019185910A2 (en) 2018-03-29 2019-10-03 Dsm Ip Assets B.V. Novel use of substituted 2h-chromens and their derivatives
BR112020019783A2 (en) 2018-03-29 2021-01-05 Dsm Ip Assets B.V. INNOVATIVE USE OF 2H-REPLACED CHROMENES AND THEIR DERIVATIVES
JP7394748B2 (en) 2018-04-26 2023-12-08 株式会社ニッスイ Microbial oil and method for producing microbial oil
RU2760575C1 (en) 2018-05-15 2021-11-29 Эвоник Оперейшнс Гмбх Method for isolating lipids from lipid-containing biomass using hydrophobic silicon dioxide
WO2019219396A1 (en) 2018-05-15 2019-11-21 Evonik Operations Gmbh Method of isolating lipids from a lysed lipids containing biomass by emulsion inversion
CN109042488A (en) * 2018-06-12 2018-12-21 山东胜伟旅游发展有限公司 The method of the fluffy feeding dorking of saline-alkali land
FR3085962B1 (en) 2018-09-14 2021-06-18 Fermentalg PROCESS FOR EXTRACTING AN OIL RICH IN PUFA
FR3085825B1 (en) * 2018-09-14 2021-07-16 Fermentalg MICROORGANISM OIL RICH IN DOCOSAHEXAENOIC ACID
WO2020061445A1 (en) * 2018-09-21 2020-03-26 Heliae Development, Llc Compositions and methods for introduction of odd-chain fatty acids into poultry eggs
BR112021008842A2 (en) 2018-11-09 2021-08-17 Evonik Operations Gmbh method for producing a biomass with an increased content of polyunsaturated fatty acids
CN112955564A (en) 2018-11-09 2021-06-11 赢创运营有限公司 Method for producing biomass that can be easily broken and has an increased polyunsaturated fatty acid content
CN110106019A (en) * 2019-05-20 2019-08-09 无限极(中国)有限公司 The method that pot algae produces compound polyunsaturated fatty acid grease is split in a kind of utilization
CN110637765B (en) * 2019-09-18 2022-01-14 武汉双水双绿科技产业有限公司 Ridge utilization method of rice and shrimp co-farming system
WO2021122770A1 (en) * 2019-12-20 2021-06-24 Dsm Ip Assets B.V. Method of reducing the self-heating propensity of microbial lc-pufa comprising biomass
EP4081045A1 (en) * 2019-12-23 2022-11-02 DSM IP Assets B.V. Fish feed pellets loaded with a microbial oil
WO2021130078A1 (en) 2019-12-23 2021-07-01 Dsm Ip Assets B.V. Aquaculture feed
EP3933016A1 (en) 2020-06-30 2022-01-05 Evonik Operations GmbH Method of isolating lipids from a lipids containing biomass
WO2022129592A1 (en) 2020-12-17 2022-06-23 Dsm Ip Assets B.V. Aquaculture feed
KR20230066973A (en) 2021-11-08 2023-05-16 씨제이제일제당 (주) Novel strain of Schizochytrium sp. with easy intracellular oil extraction and a method for producing oil containing omega3 using the same
KR20230066972A (en) 2021-11-08 2023-05-16 씨제이제일제당 (주) Novel strain of Schizochytrium sp. with easy intracellular oil extraction and a method for producing oil containing omega3 using the same
WO2023094996A1 (en) 2021-11-24 2023-06-01 Dsm Ip Assets B.V. COMPOSITIONS HAVING HIGH LEVELS OF DPA (n-3) AND METHODS FOR PRODUCING
WO2023144707A1 (en) 2022-01-25 2023-08-03 Dsm Ip Assets B.V. Media refinement and nutrient feeding approaches to increase polyunsaturated fatty acid production
WO2023148154A1 (en) 2022-02-01 2023-08-10 Dsm Ip Assets B.V. Aquaculture feed
WO2023175141A1 (en) 2022-03-18 2023-09-21 Purac Biochem B.V. Method for reducing fermentation broth viscosity
CN115040895B (en) * 2022-06-10 2024-02-09 南京中科药业有限公司 Method for removing free fatty acid in ganoderma lucidum spore powder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509355A (en) * 1989-11-17 1996-10-08 オメガテック、インコーポレーテッド ω-3 Heterotropic method for producing microbial product containing high concentration of highly unsaturated fatty acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092076B1 (en) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Lipid composition for oral, enteral or parenteral feeding
US4792418A (en) * 1985-08-14 1988-12-20 Century Laboratories, Inc. Method of extraction and purification of polyunsaturated fatty acids from natural sources
US4918104A (en) * 1987-06-16 1990-04-17 Weiss Howard S Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom
WO1989000606A1 (en) * 1987-07-20 1989-01-26 Maricultura, Incorporated Microorganism production of omega-3 (n-3) lipids
US4874629A (en) * 1988-05-02 1989-10-17 Chang Stephen S Purification of fish oil

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509355A (en) * 1989-11-17 1996-10-08 オメガテック、インコーポレーテッド ω-3 Heterotropic method for producing microbial product containing high concentration of highly unsaturated fatty acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
COMP.BIOCHEM.PHYSIOL., vol. Vol.29,(1969)p.805-811, JPN4004005227, ISSN: 0001104698 *
COMP.BIOCHEM.PHYSIOL., vol. Vol.29,(1969)p.805-811, JPNX006034034, ISSN: 0000759462 *
COMP.BIOCHEM.PHYSIOL., vol. Vol.29,(1969)p.805-811, JPNX007040781, ISSN: 0000878854 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063886A1 (en) * 2005-11-30 2007-06-07 Nagase Chemtex Corporation Method for producing phospholipid containing polyvalent unsaturated fatty acid, and phospholipid containing polyvalent unsaturated fatty acid obtained by such method

Also Published As

Publication number Publication date
AU6719590A (en) 1991-06-13
DE69031223T2 (en) 1998-03-05
JPH08509355A (en) 1996-10-08
HK1001922A1 (en) 1998-07-17
DE69031223D1 (en) 1997-09-11
US5130242A (en) 1992-07-14
CA2072978A1 (en) 1991-05-18
JP2006129882A (en) 2006-05-25
JP3669372B2 (en) 2005-07-06
JP2010136730A (en) 2010-06-24
JP4187133B2 (en) 2008-11-26
JP2009089717A (en) 2009-04-30
CA2072978C (en) 2006-10-24
JP4418930B2 (en) 2010-02-24
GR3025200T3 (en) 1998-02-27
AU657259B2 (en) 1995-03-09
WO1991007498A1 (en) 1991-05-30
ES2106736T3 (en) 1997-11-16
JP4247442B2 (en) 2009-04-02
ATE156520T1 (en) 1997-08-15
EP0512997B1 (en) 1997-08-06
EP0512997A4 (en) 1993-07-28
JP2008109944A (en) 2008-05-15
DK0512997T3 (en) 1998-02-02
EP0512997A1 (en) 1992-11-19

Similar Documents

Publication Publication Date Title
JP4247442B2 (en) Heterotropic method for producing a microbial product containing a high concentration of omega-3 highly unsaturated fatty acid
US6977167B2 (en) Mixtures of omega-3 and omega-6 highly unsaturated fatty acids from euryhaline microorganisms
US5340594A (en) Food product having high concentrations of omega-3 highly unsaturated fatty acids
US20060188969A1 (en) Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
JP3127161B2 (en) A method for heterotrophic production of microbial products containing high concentrations of omega-3 polyunsaturated fatty acids
US6410281B1 (en) Reducing corrosion in a fermentor by providing sodium with a non-chloride sodium salt
US20030100097A1 (en) Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US7033584B2 (en) Feeding Thraustochytriales to poultry for increasing omega-3 highly unsaturated fatty acids in eggs
JP2001057881A (en) Growth of microorganism containing high-concentration omega-3-based highly unsaturated fatty acid

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20001027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040817

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20041105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041110

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20041110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20041115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041130

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050214

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20050215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050518

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050815

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20050929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051012

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060111

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060728

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20061027

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20061101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070727

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071214

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20071219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080806

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080904

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110919

Year of fee payment: 3

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110919

Year of fee payment: 3